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Electrodermal Activity: What it can Contribute to the Assessment of the Autonomic Nervous System 
Hugo F. Posada-Quintero, PhD 
University of Connecticut, 2016 
About 70 million people worldwide are affected by dysfunction of the autonomic nervous system (ANS). 
These dysfunctions can lead to life-threatening conditions, because ANS controls vital functions like heart 
rate, digestion, respiration, among others.  Spectral analysis of heart rate variability (HRV) allows 
noninvasive assessment of the ANS.  However, the low frequencies (0.04-0.15 Hz) of HRV are 
influenced by the two complementary branches of the ANS, the sympathetic and parasympathetic nervous 
systems; hence, the spectral analysis cannot separate the dynamics of these autonomic tones.  Developing 
reliable noninvasive techniques for assessment of the ANS dynamics remains a challenge for scientists.  
Recently, measure of electrodermal activity (EDA) has gained popularity for ANS assessment.  EDA 
signal represents the changes of conductance in the skin, produced by purely sympathetic innervation of 
sweat glands.  Time-domain measures of EDA, such as the skin conductance level (SCL) and skin 
conductance responses (SCR), are correlated to the sympathetic control, but they lack of consistency. 
Surprisingly, EDA has been analyzed only in time domain. In this work, using a frequency domain 
measure via the spectral analysis, we established for the first time that frequency bands of the sympathetic 
tone in EDA is mostly confined to the 0.045-0.25 Hz range. We termed this power the EDASymp.  
Furthermore, utilizing a high-resolution time-varying approach we found that the frequency band of 0.08-
0.24 Hz is most responsive to sympathetic tone, which we termed, the TVSymp.  The EDASymp and 
TVSymp are more sensitive and consistent discriminators of orthostatic, physical and cognitive stress 
than time-domain measures of EDA and can quantitatively assess the sympathetic function.  Moreover, 
we found that the sympathetic tone in EDA dynamically changes to higher frequencies when subjects 
exercise.  This result can be useful for adjusting the bounds of HRV when heart rate increases.  Currently, 
the same frequency bounds for the ANS for resting and exercise conditions have been used.  Another 
application of EDA is monitoring of sleep deprivation.  Using 24-hour sleep deprivation experiments, we 
found that high-frequencies (SCR) of EDA relate to vigilance whereas low-frequencies (SCL) relate to 
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reactiveness.  Based on these results, we found that EDA could potentially be used to assist in prevention 
of fatigue and stress which are the direct and dire consequences of prolonged wakefulness. As a final aim 
of my dissertation work, evaluations of novel dry carbon/salt/adhesive (CSA) electrodes for obtaining 
electrocardiogram, surface electromyogram and EDA were investigated.  We found non-statistical 
difference between the carbon/salt/adhesive electrodes for the above mentioned applications when the 
electrodes were compared to the gold standard silver/silver chloride electrodes.  Moreover, it was found 
that carbon electrodes exhibited better response to noise and motion artifacts when compared to hydrogel 
Ag/AgCl electrodes.  Hence, we concluded that CSA electrodes can be reliably used as a surrogate of the 
Ag/AgCl electrodes along with the advantage of being more cost effective alternative as they have longer 
shelf-life.  
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Chapter 1: Introduction 
2.1  Overview 
In the autonomic nervous system (ANS), the sympathetic system stimulates the “fight or flight” 
response, and the parasympathetic system stimulates the “rest and digest” response [1]. The deterioration 
of autonomic nervous control is a marker for the onset and/or progress of many diseases [2], [3].  Even in 
healthy subjects, assessing the level of sympathetic arousal or vagal (parasympathetic) control is important 
for understanding how the ANS maintains body’s balance, and detecting when such balance is challenged 
by internal or external stimuli. We envision simple and reliable technologies for assessment of the branches 
of the ANS in wearable devices.  
Spectral analysis of heart rate variability (HRV) is a noninvasive and quantitative way to assess the 
dynamics of the ANS [4].  The high-frequency (HF, 0.15 to 0.4 Hz) components of HRV are known to be 
solely influenced by the parasympathetic system.  In contrast, the low-frequency components (LF, 0.045-
0.15 Hz), termed HRVLF, are influenced by both the sympathetic and parasympathetic nervous systems.  
Hence, current HRV analysis techniques cannot separate the dynamics of the sympathetic and 
parasympathetic nervous systems.  Given the current need to fully elucidate and delineate sympathetic 
dynamics using noninvasive means, new instrumentational devices and signal processing of electrodermal 
activity (EDA) signals have gained popularity in recent years [5]–[7].  EDA is a measure of the changes in 
electrical conductance of the skin, also termed galvanic skin response (GSR) for some authors.  The 
attractiveness of EDA is because it is a reflection of the autonomic innervation of sweat glands, reflecting 
only activity within the sympathetic branch of the ANS because there is no parasympathetic innervation of 
eccrine sweat glands [8].  It is worth mentioning that EDA can be easily collected using wearable devices. 
The overall aim of this thesis work was to determine how EDA signals can be used for assessment 
of the ANS, specifically elucidating the sympathetic dynamics.  For exploring the link between EDA and 
sympathetic arousal, we considered the spectral analysis of the EDA, studied the variations on EDA signal 
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under exercise and sleep deprivation, and tested physical media to collect EDA data.  The specific aims of 
this thesis are to assess the dynamics of the sympathetic nervous system, the limitations of the currently 
available techniques, and the potential of EDA in its contribution to the assessment of the sympathetic 
nervous system. 
2.2   Problem Statement 
The need for sensitive measures of sympathetic tone has shown practical relevancy given the 
important prognostic and diagnostic value of the sympathetic nervous system’s impairment to certain 
cardiovascular diseases and pathophysiological conditions [9], [10].  In many cardiovascular diseases, 
sympathetic control impairment participates either in the development or in the progression of the 
pathological process [11], [12].  While there are many and varied approaches to directly measure the 
sympathetic response, due to high cost, the invasiveness of the technique, the inability to provide continuous 
monitoring, or the inaccurate assessment of the sympathetic dynamics, the widespread use of these 
techniques has not been materialized.  In cardiovascular autonomic neuropathy, for instance, sympathetic 
denervation is a marker of the progress of the disease from early to severe stages [2], [3], and the gold 
standard procedure for sympathetic assessment, the cardiovascular autonomic reflex tests [13], exhibits low 
sensitivity (50%) for this task [14]. A widely used way to assess the dynamics of the ANS is to compute 
the power spectral density (PSD) of HRV [4].  Even though HRVLF (low-frequency components of HRV) 
and HRVLFn (normalized) have shown to be sensitive to postural changes, they are less sensitive to other 
tests of sympathetic tone [15].  Despite the aforementioned limitation of being also influenced by 
parasympathetic activity, HRVLF and HRVLFn have been used to assess sympathetic tone [4].  The need 
for more reliable tools to assess the ANS is evident. 
EDA is increasingly used as a surrogate measure of the sympathetic nervous system [6].  Analysis 
of EDA has been traditionally deployed in time-domain, based on skin conductance level (SCL) and 
nonspecific skin conductance responses (NS.SCRs) [5].  Because of the high variations of such indices, 
their use has not yet been popularized.  Surprisingly, frequency-domain analysis of EDA, similar to what 
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is done on HRV, has not been applied as a sympathetic measure.  Preliminary exploration showed that a 
time-frequency analysis of EDA signals can provide a more sensitive and reliable index of sympathetic 
tone [16].  Frequency-domain and time-frequency spectral analysis are promising techniques to provide 
more sensitive indices of sympathetic tone.  Furthermore, EDA can be a source of information to elucidate 
the proper adjustment in the low frequency bands of HRV under exercising conditions.  When heart rate 
increases, many studies have found that LF and/or HF bounds vary [17]–[26].  If spectral content of the 
EDA signal also shifts when heart rate increases (like during exercise), one could utilize that information 
to correct the HRV’s frequency bandwidths.  We hypothesize that HRV and EDA can be used together to 
develop more reliable indices of the sympathetic and parasympathetic tones.   
Information on the effect of sleep deprivation on EDA is scarce. However, the effect of sleep 
deprivation on humans’ performance has been widely studied.  Prolonged wakefulness has shown to have 
general detrimental effects on cognitive performance; however, such effect is different depending on the 
cognitive level of the task.  For instance, the effect of sleep deprivation on subjects performing a complex 
repeated task is much higher than when subjects are asked to perform simple tasks that require little to no 
vigilant attention (waiting for a stimulus to occur) [27]. For better understanding of the effect of sleep 
deprivation on humans’ physiology, and to evaluate the possibility of predicting the resulting detriment on 
performance, it is important to evaluate how sleep deprivation affects EDA on subjects performing a 
cognitive task.  We intend to contribute with novel diagnostic markers based on analysis of EDA to prevent 
detrimental (many times fatal) consequences of sleep deprivation.   
Besides the contribution to advance the use of EDA for extraction of the dynamics of the 
sympathetic nervous system, this work also aimed to explore novel sensing media for acquiring biomedical 
signals, including EDA. The current gold standard bioelectrical media to obtain EDA and many other 
signals is the use of Ag/AgCl electrode, mainly because of its property of avoiding polarization. The 
Ag/AgCl electrodes require application of a paste-like hydrogel over a silver disc.  While the hydrogel layer 
significantly improves the signal quality by effectively lowering the impedance that exists at the electrode-
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skin interface, when the hydrogel layer dehydrates impedance increases.  This leads to a loss of signal 
quality and an increased incidence of motion artifacts and noise [28].  Ag/AgCl electrodes are also 
expensive since silver is an expensive commodity.  For measuring EDA signals, Ag/AgCl electrodes need 
to be taped to the subject’s fingers, because they do not have any self-attaching media unlike commercial 
Ag/AgCl for ECG and surface electromyography (sEMG) that have an adhesive surrounding the hydrogel.  
We expected CSA electrodes to exhibit low impedance, low cost, long shelf life and the unnecessity of 
hydrogel layer.   
2.3  Summary of Objectives 
The hypotheses tested in this thesis are that 1) indices obtained by means of frequency-domain and 
time-frequency spectral analysis of EDA are sensitive to the sympathetic innervation, 2) EDA can 
contribute to better understanding of the sympathetic arousal under stressful conditions like exercise or 
sleep deprivation, and 3) CSA electrodes are a suitable surrogate of Ag/AgCl electrodes for measuring 
ECG, sEMG and EDA signals. The specific aims of this research are: 
Aim 1. Deploy time-frequency domain analysis for better understanding of the interplay between 
electrodermal activity variability and sympathetic control. 
Aim 2. Evaluate heart rate variability and electrodermal activity spectral components under 
exercises, to get a clearer insight of the sympathetic and parasympathetic tone responses. 
Aim 3. Study the effects of sleep deprivation on performance and electrodermal activity signals, to 
better understand the interplay between these measures and sympathetic arousal. 
Aim 4. Test Carbon/Salt/Adhesive electrodes for ECG, sEMG and EDA measurements, in order to 
examine if these newly developed sensors can potentially be used as an alternative to 
Ag/AgCl electrodes. 
To accomplish Aim 1, electrodermal activity (EDA) was explored in time (traditional) and 
frequency domain separately, to have an initial idea of the nature and characteristics of EDA, for subjects 
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under several different types of stress.  Specifically, we explored the low-frequency range of the power 
spectrum density (PSD) of EDA, in order to determine whether its dynamics are similar to heart rate 
variability (HRV), in which the sympathetic tone is reflected in the power of the low-frequency 
components.  Exploring the PSD of EDA gave us a better insight of the interplay between sympathetic 
control and EDA.  Time-frequency spectrum (TFS) analysis was employed to further analyze the EDA and 
to take advantage of the possibility of tracking the changes of power distribution of EDA components over 
time. Tests involving orthostatic, cognitive and physical stress were deployed to subjects to test our 
technique. 
For Aim 2 we proposed to use frequency and time-frequency domain analysis of EDA, to test the 
autonomic nervous system under strenuous physical activity, specifically the shifting of the frequency 
bands of the sympathetic and parasympathetic tones.  We collected ECG and EDA signals on subjects 
performing a non-maximal exercise test on a treadmill, to induce a controlled increase on the mean heart 
rate.  By doing this, we were able to see the changes on HRV and EDA frequency components.  EDA has 
never been explored in such conditions, so the observation itself is novel to the field. 
In Aim 3 analyzed the effect of sleep deprivation on subjects performing a cognitive-manual task.  
Measures of performance were used to assess fatigue and evaluated its correlation with features of EDA.  
Moreover, the evolution of EDA over time during sleep deprivation was analyzed to procure more 
comprehension of EDA singularities.  Time, frequency and time-frequency domain analysis of EDA signals 
were deployed to better elucidate the influence of prolonged wakefulness on EDA.   
Finally, to achieve Aim 4, novel Carbon/Salt/Adhesive (CSA) electrodes were designed and tested 
for the task of recording biomedical signals, including EDA. The CSA electrodes are intended to overcome 
the two salient drawbacks of the gold standard Ag/AgCl electrodes for bioelectrical signals collection: short 
shelf life and the cost.  First, the concept of CSA electrodes was explored and its functionality were 
compared to Ag/AgCl electrodes.  Diverse applications of CSA electrodes for collecting biomedical signals 
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evaluated in terms of quality of the acquired signals.  The aim will be finally fulfilled by testing the 
suitability of CSA electrodes for collecting ECG, sEMG and EDA signals. 
2.4  Dissertation Organization 
This dissertation is structured in the chapters described below, including the relevant background, 
methodology and experimental results in accordance to the specific aims.  Figure 1.1 shows a diagram of 
the general methodology and structure of the work.  Three main sections conform this thesis dissertation.  
The first section, which comprises two chapters, is about developing simpler and reliable indices of 
sympathetic control based on signal processing of EDA, expected to be deployable in wearable devices in 
the future.  The second section, including two chapters, is about using the measures developed in section 1, 
to explore applications where the sympathetic function assessment can be used.  The third section contains 
three chapters and is a hardware complement to our signal processing work, and is intended to test novel 
dry electrodes to overcome the limitations of Ag/AgCl electrodes for collecting EDA and other biomedical 
signals.  Chapters 3-9 follow the basic structure of a Journal paper, as they are either already published or 
in review.  
Chapter 2: Background 
Presents general information about the physiology of the autonomic nervous system, focusing on the 
sympathetic branch, and summarizes previous efforts on assessing it. It ends with the definition and 
meaning of electrodermal activity as well as previously reported measures based on this signal.  
Chapter 3: Power Spectral Density Analysis of Electrodermal Activity for Sympathetic Function 
Assessment 
Includes the methodology and experimental results specific to the first part of Aim 1, including the analysis 
of EDA in frequency domain, and concludes with determination of the frequency bands associated with the 
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sympathetic control.  (Posada-Quintero, H. F., Florian, J. P., Orjuela-Cañón, A. D., Aljama-Corrales, T., 
Charleston-Villalobos, S., & Chon, K. H. (2016). Power Spectral Density Analysis of Electrodermal 
Activity for Sympathetic Function Assessment. Annals of Biomedical Engineering, 1–12) 
Chapter 4: Highly Sensitive Index of Sympathetic Activity Based on Time-Frequency Domain Analysis 
of Electrodermal Activity 
Describes the methodology and experimental results regarding the achievement of the remaining portion of 
Aim 1, expanding the analysis of EDA to the time-frequency domain.  The technique used to compute the 
time-frequency spectra of EDA signals is explained in detail.  (Posada-Quintero, H. F., Florian, J. P., 
Orjuela-Canon, A. D., & Chon, K. H. (2016). Highly Sensitive Index of Sympathetic Activity based on 
Time-Frequency Spectral Analysis of Electrodermal Activity. American Journal of Physiology - 
Regulatory, Integrative and Comparative Physiology). 
 
 
Figure 1.1 – Diagram of the methodology of this research. 
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Chapter 5: Electrodermal Activity Suggests a Change in Frequencies of Sympathetic Control During 
Exercise 
Defines the methodology and experimental results regarding Aim 2, which is focused on understanding 
how the sympathetic control evolves in the frequency domain when subjects undergo physical activity  
(Posada-Quintero, H. F., Reljin, N., Mills, C., Mills, I., Florian, J. P., VanHeest, J. & Chon, K. H. Chapter 
5: Electrodermal Activity Suggests a Change in Frequencies of Sympathetic Control During Exercise.  
American Journal of Physiology - Exercise.  Submitted). 
Chapter 6: Electrodermal Activity Can Track the Effects of Sleep Deprivation on Reactiveness and 
Vigilance 
Reports the methodology and experimental results of studying EDA signals as subjects are sleep deprived 
for 24 hours.  This chapter fulfills the purposes of Aim 3.  (Posada-Quintero, H. F., Bolkhovsky, J. B., 
Reljin, N. & Chon, K. H.. Electrodermal Activity Can Track the Effects of Sleep Deprivation on 
Reactiveness and Vigilance.  To be published). 
Chapter 7: Low Impedance Carbon Adhesive Electrodes with Long Shelf Life 
Aim 4 involves the testing of carbon/salt/adhesive (CSA) electrodes for collecting EDA signals.  To fulfill 
this, three studies have been deployed: first, assessment of CSA electrodes to collect ECG; second, 
evaluation of CSA electrodes to collect surface electromyography (sEMG) signals; finally, testing of CSA 
electrodes to collect EDA.  The first part of this aim is covered in this chapter.  (Posada-Quintero, H. F., 
Reyes, B. A., Burnham, K., Pennace, J., & Chon, K. H. (2015). Low Impedance Carbon Adhesive 
Electrodes with Long Shelf Life. Annals of Biomedical Engineering, 43(10), 2374–2382) 
 
 
 9 
 
Chapter 8: Assessment of Carbon/Salt/Adhesive Electrodes for Surface Electromyography 
Measurements 
Describes the methods and results to fulfill the second part of Aim 4, evaluating CSA electrodes to collect 
sEMG signals.  A succinct yet effective methodology is described to assess sEMG CSA electrodes (Posada-
Quintero, H., Rood, R., Burnham, K., Pennace, J., & Chon, K. (2016). Assessment of Carbon/Salt/Adhesive 
Electrodes for Surface Electromyography Measurements. IEEE Journal of Translational Engineering in 
Health and Medicine, PP(99), 1–1).   
Chapter 9: Dry Carbon/Salt Adhesive Electrodes for Recording Electrodermal Activity 
The methods and results of the final part of Aim 4, evaluating CSA electrodes to sense EDA signals using 
different types of technologies and tests that are available to EDA (Posada-Quintero, H. F., Rood, R., Noh, 
Y., Burnham, K., Pennace, J. and Chon, K. H.. Dry Carbon/Salt Adhesive electrodes for recording 
Electrodermal Activity.  Sensors & Actuators: A. Physical. In process of revision for publication).   
Chapter 10: Conclusions and Future work 
Summarizes the main findings of this dissertation as well as the limitations and areas of future development 
and application of the methods proposed in this research. 
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Chapter 2: Background 
2.1  The autonomic nervous system  
The autonomic nervous system (ANS) provides a rapidly responding neural control to regulate a 
wide range of unconscious body actions.  The sympathetic and the parasympathetic systems are the two 
main divisions of the ANS [1].  The primary function of the sympathetic branch is to stimulate the body’s 
fight or flight response, and the parasympathetic activity has an antagonist or complementary function.  
Renal, endocrine, respiratory, cardiovascular and other systems are controlled by the sympathetic or the 
parasympathetic branch, or both [2].     
2.1.1 The sympathetic function 
In terms of physiological importance, sympathetic influences on the heart and peripheral circulation 
have been shown to control heart rate and blood pressure both at rest and during physiological stimuli, such 
as orthostatic stress [6].  In response to stressors of any kind, the stress system is activated to coordinate the 
adaptive responses of the organism [7]. This leads to peripheral and behavioral changes that improve the 
ability of the organism to adjust homeostasis and have better chances for survival. The sympathetic 
innervation of peripheral organs is derived from the efferent preganglionic fibers, which synapse in the 
bilateral chains of sympathetic ganglia with postganglionic sympathetic neurons that innervate eccrine 
sweat glands, among many other organs.  Sympathetic preganglionic neurons are cholinergic, whereas the 
postganglionic neurons are mostly noradrenergic [8].  
2.2  Sympathetic function assessment 
Assessment of sympathetic function is one of the major research fields in cardiovascular research, 
because alterations in sympathetic tone have been conclusively demonstrated to have important 
pathophysiological, physiological and clinical relevance [9].  The sympathetic nervous system has 
pathophysiological relevance in several diseases directly or indirectly affecting the cardiovascular system. 
This is especially important for the neuropathies [10] because sympathetic function is affected in early 
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stages [11], and in general for cardiovascular diseases in which the sympathetic activation occurring has 
been shown to participate either in the development or in the progression of the pathological process [12], 
[13].   
Techniques to assess the sympathetic activity include hemodynamic measurements [14], [15], 
adrenergic and ganglionic pharmacological blockade [16]–[19], noradrenaline measurement in urine or 
plasma [12], [20], [21], neurophysiological approach [22], [23], plasma noradrenaline kinetics [24], [25], 
heart rate variability (HRV) analysis [26]–[28] or imaging techniques [29].  Haemodynamic measurements 
and pharmacological blockade are invasive and present limited reproducibility.  Noradrenaline 
measurement provides only a ‘static’ picture of sympathetic function.  Neurophysiological approach is the 
only method for directly recording efferent postganglionic muscle sympathetic nerve activity, and allows a 
continuous measurement; however, it is an invasive technique.  Imaging techniques, including positron 
emission tomography and single photon emission computed tomography scanning, have been applied to 
visualize the sympathetic enervation of human organs with a good success in studying, for example, the 
various syndromes causing postural hypotension. Nevertheless, neuroimaging techniques require an 
elevated level of financial and technical support.   
2.2.1 Heart Rate Variability 
Given the widespread of the technique, HRV will be a common reference to compare the results of 
this work to.  HRV is a noninvasive indicator that reflects the homeostatic interplay between perturbations 
in cardiovascular functions and the dynamic responses of the cardiovascular regulatory systems [28]. HRV 
is extracted from the R-R peak series of the electrocardiogram (ECG), and spectral analysis of the R–R 
series has been widely used in HRV studies to discriminate between subjects with different cardiac 
conditions as well as to predict mortality in some groups of patients [30], [31]. HRV analysis has been 
widely deployed because it can overcome the high cost, invasiveness and inability to provide continuous 
monitoring with other techniques.   
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The power spectra of HRV is usually calculated using Welch’s periodogram method. From spectral 
analysis, two frequency bands are considered: low frequency (LF) band (0.045 to 0.15 Hz) and high 
frequency (HF) band (0.15 to 0.4 Hz) (see Figure 2.1) [28]. Very low frequency (VLF) band is not taken 
into account because their physiological correlates are still unknown [28].  The spectral frequency band is 
computed as the sum of the products of power spectral densities of the band harmonics by the sharpness of 
the spectrum (Nyquist cointerval). The LF and HF oscillatory components are reported in absolute (square 
milliseconds, ms2) and normalized (to the total power of HRV) units. These spectral parameters are known 
to reflect autonomic activity. Indeed, the parasympathetic nervous system activity is the major contributor 
to the HF component [32], [33]. The interpretation of the LF component is very difficult, but previous 
research has demonstrated that it reflects both sympathetic and parasympathetic influences [32], [34]. Many 
studies have highlighted the need for an adjustment in the frequency bands of HRV during exercise [31], 
[35]–[43].  Even though there is evidence of the frequency shifts during exercises, there is not enough 
evidence to elucidate the proper frequency bounds of HF and LF bands.  It remains unclear what is the 
evolution of the frequencies of the sympathetic and parasympathetic tones on the HRV, when subjects 
exercise. 
Although traditional spectral analysis of HRV is not reliable for separate assessment of sympathetic 
and parasympathetic functions, we used this technique as a comparison reference for assessing the ANS in 
this dissertation.  We did not directly compare the indices by merely computing the correlation of the 
sympathetic indices we developed in this work to HRVLF (normally used to assess sympathetic control); 
instead, we always showed how indices of HRV were not reliable indices for the assessment of autonomic 
control, for the tests we deployed to elicit sympathetic response on subjects. 
2.2.2 Electrodermal Activity  
Sudomotor activity is linked to the sympathetic function, and has the potential to be used to evaluate 
the autonomic functions and assess stress levels [44]–[46]. However, measuring the amount of sweat 
produced is impractical. Nevertheless, sweat glands activity modulates conductance of an applied current 
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[47]–[50].  Changes in electrical conductance of the skin are termed electrodermal activity (EDA).  
Sweating influences the electrical conductance of the skin, because although sweat contains minerals, lactic 
acid and urea, it is mostly water.  EDA has shown strong correlation to sweat production, and is thought to 
provide a quantitative functional measure of sudomotor activity [51], [52].  In other words, we can get  
signals from control centers in the brain by taking advantage of the fact that their arrival at the skin is 
indicated by EDA [50]. 
2.2.2.1 Relevant physiology 
Although primary function of most sweat glands is thermoregulation, those located on the palmar 
and plantar surfaces are thought to be more concerned with grasping performance than with temperature 
control.  Thus, they are more responsive to psychologically significant stimuli than to thermal stimuli [50].  
This is most evident in these areas because of the high gland density concentration, but all eccrine sweat 
glands are believed to be involved in emotion-evoked sweating [53].  The most widely accepted model for 
EDA is the single effector model of the sweat glands, with the level and phasic changes in EDA as outputs. 
We can think of the sweat ducts as a set of variable resistors wired in parallel. Sweat comes through the 
ducts in in varying numbers of sweat glands in variable amounts, depending on the degree of sympathetic 
 
 
Figure 2.1 – Spectral analysis of HRV.   
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activation. The higher the sweat rises, the lower the resistance in that variable resistor.  Changes in the level 
of sweat in the ducts produce observable variations in EDA [54]. 
Neurotransmitter involved in the mediation of eccrine sweat glands activity is acetylcholine,  which 
is generally a parasympathetic neurotransmitter, rather than noradrenaline, typically associated with 
peripheral sympathetic activation [55]. For that reason both the sympathetic and parasympathetic branches 
of the ANS were thought to control EDA.  It is currently accepted that human sweat glands have 
predominantly cholinergic innervation from sudomotor fibers originating in the sympathetic chain [53].  
Evidence for the sympathetic control of EDA has been provided by studies which simultaneously recorded 
sympathetic action potentials in peripheral nerves and EDA. A high correlation between bursts of 
sympathetic nerve activity and SCRs was shown [56]. 
At least three pathways lead to production of SCRs: hypothalamic control, contralateral and basal 
ganglion influences (involves one pathway of excitatory control by the premotor cortex and another 
pathway of exhibitory and excitatory influences in the frontal corterx) and the reticular formation in the 
brainstem [57], [58].  These pathways imply different functional roles associated with the central 
mechanisms: activation of the reticular formation is associated with gross movements and increased muscle 
tone; hypothalamic activity controls the thermoregulatory sweating; amygdala activation is reflecting 
affective processes; premotor cortex occur in situations requiring fine motor control; and prefrontal cortical 
activity is associated with orienting and attention [54], [59], [60].  All these processes, at certain level, 
influence the EDA signal. 
Electrodermal activity (EDA) has a long history on psychophysiological research, since Vigouroux 
studies in France, 1879. Historically, most of the studies evaluated EDA as a response to mental (e.g. 
emotional, cognitive) stress.  However, skin resistance varies with the state of sweat glands in the skin, 
controlled by the sympathetic nervous activity, making skin conductance an indication of not only 
psychological but also general sympathetic arousal.  Despite the wide acceptation of this concept, using 
EDA for pathophysiological assessment is rather novel.   
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2.2.2.2   Recording devices 
Although it is possible to collect EDA signals without an external source (endosomatic recording), 
most EDA devices involve the application of an external constant current or voltage source (exosomatic 
recordings) via electrodes on the skin [49].  Endosomatic devices are simpler as they require only a high 
input impedance amplifier (>10 MΩ), However, they are not.  Requirement on amplifier’s gain and the 
need for a floating reference to measure the potential difference between the two electrodes, make this 
approach difficult. 
Exosomatic devices measure the modulated current or voltage, depending on whether the constant 
source is voltage or current, to compute the skin conductance. The constant source can be either direct 
current (DC) or alternating current (AC).  Electrodermal measurements with DC source is accomplished by 
means of operational amplifiers [61].  Although constant current and constant voltage can be used, the latter 
is widely preferred [62].  Given that the floating reference is common to output and input, the voltage 
difference is independent of a reference electrode position, preventing endosomatic contamination of 
exosomatic measurements. 
Measuring EDA using AD devices requires more elaborate instrumentation than the DC approach, 
because of the capacitive properties of the stratum corneum.  Given that conductance and capacitance are 
physically in parallel, constant amplitude excitation is preferred (measuring changes in current).  A phase-
sensitive rectifier can be used to separate components of conductive and capacitive contributions.  The main 
advantage of AC source devices is avoiding electrode polarization [49].  In spite of this advantage of AC-
source devices over DC-source devices, both types are still widely used [49].  
2.2.2.3 Electrodes for collecting EDA  
Special electrodes, electrode gels, and recording devices may be required for recording EDA.  
Those can be different from the ones utilized for other psychophysiological measures, given the nature of 
EDA and the location where the signal is acquired.  Electrodes are an important factor for the quality of the 
measures because they are the biomedical sensors.  Electrodes for EDA recording are normally of metal, 
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but can be potentially made with carbon [49]. Using the same metal for the two electrodes is important, 
mainly in DC-source devices, because the difference in metals will introduce a potential difference.  
In exosomatic DC-source devices the electrodes carry a DC current and become anode and cathode 
in an electric system.  The electrodes are polarized by electrolysis. The use of silver-silver chloride  
(Ag/AgCl) electrodes is standard in order to minimize both polarization of the electrode and the bias 
potential between the electrodes.  Reusable EDA electrodes, often commercially available are much more 
expensive than disposable AgCl electrodes with very thin layers of silver chloride.  With low DC current 
in prolonged use, the charge may be high enough to remove part of the AgCl layer at the cathode and 
increase the layer at the anode. After some time, large bias voltage levels may result [62].   
For its part, stainless steel electrodes have the advantages of not corroding and also being 
mechanically strong.  However, they are more prone to polarizing effects than Ag/AgCl electrodes.  Carbon 
is a promising alternative to metal for both the wires and the electrodes. Besides reducing polarization 
effects , using carbon can make the electrodes radiotranslucent, and compatible with MRI [49]. 
2.2.2.4 Measures of EDA  
The most salient characteristic of EDA signal is the occurrence of skin conductance responses 
(SCR), as a result of instantaneous or tonic stimuli.  The SCRs are those noticeable rapid transient events.  
SCRs have the smooth waveform as shown in Figure 2.2.  Elicited SCRs are used to evaluate subjects’ 
response on event-related experiments (“startle-like” stimuli) or tonic stimuli tests (like a change in 
condition, workload, cognitive stress, etc.).  In event-related experiments, the occurrence of a SCR is 
 
 
Figure 2.2 – Electrodermal activity signal and skin conductance response. 
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expected after the stimulus is applied.  In such experiments the SCRs are usually called event related SCRs 
(ER.SCRs). ER.SCRs’ stimulus-onset latency, amplitude (peak-to-onset value difference), rise time (also 
called onset-to-peak time), among others, are measures used to assess the level of stress induced by the 
stimulus (Figure 2.3).   
In tonic stimulus tests, skin conductance level (SCL) and nonspecific skin conductance responses 
(NS.SCRs) [49], are the used measures (Figure 2.4). SCL (usually expressed in microsiemens, µS) is a 
measure related to the slow shifts of EDA, and specifically refers to the level of skin conductance.  SCL is 
typically computed as a mean of several measurements taken during a specific non-stimulation rest period, 
e.g. the mean of the “tonic EDA” component shown in Figure 2.4. The non-specific SCRs (NS.SCRs) are 
the number of SCRs in a period of time, and are considered a tonic measure because they occur post-stimuli, 
over a period of time, e.g. the SCRs that overpass the defined threshold in Figure 2.4. A key concern for 
the SCL and NS.SCRs is that these indices are highly variable between subjects [63].  This is due to the 
frequent occurrence of a second response before the completion of a given SCR, which can be detected by 
visual inspection, but its detection is not easy to automate [49]. In addition, periodic shifts in the background 
SCL (like a DC shift) could be important if they appear to occur in conjunction with specific components 
 
  
Figure 2.3 – Time-domain measures of EDA based on the specific SCR caused by an instantaneous 
stimulus 
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of the experiment, and only a visual analysis would reveal the difference between a SCR and unimportant  
drift factors (artifacts) [64]. Furthermore, obtaining NS.SCRs requires an observer to count SCRs, which 
could be problematic if there are motion artifacts during EDA measurements.  
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Chapter 3: Power Spectral Density Analysis of Electrodermal Activity for 
Sympathetic Function Assessment 
(Posada-Quintero, H. F., Florian, J. P., Orjuela-Cañón, A. D., Aljama-Corrales, T., Charleston-Villalobos, 
S., & Chon, K. H. (2016). Power Spectral Density Analysis of Electrodermal Activity for Sympathetic 
Function Assessment. Annals of Biomedical Engineering, 44(10)) 
 
3.1  Introduction  
In this study we are more interested in the post-transient SCRs (the NS.SCRs) due to posture, cold 
pressor or Stroop test, which occur after the ER-SCR (Event-related SCR).  A key concern for the SCL and 
NS.SCRs is that these indices are highly variable between subjects [15].  This is due to the frequent 
occurrence of a second response before the completion of a given SCR, which can be detected by visual 
inspection, but its detection is not easy to automate [10]. In addition, periodic shifts in the background SCL 
(like a DC shift) could be important if they appear to occur in conjunction with specific components of the 
experiment, and only a visual analysis would reveal the difference between a SCR and unimportant drift 
factors (artifacts) [16]. Furthermore, obtaining NS.SCRs requires an observer to count SCRs but this could 
be problematic if there are motion artifacts during EDA measurements. These circumstances necessitate a 
trained observer to compute NS.SCRs, thereby limiting the full potential of the usefulness of EDA.  
Moreover, it has not yet been established whether or not dynamics of the sympathetic tone measured from 
EDA can be used as a surrogate for HRV’s derived LF response.  This would require EDA analysis similar 
to HRV analysis using the PSD.  The response to stress of the spectral components of EDA signals has 
rarely been examined.  To the best of our knowledge, only one study has explored the matter.  This study 
found elevation of power within the 0.03 to 0.5 Hz band in response to increased mental workload [17].   
Thus, the aim of this work is to examine if a similar association of LF components of HRV to 
sympathetic function also exists with the sudomotor function as measured by EDA.  Specifically, we are 
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interested in examining if EDA analysis yields similar frequency dynamics at the HRV’s prescribed LF 
range of 0.045-0.15 Hz.  If such relation occurs, we can overcome the main disadvantage of LF domain 
analysis of HRV because EDA is not influenced by the parasympathetic branch of the autonomic nervous 
system, and we could provide a better quantitative evaluation of sympathetic tone.  To test our aim, we 
determined the EDA differences between baseline conditions and three maneuvers to elicit sympathetic 
activation: postural stimulation, cold pressor test, and Stroop test.  These tests were selected because they 
are among the stimuli that most efficiently release sympathetic neurotransmitters [18], and they cover three 
relevant types of stressors (i.e. orthostatic, physical and cognitive).     
3.1 Materials and Methods 
3.1.1 Protocol 
Twelve healthy volunteers (10 males, 2 female) of ages ranging from 19 to 36 years old (26.2 ± 
6.14; mean ± SD), weight 64.63 ± 7.01 kg, and height 171.45 ± 9.64 cm, were enrolled in this study.  No 
gender-related differences have been reported for EDA or sympathetic function.  To induce a wide variety 
of sympathetic arousal types, subjects underwent three tests: postural stimulation (orthostatic stress), cold 
pressor (physical stress) and Stroop task (cognitive stress).   
Before any test, subjects were asked to stay in the supine position for at least 5 minutes to ensure 
hemodynamic stabilization, before the start of data recording.  Postural stimulation tests consisted of 5 
minutes in the supine position (baseline) followed by 5 minutes standing.  Similarly, the cold-pressor test 
included 5 minutes of baseline with the subjects supine; then the subjects were asked to immerse their left 
hand to the wrist level into a 0-1 °C water bath for a period of 3 minutes.  For Stroop tests, 5 minutes of 
baseline were also recorded with subjects relaxing in the supine position.  Then, subjects were asked to 
speak a word which named a color.  They were shown a congruent visualization (the word was written in 
the color it expressed) and an incongruent visualization (the word and the color it was printed in were 
different) to induce cognitive stress [19]. The words and colors were “blue,” “yellow,” “green,” “red,” 
“purple,” and “black.”  The background also changed to be randomly congruently or incongruently colored 
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with the word.  A computerized version of the original Stroop task was developed in our lab using 
customized software.  The Stroop task was 5 minutes total, and the first minute was used for training. 
Participants were asked to avoid caffeine and alcohol for 24 hours preceding the test, and instructed 
to fast for at least 3 hours before testing.  The experiments were carried out in a quiet, dimly lit room 
(ambient temperature 26-27 °C), in order to avoid other stimuli.  The study protocol was approved by the 
Institutional Review Board of The University of Connecticut and all volunteers consented to be subjects 
for the experiment.  ECG and EDA signals were simultaneously recorded throughout all tests.  An HP 
78354A (Hewlett-Packard, FDA approved) and a GSR amplifier FE116 (fully isolated AC excitation and 
automatic zeroing low voltage amplifier, 22 mVrms @75 Hz, ADINSTRUMENTS) were used to collect 
ECG and EDA, respectively.  No on-line filtering was applied during the signal recording.  ECG electrodes 
were placed following the recommendation to acquire Lead I, and EDA electrodes were placed on the index 
and middle fingers for all subjects.  Skin was prepared with alcohol before placing the electrodes.  Signals 
were digitized using a PowerLab system at 400 Hz, 12 bits resolution.   
3.1.2 Signal processing 
Figure 3.1 shows heart rate and EDA signals for two minutes of baseline and the corresponding 
three tests (postural, cold pressor and Stroop) for a given subject.  Negative values in EDA signals refer to 
a reduction of the skin conductance with respect to the level at the beginning of the test, when the calibration 
was performed (zeroing of the signal).  Note that HR and EDA differences between the baseline and each 
of the test cases are pronounced.  Figure 3.2 delineates the signal processing procedures used to compute 
the set of HRV and EDA indices used in this study.  The HRVLF power (and normalized power, HRVLFn), 
SCL, NS.SCRs, and the PSD of high-pass filtered data of EDA were computed in order to quantify the 
elicited changes of the sympathetic nervous system due to postural stimulation and the cold pressor and 
Stroop tests.   
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3.1.2.1 Heart rate variability indices 
For HRV analysis, ECG signals were band-pass filtered (0.05-40 Hz) to reduce noise and motion 
artifacts.  The R-waveform peaks were detected using the detection algorithm that defines a delineation 
function based on the envelope of the ECG signal [20], [21].  All the segments were visually inspected to 
 
  
Figure 3.1 – ECG and EDA signals for a given subject, undergoing postural stimulation (top), cold pressor 
test (middle) and Stroop test (bottom).   
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ensure that no beat was missed.  After accounting for the missed R-wave beats, the HR time series were 
computed.  The power spectra of HRV were then calculated using Welch’s periodogram method with 50% 
data overlap.  The RR interval series were converted to an evenly time-sampled signal (4 Hz) by cubic 
spline interpolation.  A Blackman window (length of 256 points) was applied to each segment and the Fast 
Fourier Transform was calculated for each windowed segment.  Finally, the power spectra of the segments 
were averaged.  The low-frequency index (HRVLF [ms2], 0.045 to 0.15 Hz) [9] and normalized LF 
(HRVLFn = (HRVLF)/Total power, normalized units [n.u.]) were computed.  Four minutes of clean ECG 
signals were used to compute HRV for postural stimulation and the Stroop test, and three minutes for the 
cold pressor test as most subjects could not withstand the cold temperature for four minutes.  For each test, 
the same data length was used consistently for baseline and test segments.   
3.1.2.2 Time-domain indices of Electrodermal Activity 
Two minutes of baseline EDA and two minutes of test EDA were selected for each test.  Figure 
3.3 illustrates the process of computing SCL and NS.SCRs.  Baseline signals were always the two minutes 
 
  
Figure 3.2 – Signal processing procedures to compute HRV and EDA indices.   
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prior to the subject performing a test.  For the postural stimulation test, the two-minute EDA test signal was 
extracted starting from 30 seconds after the subject stood up, to avoid the motion artifacts during the 
movement process.  For the cold pressor test, the first minute was avoided because the maximal discomfort 
occurs during this time.  The subsequent two minutes were used as the test EDA signals.  For the Stroop 
test, the two-minute segments were extracted after discarding the first minute of data after the training 
period.   
To extract the tonic component of the EDA signals (SCL), a 10th-order low-pass finite impulse 
response filter with a cut-off frequency of 0.0004 Hz was applied.  The remaining signal (raw signal minus 
tonic component) was used to compute the NS.SCRs.  The SCL index was computed using the mean of the 
tonic EDA over the two-minute period.  NS.SCRs were obtained manually for each minute and then 
averaged over the two-minute period.  It is important to note that for defining a non-negligible occurrence 
of NS.SCRs, a minimum change in conductance needs to be considered.  A recommended threshold value 
of 0.05 µS was used [10].  In addition, when a second response occurred before completion of the prior 
response, the two responses were counted as two positive NS.SCRs even though they overlapped.   
3.1.2.3 Power spectral density analysis of Electrodermal Activity 
For frequency-domain analysis, EDA signals were down–sampled to 2 Hz.  Before down-sampling, 
the data was filtered with an 8th-order Chebyshev Type I low-pass filter (0.8 Hz). Down-sampling from 
400 Hz to 2 Hz was performed in two steps (using consecutive down-sampling factors of 1/20 and 1/10, 
respectively).  Finally, signals were high-pass filtered (0.01 Hz, Butterworth, 8th order) to remove any 
trend.  The power spectra of EDA signals were calculated using Welch’s periodogram method with 50% 
data overlap.  A Blackman window (length of 128 points) was applied to each segment, the Fast Fourier 
Transform was calculated for each windowed segment, and the power spectra of the segments were 
averaged.  Note that the down-sampling frequency for EDA was half of the sampling frequency for HRV.  
This down-sampling frequency (2 Hz) is sufficient given that the dynamics of the EDA spectrum are largely 
confined to frequencies less than 0.4 Hz as observed in this work and as reported [17]. Total power [µS2] 
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and the power within the frequency bands of interest (VLF = 0 to 0.045 Hz, LF = 0.045 to 0.15 Hz, HF1 = 
0.15 to 0.25 Hz, HF2 = 0.25 to 0.4 Hz and VHF = 0.4 to 0.5 Hz) were computed.  After determining the 
frequency range for sympathetic assessment, EDASymp and EDASympn [n.u.] = EDASymp/(Total power) 
were computed.     
3.1.3 Statistics 
The full set of indices is HRVLF, HRVLFn, SCL, NS.SCRs, EDA-Total power, EDASymp and 
EDASympn.  First, the paired t-test was applied to test the null hypothesis that elicited responses as 
measured by each of the above-defined indices are equal to the baseline values.  These results are useful to 
evaluate the suitability of the indices to quantitatively assess the sympathetic function on healthy subjects, 
for the types of stress induced in the present study.   
Time- and frequency-domain indices of EDA (SCL, NS.SCRs and EDASympn) were further 
compared using a detection theory for which summary statistics are provided, including the maximum 
Youden's index (J = Sensitivity + Specificity – 1, a measure of the performance of the detector), the area 
 
  
Figure 3.3 – Exemplification of acquired measures of tonic EDA (SCL and NS.SCRs).  
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under the ROC curve (AUC, the probability that the index will assign to a positive instance a higher value 
than to a negative one), and the maximum accuracy of the given index used as detector.   This analysis 
allows us to test the ability of these indices to correctly identify the presence of the stressors. 
In order to assess inter-subject variability and degree of consistency of each index, the coefficient 
of variation (CV) (i.e. the standard deviation between all the measurements divided by the mean) and the 
intra-class correlation (ICC) were computed for the SCL, NS.SCRs and EDASympn indices, respectively.  
ICC has been computed as defined in the literature [22], for the N=12 independent subjects, using the 6 
available measures (3 tests, baseline and test measure). 
3.2  Results 
Figure 3.4 shows the NS.SCRs throughout the experiment (during postural stimulation, cold 
pressor and Stroop tests), for a given subject.  Note that during baseline periods, there were no positive 
NS.SCRs for this subject, for any test.  Some subjects exhibited a few NS.SCRs in the supine position but 
this was a rare occurrence.  All subjects consistently produced more NS.SCRs when performing the tests 
than during the baseline for all three tests. 
The power spectra of the HRV series and the EDA signal for a given subject are included in Figure 
3.5 and Figure 3.6.  Note that for both, this subject exhibits marked differences between baselines and 
Table 3.1 Percentage of energy within the frequency bands for EDA and HRV 
    Postural Stimulation Cold Pressor Stroop Test 
    Baseline Test Baseline Test Baseline Test 
EDA 
VLF (0 to 0.045 Hz) 86.2 % 65 % 79.2 % 51.2 % 87.3 % 51.6 % 
LF   (0.045 to 0.15 Hz) 11.6 % 28.5 % 14.6 % 31.7 % 8.07 % 32.9 % 
HF1 (0.15 to 0.25 Hz) 1.24 % 4.67 % 3.7 % 10.9 % 2.07 % 10.7 % 
HF2 (0.25 to 0.4 Hz) 0.36 % 1.3 % 1.35 % 4.44 % 1.44 % 3.77 % 
 VHF (0.4 to 0.5 Hz) 0.19 % 0.25 % 0.86 % 1.72 % 0.7 % 0.96 % 
HRV 
VLF (0 to 0.045 Hz) 36.8 % 36 % 29.2 % 34.8 % 27.8 % 29.6 % 
LF (0.045 to 0.15 Hz) 23.5 % 51.4 % 32.1 % 27 % 36.6 % 39.2 % 
HF (0.15 to 0.4 Hz) 36.5 % 10.9 % 35.6 % 34.4 % 32.8 % 25.9 % 
VHF (0.4 to 1 Hz) 2.17 % 0.93 % 2.53 % 2.91 % 2.33 % 4.63 % 
Values represent percentage of power considering all the subjects together. 
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each of the three induced tests. As expected, HRV power spectra show frequency components above 0.15 
Hz.  These components are known to be related to parasympathetic function.  For EDA spectra, spectral 
power beyond 0.25 Hz is minimal at best for all three induced stimuli.   
HRV is heart rate variability, EDA is electrodermal activity, VLF is power of very low-frequency 
components, LF is power of low-frequency components, HF is power of high-frequency components, and 
VHF is power of very high-frequency components. 
To quantitatively assess the dynamic frequency ranges of the EDA, we computed the percentage 
of energy within the five frequency bands as shown in Table 1.  For HRV, the HF was computed from the 
standard frequency band of 0.15 to 0.4 Hz.   As shown in Table 1, the VLF power is consistently high for 
EDA for all three baseline and test stimuli conditions.  The largest increase in EDA spectral power was 
found in the LF, post-stimuli, for all three test conditions.  With stimuli, the EDA’s HF1 (0.15-0.25 Hz) 
and HF2 (0.25-0.4 Hz) contain 5-10% and 1-4%, respectively, of the total spectral power, and the VHF of 
 
Figure 3.4 – NS.SCRS for a given subject during baseline (left) and test (right), for postural 
stimulation, cold pressor and Stroop test.  
 
Table 3.2 Sympathetic function indices. 
 Postural Stimulation Cold Pressor  Stroop task  
 Baseline Test Baseline Test Baseline Test 
HRV indices       
HRVLF (ms2) 4.8 ± 5.98 27.67 ± 31.45* 7.14 ± 6.396 4.77 ± 3.27 4.18 ± 3.36 6.11 ± 4.44* 
HRVLFn (n.u.) 0.24 ± 0.06 0.54 ± 0.17* 0.33 ± 0.13 0.27 ± 0.14 0.35 ± 0.13 0.39 ± 0.08 
Time-domain indices of EDA      
SCL (µS) 4.14 ± 8.11 10.79 ± 7.47* 0.77 ± 4.68 4.47 ± 7.50* -1.28 ± 3.92 6.31 ± 4.01* 
NS.SCRs (#/min) 1.83 ± 2.03 6.00 ± 2.86* 2.67 ± 2.9 4.958 ± 4.53* 0.96 ± 1.5 9.75 ± 3.89* 
Frequency-domain indices of EDA     
Total EDA (µS2) 1.71 ± 4.49 0.50 ± 0.46 0.11 ± 0.19 0.24 ± 0.42 0.019 ± 0.036 0.46 ± 0.45* 
EDASymp (µS2) 0.82 ± 2.48 0.28 ± 0.31 0.028 ± 0.056 0.15 ± 0.28 0.008 ± 0.016 0.198 ± 0.25* 
EDASympn (n.u.) 0.29 ± 0.17 0.47 ± 0.22* 0.23 ± 0.158 0.42 ± 0.20* 0.28 ± 0.20 0.48 ± 0.18* 
Values are expressed as mean ± standard deviation. 
*Statistically significantly higher with respect to baseline (p<0.05) 
HRV is heart rate variability, LF is power of low-frequency components, LFn is normalized power of low-frequency 
components, SCL is skin conductance level, NS.SCRs ares non-specific skin conductance responses, EDASymp and 
EDASympn indicate non-normalized and normalized power spectra, respectively, in the frequency band between 
0.045 and 0.25 Hz. 
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EDA contains less than at most 2% of the total spectral power.  Given that HF1 comprises 5-10% of the 
power associated with the sympathetic dynamics, and as 95% of the total spectral power of EDA is 
accounted for by including VLF, LF and HF1, the frequency range relevant to the sympathetic component 
of the EDA (EDASymp) can be defined to be in the range of 0.045-0.25 Hz.  This excludes VLF because, 
as shown in Table 1, its power decreases with stress induction.  Henceforth, “EDASymp” refers to spectral 
dynamics in the frequency range of 0.045 to 0.25 Hz.  
HRV is heart rate variability, LF is power of low-frequency components, LFn is normalized power 
of low-frequency components, SCL is skin conductance level, NS.SCRs ares non-specific skin conductance 
responses, EDASymp and EDASympn indicate non-normalized and normalized power spectra, 
respectively, in the frequency band between 0.045 and 0.25 Hz. 
Table 2 incorporates the mean time- and frequency-domain results for all subjects.  The postural 
stimulation test (orthostatic stress) produced significant increases in HRVLF, HRVLFn, SCL, NS.SCRs 
and EDASympn indices.  Total EDA and EDASymp were not found to be statistically different under this 
test.  The cold pressor test (physical stress) elicited differences in the SCL, NS.SCRs and EDASympn.  
 
Figure 3.5 – Power spectra of HRV for a given subject during baseline (left) and test (right), for 
postural stimulation, cold pressor and Stroop test.  Lines denote 0.045 and 0.15 Hz. 
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Note that these three indices were found to be statistically different than under postural stimulation.  
However, HRV indices were not significantly different during this test.  Total EDA and EDASymp were 
not found to be statistically different either.  The stroop task test (cognitive stress) induced differences in 
HRVLF, SCL, NS.SCRs, total EDA, EDASymp and EDASympn.  In other words, while low-frequency 
components of HRV (HRVLF) were sensitive to orthostatic and cognitive stress, normalized HRVLF 
(HRVLFn) was different only under orthostatic stress. The SCL and NS.SCRs always exhibited 
statistically-significant differences under any kind of stress tested in this study. EDASymp and total power 
of EDA were significantly increased by only cognitive stress, and normalized low-frequency components 
of EDA were sensitive to all three types of stress.  This suggests that the normalized low-frequency 
components of EDA and the time domain SCL and NS.SCRs are the most sensitive markers for 
differentiating changes induced by stressors.  
We used a detection theory and receiver operating characteristic (ROC) curves to test the ability of 
the different indices to correctly identify the presence of the stressors (orthostatic, physical or cognitive) 
when compared to their baseline conditions.  Table 3 shows the maximum Youden's index, the area under 
the ROC curve, and the highest possible accuracy for each index used as a detector.  EDASympn had better 
results than SCL and NS.SCRs for these three measures for the cold pressor test.  However, for both 
orthostatic and Stroop stimuli, the NS.SCRs provided the best results for the Youden’s index, AUC, and 
the accuracy values. 
Table 3.3 Statistics of EDA indices 
 Postural Stimulation Cold Pressor Stroop task   
 J AUC Acc J AUC Acc J AUC Acc 
Average 
CV 
ICC (LB UB) 
SCL 0.58 0.69 0.79 0.50 0.66 0.75 0.83 0.85 0.92 1.32 0.88 (0.68 0.98) 
NS.SCRs  0.83 0.87 0.92 0.33 0.61 0.67 0.92 0.92 0.96 0.93 0.93 (0.79 0.99) 
EDASympn 0.5 0.6 0.75 0.7 0.78 0.85 0.5 0.71 0.75 0.55 0.82 (0.48 0.97) 
 
EDA is electrodermal activity, SCL is skin conductance level, NS.SCRs are the non-specific skin conductance 
responses, EDASympn indicates the normalized spectral power in the frequency band between 0.045 to 0.25 Hz, J is 
Youden's index, AUC is Area under the ROC  curve, Acc is accuracy; CV is coefficient of variation, ICC is Intra-
class correlation, and LB and UB are upper and lower bounds of the ICC with a level of significance of 0.05. 
 
 
 36 
 
The high variability of EDA measurements has been a concern among researchers, impeding the 
widespread use of these indices for assessing the general state of activation of the sympathetic system.  
Table 3 shows the coefficient of variation (CV) and intra-class correlation (ICC) for SCL, NS.SCRs and 
EDASympn.  The total average of CV for the given index is also shown.  Although the NS.SCRs showed 
lower variability than did SCL, both SCL and NS.SCRs exhibited higher variability compared to 
EDASympn for all stimuli.   Finally, ICC was higher for the SCL and NS.SCRs, which suggests that these 
indices are more consistent than EDASympn.  
3.3 Discussion 
The main goal of this work was to determine the dynamic frequency response characteristics of 
EDA through the use of power spectral density.   Specifically, the intent was to systematically determine 
the frequency band limits of the sympathetic nervous activities derived from the EDA signal.  Moreover, 
we were interested in examining the hypothesis that if EDA does represent the dynamics of the cardiac and 
peripheral sympathetic nervous systems, the spectral power should be largely present in the low frequency 
band (0.04-0.15 Hz).   Indeed, this was the case, as we found that most of the significant increase in the 
 
Figure 3.6 – Power spectra of EDA for a given subject during baseline (left) and test (right), for 
postural stimulation, cold pressor and Stroop test.  Lines denote 0.045 and 0.15 Hz. 
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spectral power is confined in the low frequency band for all three test stimuli and this observation is in 
agreement with the LF band derived from HRV which contains the dynamics of the cardiac sympathetic 
nervous system.  To account for the additional 5-10% of spectral power largely seen in the HF band with 
induction of stimuli, we determined that the frequency response of the sympathetic activities represented in 
the EDA signal can be defined to be within 0.045-0.25 Hz (EDASymp). 
EDA data analysis in either the time or frequency domain consistently provided significantly 
elevated responses for all test stimuli in this study.  However, for HRV, the cold pressor stimulus did not 
provide significant changes whereas the other two stimuli (posture and Stroop tests) did.  The increase of 
the sympathetic tone with postural stimulation is a consistent finding when compared to previous studies 
[7], [23], [24].  However, the reliability of low-frequency components of HRV for sympathetic assessment 
is a sustained scientific concern.  For example, in the supine position, it has been shown that HRVLF and 
HRVLFn exhibit poor relative reliability (i.e. high inter-subject variability), and all HRV indices have poor 
absolute reliability (i.e. high intra-subject variability) [25], [26].  Another study reported poor 
reproducibility of HRV measured after an orthostatic challenge in healthy subjects, also suggesting an even 
poorer reproducibility in a clinical population [27].  EDA has been used to provide a quantitative functional 
measure of sudomotor activity [28], [29], which is controlled by the sympathetic nervous system [30]–[32].  
More recently, EDA has been used as a surrogate measure of the sympathetic activities [11].  However, due 
to the high variability of the time-domain measures of EDA, which largely consist of the SCL and NS.SCRs, 
its use has not yet been popularized.  Surprisingly, the PSD of EDA, similar to the PSD of HRV, is not yet 
a widely-adopted measure.  With EDASympn, we found evidence that postural stimulation  invokes the 
central and cardiac sympathetic nervous dynamics [11].  The added benefit of analyzing EDA in the 
frequency domain is that it can lead to less variability in the features estimated due to the inherent filtering 
properties of the frequency domain.  More importantly, the EDA represents only the sympathetic nervous 
activities whereas the LF of the HRV exhibits both the parasympathetic in addition to the sympathetic tone.  
The other main objective of this work was to determine if non-cardiac related sympathetic-inducing 
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stressors such as the cold pressor test could also be assessed via EDA analysis, and if their frequency 
responses are also in the prescribed LF range.    
Scant results have been reported about the influence of postural changes on EDA, because EDA 
measurement has been mainly used in psychophysiological research [10]. However, the SCL and NS.SCRs 
have shown good correlation with sympathetic arousal [33]–[35].  Note that the SCL and NS.SCRs can also 
be interpreted as the response of EDA in two different frequency bands, as the SCL comprises the slow 
changes (low frequency) and NS.SCRs represent rapid shifts (higher frequencies). We also tested the 
variability of EDA, from which we concluded that frequency-domain components are more reproducible 
than time-domain measures (number of SCRs and changes in SCL).  In this study we found significant 
differences in SCL and NS.SCRs after postural stimulation when compared to the baseline.  We found that 
the main drawbacks of these indices are their high variability (in the case of SCL) and the need for manual 
computing (to count NS.SCRs) (Tables 2 and 3).  It is worth mentioning that there are many studies that 
have examined automatic ways to count spontaneous SCRs, extract amplitude or other measures of a single 
causal SCR, and deal with motion artifacts and superposition on the SCRs [29], [36]–[38].  There are also 
publically-available toolboxes for these tasks (pspm.sourceforge.net and www.ledalab.de).  While these 
time-domain methods are reliable, the proposed EDASympn does not rely on either manual or automatic 
SCR detection, which is usually more complex and time consuming.  Using PSD analysis on EDA signals, 
we were able to determine that EDASympn was significantly increased in healthy subjects, when they 
changed their posture from supine to standing.  EDASympn exhibited lower variability, and can easily be 
implemented in an automated fashion for sympathetic function assessment under orthostatic stress. 
 The cold pressor stimulus has been increasingly used in clinical practice to evaluate 
autonomic function in cardiovascular regulation, because stressful cooling evokes an increase in 
sympathetic neurotransmissions [18].  The responses of HRV dynamics and EDA to cold stress are also 
poorly understood.  In this study, no significant differences were found in HRVLF and HRVLFn between 
cold pressor and baseline.  The reported results on HRVLF and HRVLFn in response to cold pressor are 
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not congruent.  Although some studies reported increases [39], [40], decreases or insignificant changes are 
reported more often [41]–[44].  In this study we found non-significant decreases in HRVLF and HRVLFn. 
Previous studies have tested EDA dynamics in response to the cold pressor test [45], [46].  Those 
works found increases in SCL and NS.SCRs in healthy subjects when cold stressor was applied.  
Consistently with those reports, we found significant differences in NS.SCRs and SCL indices when 
comparing cold pressor to baseline.  Nonetheless, these indices showed higher variability on this test when 
compared to postural stimulation.  Using PSD analysis of EDA signals, we found significant increases in 
EDASympn between cold pressor and baseline, with much less variability when compared to NS.SCRs and 
SCL. 
Significant increases in the low-frequency components of HRV during Stroop tests have been 
previously reported [47]–[49].  We also found significant differences in HRVLF between Stroop tasks and 
baseline, but not in HRVLFn.  The SCL and NS.SCRs indices were significantly higher during the Stroop 
test when compared to baseline.  Besides the sensitivity of these indices, their variability was also high for 
this test.  In frequency-domain analysis, not only the normalized index (EDASympn) was significantly 
increased, but the integral of sympathetic components (EDASymp) also exhibited a significant increase.  
The effect of the Stroop test on the power spectrum of EDA was a combined increase in the LF + HF1 
(EDASymp) and VLF range, which influence the total power (Table 2).    
While the number of subjects enrolled for this study was relatively low, significant differences 
between baseline and stimuli-induced conditions enabled the opportunity to examine if time- and 
frequency-domain indices can discriminate between the absence and presence of the specific stressor.  We 
were also interested in further investigating the ability of SCL, NS.SCRs and EDASympn indices to 
discriminate whether the stressors (orthostatic, physical or cognitive) were present when the data were 
collected.  To compare the indices’ performance on these task stimuli, the Youden's index (J), the area 
under the ROC curve (AUC) and the maximum accuracy of the detector (Acc) were computed (Table 3).  
The EDASympn exhibited the best performance in detecting the induced cold pressor stimuli as measured 
by the Youden’s index.  However, both SCL and NS.SCRs performed better than EDASympn for 
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orthostatic and cognitive stress.  It should be noted, however, that the EDASympn provided the lowest 
coefficient of variation values for all three stimuli conditions.   
Even though SCL and NS.SCRs have been shown in the literature to be elevated by administration 
of dextroamphetamine, caffeine, and threatening instructions [33]–[35] (consistent with sympathetic 
arousal), they are only moderately positively correlated with each other and have relatively low within-
subject variability (correlation of test-retest ranges from 0.50 to 0.70) and high variability between subjects 
[15].  We also found evidence of such high variability in this study, as SCL exhibited a coefficient of 
variability more than four times larger than the EDASympn index.  The NS.SCRs also had a higher 
coefficient of variability.  As for the consistency of the indices, although the SCL and NS.SCRs 
demonstrated a higher degree of consistency (ICC) than EDASympn (Table 3), all three indices presented 
a consistency beyond chance (> 0.75) [50]. 
Because of the high sensitivity to three different types of stimuli and relatively low variability, 
EDASympn can be recognized as a suitable index of sympathetic function during such stressors in healthy 
individuals.  While there are many and varied approaches to directly measure the sympathetic response, 
due to high cost, or the invasiveness of the technique, or the inability to provide continuous monitoring, or 
the inaccurate assessment of the sympathetic dynamics, the widespread use of these techniques in practice 
is not practical.   
3.4 Conclusion 
In summary, the EDASympn index is a suitable discriminator of orthostatic, physical and cognitive 
stress, and has the potential to be used as a reliable marker of quantitative assessment of the sympathetic 
function.  It was found to be more reliable and sensitive than the LF index of HRV, was consistent between 
the subjects, and exhibited a lower variability compared to the time-domain measures of EDA.  Finally, the 
frequency bands of the sympathetic nervous activities can be defined to be within 0.045-0.25 Hz based on 
spectral analysis of EDA.  
 41 
 
3.5 References 
[1] K. H. Chon, B. Yang, H. F. Posada-Quintero, K. L. Siu, M. Rolle, P. Brink, A. Birzgalis, and L. C. 
Moore, “A novel quantitative method for diabetic cardiac autonomic neuropathy assessment in type 1 
diabetic mice,” J. Diabetes Sci. Technol., vol. 8, no. 6, pp. 1157–1167, Nov. 2014. 
[2] G. Grassi and M. Esler, “How to assess sympathetic activity in humans,” J. Hypertens., vol. 17, 
no. 6, pp. 719–734, Jun. 1999. 
[3] Y. Bai, R. T. Mahon, J. C. White, P. R. Brink, and K. H. Chon, “Impairment of the autonomic 
nervous function during decompression sickness in swine,” J. Appl. Physiol. Bethesda Md 1985, vol. 106, 
no. 3, pp. 1004–1009, Mar. 2009. 
[4] Y. Bai, N. Selvaraj, K. Petersen, R. Mahon, W. A. Cronin, J. White, P. R. Brink, and K. H. Chon, 
“The autonomic effects of cardiopulmonary decompression sickness in swine using principal dynamic 
mode analysis,” Am. J. Physiol. - Regul. Integr. Comp. Physiol., vol. 305, no. 7, pp. R748–R758, Oct. 2013. 
[5] M. Esler, G. Jennings, P. Korner, I. Willett, F. Dudley, G. Hasking, W. Anderson, and G. Lambert, 
“Assessment of human sympathetic nervous system activity from measurements of norepinephrine 
turnover,” Hypertension, vol. 11, no. 1, pp. 3–20, Jan. 1988. 
[6] J. L. Rouleau, L. A. Moyé, J. de Champlain, M. Klein, D. Bichet, M. Packer, G. Dagenais, B. Sussex, 
J. M. Arnold, and F. Sestier, “Activation of neurohumoral systems following acute myocardial infarction,” 
Am. J. Cardiol., vol. 68, no. 14, p. 80D–86D, Nov. 1991. 
[7] D. J. Ewing and B. F. Clarke, “Diagnosis and management of diabetic autonomic neuropathy.,” 
Br. Med. J. Clin. Res. Ed, vol. 285, no. 6346, pp. 916–918, Oct. 1982. 
[8] C. J. Mathias and R. Bannister, “Investigation of autonomic disorders,” in Autonomic failure: a 
textbook of clinical disorders of the autonomic nervous system, C. J. Mathias and R. Bannister, Eds. 
Oxford: Oxford University Press, 1999, pp. 169–195. 
[9] Task Force of the European Society of Cardiology and the North American Society of Pacing and 
Electrophysiology, “Heart rate variability. Standards of measurement, physiological interpretation, and 
clinical use,” Eur. Heart J., vol. 17, no. 3, pp. 354–381, Mar. 1996. 
[10] W. Boucsein, D. C. Fowles, S. Grimnes, G. Ben-Shakhar, W. T. roth, M. E. Dawson, D. L. Filion, and 
Society for Psychophysiological Research Ad Hoc Committee on Electrodermal Measures, “Publication 
recommendations for electrodermal measurements,” Psychophysiology, vol. 49, no. 8, pp. 1017–1034, 
Aug. 2012. 
[11] R. Freeman and M. W. Chapleau, “Testing the autonomic nervous system,” Handb. Clin. Neurol., 
vol. 115, pp. 115–136, 2013. 
[12] A. P. Colbert, K. Spaulding, A. Larsen, A. C. Ahn, and J. A. Cutro, “Electrodermal activity at 
acupoints: literature review and recommendations for reporting clinical trials,” J. Acupunct. Meridian 
Stud., vol. 4, no. 1, pp. 5–13, Mar. 2011. 
 42 
 
[13] H. D. Critchley, “Electrodermal responses: what happens in the brain,” Neurosci. Rev. J. Bringing 
Neurobiol. Neurol. Psychiatry, vol. 8, no. 2, pp. 132–142, Apr. 2002. 
[14] R. Edelberg, “Electrical activity of the skin: Its measurement and uses in psychophysiology,” 
Handb. Psychophysiol., vol. 12, p. 1011, 1972. 
[15] A. Crider and R. Lunn, “Electrodermal lability as a personality dimension,” J. Exp. Res. Personal., 
vol. 5, no. 2, pp. 145–150, 1971. 
[16] J. J. Braithwaite, D. G. Watson, R. Jones, and M. Rowe, “A guide for analysing electrodermal 
activity (EDA) & skin conductance responses (SCRs) for psychological experiments,” University of 
Birmingham, UK, Technical, 2013. 
[17] Y. Shimomura, T. Yoda, K. Sugiura, A. Horiguchi, K. Iwanaga, and T. Katsuura, “Use of frequency 
domain analysis of skin conductance for evaluation of mental workload,” J. Physiol. Anthropol., vol. 27, 
no. 4, pp. 173–177, Jun. 2008. 
[18] D. Robertson, G. A. Johnson, R. M. Robertson, A. S. Nies, D. G. Shand, and J. A. Oates, 
“Comparative assessment of stimuli that release neuronal and adrenomedullary catecholamines in 
man.,” Circulation, vol. 59, no. 4, pp. 637–643, Apr. 1979. 
[19] R. J. Stroop, “Studies of interference in serial verbal reactions,” J. Exp. Psychol., vol. 18, no. 6, pp. 
643–662, 1935. 
[20] M. E. Nygårds and L. Sörnmo, “Delineation of the QRS complex using the envelope of the e.c.g,” 
Med. Biol. Eng. Comput., vol. 21, no. 5, pp. 538–547, Sep. 1983. 
[21] C. Vidaurre, T. H. Sander, and A. Schlögl, “BioSig: the free and open source software library for 
biomedical signal processing,” Comput. Intell. Neurosci., vol. 2011, p. 935364, 2011. 
[22] K. O. McGraw and S. P. Wong, “Forming inferences about some intraclass correlation 
coefficients.,” Psychol. Methods, vol. 1, no. 1, p. 30, 1996. 
[23] J. W. Williamson, R. McColl, and D. Mathews, “Evidence for central command activation of the 
human insular cortex during exercise,” J. Appl. Physiol. Bethesda Md 1985, vol. 94, no. 5, pp. 1726–1734, 
May 2003. 
[24] W. Wieling, J. F. van Brederode, L. G. de Rijk, C. Borst, and A. J. Dunning, “Reflex control of heart 
rate in normal subjects in relation to age: a data base for cardiac vagal neuropathy,” Diabetologia, vol. 
22, no. 3, pp. 163–166, Mar. 1982. 
[25] J. W. Sacre, C. L. Jellis, T. H. Marwick, and J. S. Coombes, “Reliability of heart rate variability in 
patients with type 2 diabetes mellitus,” Diabet. Med. J. Br. Diabet. Assoc., vol. 29, no. 7, pp. e33-40, Jul. 
2012. 
[26] G. D. Pinna, R. Maestri, A. Torunski, L. Danilowicz-Szymanowicz, M. Szwoch, M. T. La Rovere, and 
G. Raczak, “Heart rate variability measures: a fresh look at reliability,” Clin. Sci. Lond. Engl. 1979, vol. 
113, no. 3, pp. 131–140, Aug. 2007. 
[27] G. R. H. Sandercock, P. D. Bromley, and D. A. Brodie, “The reliability of short-term 
measurements of heart rate variability,” Int. J. Cardiol., vol. 103, no. 3, pp. 238–247, Sep. 2005. 
 43 
 
[28] P. H. Ellaway, A. Kuppuswamy, A. Nicotra, and C. J. Mathias, “Sweat production and the 
sympathetic skin response: Improving the clinical assessment of autonomic function,” Auton. Neurosci., 
vol. 155, no. 1–2, pp. 109–114, Jun. 2010. 
[29] M. Benedek and C. Kaernbach, “A continuous measure of phasic electrodermal activity,” J. 
Neurosci. Methods, vol. 190, no. 1–5, pp. 80–91, Jun. 2010. 
[30] B. M. W. Illigens and C. H. Gibbons, “Sweat testing to evaluate autonomic function,” Clin. Auton. 
Res., vol. 19, no. 2, pp. 79–87, Apr. 2009. 
[31] C. Setz, B. Arnrich, J. Schumm, R. La Marca, G. Tröster, and U. Ehlert, “Discriminating stress from 
cognitive load using a wearable EDA device,” IEEE Trans. Inf. Technol. Biomed. Publ. IEEE Eng. Med. Biol. 
Soc., vol. 14, no. 2, pp. 410–417, Mar. 2010. 
[32] J. . Healey and R. W. Picard, “Detecting stress during real-world driving tasks using physiological 
sensors,” IEEE Trans. Intell. Transp. Syst., vol. 6, no. 2, pp. 156–166, Jun. 2005. 
[33] T. P. Zahn, J. L. Rapoport, and C. L. Thompson, “Autonomic effects of dextroamphetamine in 
normal men: implications for hyperactivity and schizophrenia,” Psychiatry Res., vol. 4, no. 1, pp. 39–47, 
Feb. 1981. 
[34] T. P. Zahn and J. L. Rapoport, “Autonomic nervous system effects of acute doses of caffeine in 
caffeine users and abstainers,” Int. J. Psychophysiol. Off. J. Int. Organ. Psychophysiol., vol. 5, no. 1, pp. 
33–41, May 1987. 
[35] G. Bohlin, “Delayed habituation of the electrodermal orienting response as a function of 
increased level of arousal,” Psychophysiology, vol. 13, no. 4, pp. 345–351, Jul. 1976. 
[36] D. R. Bach and K. J. Friston, “Model-based analysis of skin conductance responses: Towards 
causal models in psychophysiology,” Psychophysiology, vol. 50, no. 1, pp. 15–22, Jan. 2013. 
[37] T. Chaspari, A. Tsiartas, L. I. Stein, S. A. Cermak, and S. S. Narayanan, “Sparse representation of 
electrodermal activity with knowledge-driven dictionaries,” IEEE Trans. Biomed. Eng., vol. 62, no. 3, pp. 
960–971, Mar. 2015. 
[38] A. Greco, G. Valenza, A. Lanata, E. Scilingo, and L. Citi, “cvxEDA: a Convex Optimization Approach 
to Electrodermal Activity Processing,” IEEE Trans. Biomed. Eng., Aug. 2015. 
[39] M. A. Sanchez-Gonzalez, R. W. May, A. P. Koutnik, M. Kabbaj, and F. D. Fincham, “Sympathetic 
Vasomotor Tone Is Associated With Depressive Symptoms in Young Females: A Potential Link Between 
Depression and Cardiovascular Disease,” Am. J. Hypertens., vol. 26, no. 12, pp. 1389–1397, Dec. 2013. 
[40] E. S. Prakash, Madanmohan, K. R. Sethuraman, and S. K. Narayan, “Cardiovascular autonomic 
regulation in subjects with normal blood pressure, high-normal blood pressure and recent-onset 
hypertension,” Clin. Exp. Pharmacol. Physiol., vol. 32, no. 5–6, pp. 488–494, May 2005. 
[41] Y.-P. Liu, Y.-H. Lin, Y.-C. Chen, P.-L. Lee, and C.-S. Tung, “Spectral analysis of cooling induced 
hemodynamic perturbations indicates involvement of sympathetic activation and nitric oxide production 
in rats,” Life Sci., vol. 136, pp. 19–27, Sep. 2015. 
 44 
 
[42] L. D. DeBeck, S. R. Petersen, K. E. Jones, and M. K. Stickland, “Heart rate variability and muscle 
sympathetic nerve activity response to acute stress: the effect of breathing,” Am. J. Physiol. Regul. 
Integr. Comp. Physiol., vol. 299, no. 1, pp. R80-91, Jul. 2010. 
[43] Z. B. Moses, L. J. Luecken, and J. C. Eason, “Measuring task-related changes in heart rate 
variability,” Conf. Proc. Annu. Int. Conf. IEEE Eng. Med. Biol. Soc. IEEE Eng. Med. Biol. Soc. Annu. Conf., 
vol. 2007, pp. 644–647, 2007. 
[44] J. P. Florian, E. E. Simmons, K. H. Chon, L. Faes, and B. E. Shykoff, “Cardiovascular and autonomic 
responses to physiological stressors before and after six hours of water immersion,” J. Appl. Physiol. 
Bethesda Md 1985, vol. 115, no. 9, pp. 1275–1289, Nov. 2013. 
[45] E. S. Mezzacappa, R. M. Kelsey, and E. S. Katkin, “Breast feeding, bottle feeding, and maternal 
autonomic responses to stress,” J. Psychosom. Res., vol. 58, no. 4, pp. 351–365, Apr. 2005. 
[46] G. H. Prystav, “Electrodermal, Cardiac, and Respiratory Activity to Repeated Cold Pressor 
Stimulation in Drug Addicts,” J. Gen. Psychol., vol. 94, no. 2, pp. 259–270, Apr. 1976. 
[47] A. Garafova, A. Penesova, E. Cizmarova, A. Marko, M. Vlcek, and D. Jezova, “Cardiovascular and 
sympathetic responses to a mental stress task in young patients with hypertension and/or obesity,” 
Physiol. Res. Acad. Sci. Bohemoslov., vol. 63 Suppl 4, pp. S459-467, 2014. 
[48] Z. Visnovcova, M. Mestanik, M. Javorka, D. Mokra, M. Gala, A. Jurko, A. Calkovska, and I. 
Tonhajzerova, “Complexity and time asymmetry of heart rate variability are altered in acute mental 
stress,” Physiol. Meas., vol. 35, no. 7, pp. 1319–1334, Jul. 2014. 
[49] J. P. Delaney and D. A. Brodie, “Effects of short-term psychological stress on the time and 
frequency domains of heart-rate variability,” Percept. Mot. Skills, vol. 91, no. 2, pp. 515–524, Oct. 2000. 
[50] J. R. Landis and G. G. Koch, “The measurement of observer agreement for categorical data,” 
Biometrics, vol. 33, no. 1, pp. 159–174, Mar. 1977. 
 
  
 45 
 
Chapter 4: Highly Sensitive Index of Sympathetic Activity based on Time-
Frequency Domain Analysis of Electrodermal Activity 
(Posada-Quintero, H. F., Florian, J. P., Orjuela-Canon, A. D., & Chon, K. H. (2016). Highly Sensitive 
Index of Sympathetic Activity based on Time-Frequency Spectral Analysis of Electrodermal Activity. 
American Journal of Physiology - Regulatory, Integrative and Comparative Physiology) 
 
4.1 Introduction  
Time-invariant frequency-domain analysis of EDA was explored in the previous chapter as a tool 
for sympathetic tone assessment and it was termed EDASympn [16].  The usefulness of EDASympn was 
demonstrated, with lower variability compared to time-domain measures of EDA, but the technique 
exhibited only acceptable consistency, with lower sensitivity for orthostatic (stand test) and cognitive stress 
compared to SCL and NS.SCRs.   
Given that the sympathetic tone is time varying, especially when experiments are specifically 
designed to invoke its dynamics, we hypothesized that time-varying analysis of EDA may provide more 
sensitive results than the time-invariant frequency-domain analysis (42) and time-domain indices consisting 
of SCL and NS.SCRs.  To this end, we performed time-frequency analysis of EDA signals to examine if 
we can obtain an even more sensitive and reliable index of sympathetic tone.  Specifically, variable 
frequency complex demodulation (VFCDM), a time-frequency spectral (TFS) analysis technique that 
provides accurate amplitude estimates and one of the highest time-frequency resolutions [17] was employed 
in this study to develop an index of sympathetic tone.  The time-varying EDA index of sympathetic control 
(TVSymp) was computed by using the mean spectral amplitudes in the frequency band associated with 
sympathetic tone of the EDA.   
To test our hypothesis, we have computed TVSymp and a full set of EDA (SCL, NS.SCRs and 
EDASympn) and HRV (HRVLF and HRVLFn) indices of sympathetic control for subjects undergoing four 
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tests known to elicit sympathetic tone arousal: cold pressor test, 70° head-up tilt (HUT) test, stand test, and 
Stroop task.  Sensitivity, consistency and variability of TVSymp were computed and compared gainst the 
time-domain and time-invariant spectral indices. 
 
4.2 Materials and Methods 
4.2.1 Protocol 
Participants were asked to avoid caffeine and alcohol and to not exercise during the 24 hours 
preceding the test, and were instructed to fast for at least 3 hours before testing.  Prospective subjects using 
psychoactive drugs, nicotine or other recreational drugs, and taking any medicine were asked to exclude 
themselves from the study.  The experiments were carried out in a quiet, dimly lit room (ambient 
temperature, 26-27 °C).  The study protocol was approved by the Institutional Review Board of The 
University of Connecticut and all volunteers provided written informed consent to participate in the 
experiment.  ECG and EDA signals were simultaneously recorded throughout all tests (Hewlett-Packard 
HP 78354A and ADINSTRUMENTS GSR module, respectively).  After preparing the skin with alcohol, 
ECG electrodes were placed to acquire Lead I, and EDA electrodes were placed on the index and middle 
finger for all subjects.  Signals were digitized using a PowerLab system at 1 kHz, 12-bit resolution.   
Twelve healthy volunteers (10 males, 2 female) of ages ranging from 19 to 36 years old (26.2 ± 
6.1; mean ± SD), weight 64.6 ± 7 kg, and height 171.5 ± 9.6 cm, were enrolled in this study.  No gender-
related differences have been reported for EDA or sympathetic function.  To induce a wide variety of 
sympathetic arousal types, subjects underwent four tests, in the following order: cold pressor (physical 
stress), 70° HUT, stand test (orthostatic stress) and Stroop task (cognitive stress).  The order of tests was 
the same for all the subjects. 
Before each test, subjects remained in the supine position for at least 5 minutes to ensure 
hemodynamic stabilization (end-point criteria was when the subject achieved a baseline level of heart rates).  
After the stabilization period, 5 minutes of resting baseline data were recorded with subjects in the supine 
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position before each test.  For the cold pressor test, subjects were asked to immerse their left hand to the 
wrist level into a 0-1 °C water bath for a period of 3 minutes.  For HUT, subjects were tilted from 0 to 70 
degrees and remained tilted for 5 minutes. The stand test consisted of a 5-minute standing period in which 
subjects were asked not to move and not to actively contract their leg muscles.  For the Stroop task, subjects 
were asked to speak a word which named a color.  They were shown congruent (the word was written in 
the color it expressed) and incongruent (the word and the color it was printed in were different) 
combinations to induce cognitive stress [18]. The words and colors were “blue,” “yellow,” “green,” “red,” 
“purple” and “black”.  The background also changed to be randomly congruently or incongruently colored 
with the word.  A computerized version of the original Stroop task was designed.  The Stroop task was 5 
minutes total, with the first minute used for training. 
4.2.2 Signal processing 
Time-frequency spectra (TFS) of EDA signals were used to quantify the elicited changes of the 
sympathetic nervous system due to the cold pressor test, HUT, stand test, and Stroop task.  Prior to time-
frequency analysis, EDA signals were down–sampled to 2 Hz and high-pass filtered (0.01 Hz) to remove 
any trends.  The VFCDM technique has been described in detail previously [17], [19], and tested with 
different physiological signals [19]–[21], hence the technique will be only briefly summarized.  
4.2.2.1  Variable Frequency Complex Demodulation Algorithm 
 The first step is to use complex demodulation (CDM) to obtain an estimate of the TFS.  In CDM, 
a bank of low pass filters (LPFs) is used to decompose the signal into a suite of band-limited signals.  The 
analytic signals that are obtained from these, through use of the Hilbert transform, then provide estimates 
of instantaneous amplitude, frequency, and phase within each frequency band.  Consider a sinusoidal signal 
x(t) to be a narrow-band oscillation with a center frequency f0, instantaneous amplitude A(t), phase ɸ(t), 
and the direct current component dc(t) defined as: 
)).(2cos()()()( 0 ttftAtdctx                                                                                   ( 1 ) 
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For a given center frequency (or carrier), we can extract the instantaneous amplitude information 
A(t) and phase information ɸ(t) by multiplying x(t) by 
tfj
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2
, which results in the following: 
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A leftward shift by 
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 moves the center frequency f0 to zero frequency in the spectrum of z(t).  
If z(t) is subjected to an ideal LPF with a cutoff frequency fC < f0, then the filtered signal z1P(t) will contain 
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Figure 4.1 – Normalized amplitude time-frequency spectrum of an EDA signal, obtained via the complex 
demodulation method (VFCDM), for a given subject under cold pressor test.   
Vertical line represents the start of the cold pressor.  Color bar shows the logarithmic scale in dB.   
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Consider a case when a modulating frequency is not fixed as described before but varies as a 
function of time. In this case, the signal x(t) can be written in the following form: 
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Similar to the operations in (1) and (2), multiplying (6) by 
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amplitude, A(t), and instantaneous phase, ɸ(t) [22], so that:  
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From (7), when z(t) is filtered with an ideal LPF with a cutoff frequency fC < f0, then the filtered 
signal z1P(t) will be obtained with the same instantaneous amplitude A(t) and phase ɸ(t) as provided in (4) 
and (5).  The instantaneous frequency, as reported previously [23], is given by: 
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For this study, x(t) corresponds to the EDA signal. The instantaneous frequency and amplitude of 
di can be calculated using the Hilbert transform [24].  The entire time-frequency spectrum can be obtained 
by the calculation of the Hilbert transform of the equation above for all time points for the obtained low-
pass filtered frequency components.  Therefore, by the combination of the CDM and Hilbert transform, a 
high TF resolution spectrum and accurate amplitude information can be obtained.   
The procedure for the implementation of the CDM-based TFS is summarized next. 
1. Design a finite-impulse response (FIR) LPF with the bandwidth and the length of the filter 
set to Fω and Nω, respectively. Set center frequencies as 
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where the bandwidth between neighboring center frequencies is 2Fω, and fmax represents 
the highest signal frequency. 
2. Use the CDM to extract the dominant frequency within the confined bandwidth and repeat 
it over the entire frequency band (by incrementing f0i ). 
3. Decompose the signal into sinusoidal modulations via the CDM. 
4. Calculate the instantaneous frequencies using (8) based on the phase (5) and the 
instantaneous amplitudes (4) of each sinusoidal modulation component using the Hilbert 
transform. 
5. Obtain the TF representation of the signal using the estimated instantaneous frequencies 
and amplitudes.  
 
4.2.2.2 Determining the relevant components for the sympathetic responses. 
Once the TFS is obtained via the VFCDM method as described above (e.g. Figure 4.1), the 
resulting time-varying spectral amplitudes at each frequency interval are analyzed to examine whether they 
evolve in time in response to sympathetic stimulation.  These spectral amplitudes are not rigid bands of 
frequency. Instead, they represent the evolution over time of a spectral amplitude that changes within a 
range of frequencies (see Figure 4.2).  These frequencies depend on the sampling frequency (fs) and given 
that fs = 2 Hz was selected, the spectral frequencies are centered on 0.04 Hz, 0.12 Hz, 0.2 Hz, 0.28 Hz, 0.36 
Hz, 0.44 Hz, 0.52 Hz, 0.6 Hz, 0.68 Hz, 0.76 Hz, 0.84 Hz and 0.92 Hz.  Finer spectral resolution was 
explored.  Since we were only interested in the sum of time-varying spectral amplitudes in the frequency 
range that may correspond to the sympathetic dynamics (e.g., 0.045-0.25 Hz), finer frequency resolution 
was not found informative.  
The power contained in each frequency resolution band was computed for all subjects to determine 
sympathetic-relevant dynamics. Those powers that did not change from baseline to stimuli stage were 
considered insensitive to sympathetic control and subsequently considered irrelevant.  The time-varying 
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spectral powers with a low value (comprising less than 5% of the total spectral power) were also considered 
irrelevant.  It was recently shown that ~5% of time-invariant spectral content of HRV is also enclosed in 
frequencies above HF (> 0.4 Hz) [16].   In the same study, the frequency bound of EDA associated with 
the sympathetic activity was largely confined to 0.045 Hz to 0.25 Hz, with about 5% of the power in the 
frequencies beyond 0.25 Hz.  
 
 
 
 
Figure 4.2 – Exemplification of the twelve resulting VFCDM components, shown in frequency 
domain.  Sampling frequency is 2 Hz. 
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4.2.2.3 Computing the index of sympathetic control. 
Time-varying spectral amplitudes in the frequency bands that are considered to be responsive to 
sympathetic stimuli are summed together to obtain an estimated reconstructed EDA signal (X’(t)), which 
is then normalized to unit variance (divided by its standard deviation), and its instantaneous amplitude is 
computed using Hilbert transform [24], as follows 

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where P indicates the Cauchy principal value.  X’(t) and Y’(t) form the complex conjugate pair, so 
we can define an analytic signal, Z(t), as 
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Figure 4.3 – Computed envelope for the sum of selected VFCDM backbones, for a given subject, 
during stand test. 
Blue line is the reconstructed signal using the two components with the most power.  Red line 
represents the envelope, estimated via instantaneous amplitude.  Vertical black line represents the 
moment when the subject stood up. 
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The resulting a(t) is considered the instantaneous amplitude of Z(t) (see Figure 4.3).  The mean 
amplitude of a(t), termed TVSymp, was computed for the four tests for all subjects.  This value constitutes 
our intended index of sympathetic tone.  Notice that TVSymp is a dimensionless quantity as it was 
normalized to the standard deviation.     
 
4.2.2.4 EDA indices 
To extract the conductance level of EDA, a 10th-order low-pass FIR filter with a cut-off frequency 
of 0.0004 Hz was applied.  The raw signal minus the conductance level was used to compute the NS.SCRs.  
The SCL index was computed using the mean of the conductance level over the two-minute period.  
NS.SCRs were obtained by visual inspection over the two-minute period, and averaged per minute.  A 
threshold value of 0.05 µS was used to determine relevant SCRs [14].  In addition, when a second response 
occurred before completion of the prior response, the two responses were counted as two NS.SCRs even 
though they were overlapped.   
The time-invariant frequency domain index of EDA, EDASympn, was also computed.  Power 
spectral density analysis of EDA signals was performed on the same two-minute segments used to compute 
SCL and NS.SCRs. For this process, EDA signals were down–sampled to 2 Hz.  Before down-sampling, 
the data were filtered with an 8th-order Chebyshev Type I low-pass filter (0.8 Hz). Down-sampling from 
400 Hz to 2 Hz was performed in two steps (using consecutive down-sampling factors of 1/20 and 1/10, 
respectively).  Finally, signals were high-pass filtered (0.01 Hz, Butterworth, 8th order) to remove any 
trend.  The power spectra of EDA signals were calculated using Welch’s periodogram method with 50% 
data overlap.  A Blackman window (length of 128 points) was applied to each segment, the Fast Fourier 
Transform was calculated for each windowed segment, and the power spectra of the segments were 
averaged.  EDASympn was computed as the normalized power within the frequency band of interest (0.045 
to 0.25 Hz) [16].     
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4.2.2.5 HRV analysis 
For HRV analysis, ECG signals were band-pass filtered (0.05-40 Hz) to reduce noise and motion 
artifacts.  The R-waveform peaks were detected using a widely-used peak detection algorithm (57), and 
HRV series (from RR segments) were computed.  The power spectra of HRV were calculated using Welch’s 
periodogram method with 50% data overlap.  The RR interval series were converted to an evenly time-
sampled signal (4 Hz) by cubic spline interpolation.  A Blackman window (length of 256 points) was 
applied to each segment and the Fast Fourier Transform was calculated for each windowed segment.  
Finally, the power spectra of the segments were averaged.  The low-frequency index (HRVLF [ms2], 0.04 
to 0.15 Hz) (67) and normalized LF index (HRVLFn = (HRVLF)/Total power, normalized units) were 
computed.  Four minutes of clean ECG signals were used to compute HRV for HUT, the stand test, and the 
Stroop task, and three minutes for the cold pressor test given the extreme characteristics of this physical 
test.  Within each test, the same data length was used consistently for baseline and test segments.     
 
4.2.3 Statistics 
Six indices of sympathetic control were computed, including one time-frequency domain index, 
TVSymp, two time-domain indices, SCL (µS) and NS.SCRs (#/min), and three frequency-domain indices, 
EDASympn (normalized units, n.u.), HRVLF (ms2) and HRVLFn (n.u.).  All the statistical analysis was 
performed using MATLAB ®.  The paired t-test was applied to test the null hypothesis that elicited 
responses to the cold pressor test, HUT testing, the stand test and Stroop task, as measured by each of the 
above-defined indices, are equal to the baseline values.  A p value <= 0.05 was set to define statistical 
significance.  These results are useful to evaluate the suitability of the indices to quantitatively assess 
sympathetic function in healthy subjects.   
Measures from detection theory analysis were employed to assess sensitivity of the indices, 
including the receiver operating characteristic (ROC) curve (39), Youden's index (J = Sensitivity + 
Specificity – 1, to assess the performance of the detector) (62), the area under the ROC curve (AUC, the 
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probability that the index will assign to a positive instance a higher value than to a negative one) (25), and 
the maximum accuracy of the detector.  The coefficient of variation (CV) (i.e. the standard deviation 
between all the measurements divided by the mean) and the intra-class correlation (ICC) (38) were 
computed for all the indices in order to assess inter-subject variability and degree of consistency of each 
index, respectively.  
 
4.3  Results 
Figure 4.2 illustrates how the time-varying spectral powers are distributed in the frequency 
domain.  Notice how as frequency increases, the power decreases (note that y-axes are not equal).  Table 
4.1 shows the percentage of spectral power contained in three bands of frequencies throughout the subjects. 
The time-varying spectral amplitudes in the first band comprise most of the spectral content of the signal 
(> 60%) for any test.  The percentage of spectral power at the very low frequencies (< 0.08 Hz) is usually 
reduced under testing conditions when compared to the baseline, because sympathetic dynamics become 
more pronounced with test stimuli [16].  Time-varying spectral components at frequencies between 0.08 
and 0.24 Hz (2nd and 3rd center frequencies) are the ones that bear the most power and increase the most 
between baseline and tests.  Although some of the remaining spectral power increased during testing at > 
0.24 Hz, it was less than 5% of the power.  For this reason, we have selected the spectral amplitudes in the 
0.08 to 0.24 Hz range to compute the sympathetic index.   
 
Table 4.1 Percentage of power for the resulting backbones of VFCDM. 
 Cold Pressor 70° Head-up Tilt Stand Test Stroop Task 
Frequency range Baseline Test Baseline Test Baseline Test Baseline Test 
0 to 0.08 Hz 88.3 67.7 86 83.8 91.1 81.8 89.4 81 
0.08 to 0.24 Hz 6.9 19.5 8.4 7.5 5.4 10 6.5 11.4 
0.24 to 1 Hz 2.2 4.3 1.7 2.9 0.7 1.9 2.2 2.3 
Values are % of total power throughout the full set of subjects. 
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Table 4.2 shows the overall EDA and HRV response for cold pressor test, HUT, stand test, and 
Stroop task, along with the significance of differences found between baseline and stimuli for each index.  
All EDA measures (TVSymp, SCL, NS.SCRs and EDASympn) significantly increased between baseline 
and test stages.  HRVLF only exhibited significant differences during the stand test and Stroop task.  
HRVLFn showed differences during HUT and the stand test, but not during cold pressor and Stroop task.  
Figure 4.4 shows 8 minutes (6 minutes in the case of cold pressor as this tests was shorter) of time evolution 
(mean ± standard deviation) of TVSymp for cold pressor, HUT, stand test and Stroop task.   For all stimuli, 
TVSymp reaches a maximum value at ~2 minutes and then gradually decrease with time.  However, the 
Stroop test differs from other stimuli in that the maximum values linger for long time durations and then 
gradually decrease to a baseline values.  Note that before each test, subjects remained in the supine position 
for at least 5 minutes to ensure hemodynamics stabilization.  This can be seen in Table 4.2 especially for 
TVSymp as its baseline values are nearly identical prior to stimuli. 
 
Table 4.2 Results for EDA and HRV indices. 
Index Stage Cold  
Pressor 
70° Head-
up Tilt 
Stand Test 
Stroop  
Task 
TVSymp Baseline 0.5 ± 0.3 0.3 ± 0.3 0.3 ± 0.3 0.2 ± 0.3 
Test 1.4 ± 0.7* 1.6 ± 0.7* 1.6 ± 0.7* 1.4 ± 0.7* 
SCL (µS) Baseline 0.8 ± 4.7 2.9 ± 6.2 4.1 ± 8.1 -1.3 ± 3.9 
Test 4.5 ± 7.5* 6.5 ± 8.4* 10.8 ± 7.5* 6.3 ± 4.0* 
NS.SCR (#/min) Baseline 2.7 ± 2.9 1.5 ± 2.3 1.8 ± 2 0.9 ± 1.5 
Test 4.9 ± 4.5* 3.6 ± 2.7* 6 ± 2.9* 9.8 ± 3.9* 
EDASympn (n.u.) Baseline 0.2 ± 0.2 0.2 ± 0.2 0.3 ± 0.2 0.3 ± 0.2 
Test 0.4 ± 0.2* 0.4 ± 0.2* 0.5 ± 0.2* 0.5 ± 0.2* 
HRVLF (ms2) Baseline 7.1 ± 6.4 4.7 ± 3.9 3.8 ± 3.9 4.2 ± 3.4 
Test 4.8 ± 3.3 16 ± 21 36 ± 33* 6.1 ± 4.4* 
HRVLFn (n.u.) Baseline 0.3 ± 0.1 0.3 ± 0.1 0.2 ± 0.05 0.4 ± 0.1 
Test 0.3 ± 0.1 0.5 ± 0.2* 0.6 ± 0.2* 0.4 ± 0.1 
Values are mean ± standard deviation 
* represents significant difference compared to baseline stage (p<0.05) 
TVSymp, Time-varying index of sympathetic tone; SCL, skin conductance level; NS.SCRs, non-specific skin 
conductance responses; EDASympn, normalized sympathetic component of the EDA; HRVLF, low frequency 
components of HRV; HRVLFn, normalized low frequency components of HRV 
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Results for the analysis of sensitivity are shown in Table 4.3.  TVSymp outperformed all the other 
indices (highest J) at detecting stress, with the only exception being HRVLFn which exhibited a higher 
performance (J=1 vs. J=0.83) during the stand test.  NS.SCRs and TVSymp exhibited equal J values for the 
stand test.  TVSymp also showed a higher probability to assign a higher value to a positive instance than to 
a negative one (highest AUC).  NS.SCRs and HRVLFn equaled TVSymp on this measure for Stroop task 
and postural stimulation (stand test), respectively.   Similar behavior was found for the accuracy, where 
TVSymp surpassed all the other indices, with the only exception being HRVLFn during the stand test (Acc 
= 1 vs. Acc = 0.92).   Figure 4.5 includes ROC curves for the four tests.  Notice how the TVSymp ROC 
curve is more pronounced towards the left top corner, with the only exception being the stand test curve, 
where HRVLFn curve is slightly higher. 
As for the measures of variation and consistency, Table 4.4 shows how TVSymp exhibits higher 
variation during baseline, compared to the four tests.  However, such variation is almost always lower than 
the variation of SCL and NS.SCRs.  NS.SCRs were only less variable during the stand test baseline.  That 
is consistent with studies that report high variability of SCL and NS.SCRs, a concern among researchers 
[15], impeding the widespread use of these indices for assessing the general state of activation of the 
sympathetic system.  Compared to EDASympn, TVSymp exhibited similar CV, slightly lower for cold 
pressor and HUT, and higher for stand test and Stroop task baselines.  HRVLF was one of the more variable 
Table 4.3 Sensitivity analysis of sympathetic indices. 
 Cold Pressor 70° Head-up Tilt Stand Test Stroop task 
Index J AUC Acc J AUC Acc J AUC Acc J AUC Acc 
TVSymp 0.75 0.80 0.88 0.92 0.91 0.96 0.83 0.88 0.92 1.00 0.92 1.00 
SCL 0.50 0.66 0.75 0.42 0.63 0.71 0.58 0.69 0.79 0.83 0.85 0.92 
NS.SCR 0.33 0.61 0.67 0.50 0.73 0.75 0.83 0.87 0.92 0.92 0.92 0.96 
EDASympn 0.58 0.70 0.79 0.50 0.66 0.75 0.50 0.63 0.75 0.42 0.69 0.71 
HRVLF 0.25 0.42 0.63 0.38 0.59 0.69 0.75 0.80 0.88 0.50 0.55 0.75 
HRVLFn 0.38 0.48 0.69 0.88 0.81 0.94 1.00 0.88 1.00 0.38 0.44 0.69 
J is Youden's index, AUC is Area under the ROC curve, Acc is accuracy. 
TVSymp, Time-varying index of sympathetic tone; SCL, skin conductance level; NS.SCRs, non-specific skin conductance 
responses; EDASympn, normalized sympathetic component of the EDA; HRVLF, low frequency components of HRV; 
HRVLFn, normalized low frequency components of HRV 
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indices, ranking third overall after SCL and NS.SCRs.  In contrast, HRVLFn was the least variable index 
overall. 
  TVSymp was the most consistent index, as its intra-class correlation achieved a very high value 
of 0.96 with bounds between 0.9 and 0.99 for a level of significance of 0.05.  Even though SCL’s and 
NS.SCRs’ consistencies were high, in agreement with previously reported values [16], their consistencies 
were not as high as those of TVSymp. The least consistent index was the EDASympn.  HRVLF and 
HRVLFn proved to be moderately consistent indices.  
 
 
 
 
Figure 4.4 – Evolution (mean ± standard deviation) of TVSymp, Time-varying index of sympathetic 
tone, for the four tests: cold pressor, HUT (head-up tilt), stand test and Stroop task. 
TVSymp is at baseline levels before the test is performed. 
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4.4 Discussion 
The time-varying spectral EDA index of sympathetic control, TVSymp, was significantly higher 
during the cold pressor test, HUT, stand test and Stroop task, compared to baseline.  TVSymp can be used 
as a noninvasive measure for assessing sympathetic function, as these induced stressors are known to invoke 
the sympathetic nervous system’s response.  Measures of detection theory showed that TVSymp is the most 
sensitive index of sympathetic arousal overall for the four stimuli experiments in the study, with the 
exception of the stand test where HRVLFn was slightly better.  Furthermore, TVSymp exhibited lower 
variability (coefficient of variation) than did time-domain EDA indices (SCL and NS.SCRs), and higher 
consistency (intra-class correlation coefficient) than any other tested index of sympathetic control. Time-
frequency analysis of EDA provides relevant information about sympathetic arousal in different scenarios, 
as all biological systems are time-variant, increasing the potential for an EDA signal to be used for detecting 
the onset and level of stress induced by various stimuli.  However, more testing is needed to determine the 
method can be applied to diagnosis of the onset and progression of diseases that affect the autonomic 
nervous system.  
Traditionally, techniques for sympathetic function assessment have involved hemodynamic 
measurements [25], [26], adrenergic and ganglionic pharmacological blockade [27]–[30], noradrenaline 
measurement in urine or plasma [3], [31], [32], microneurography [33], [34], plasma noradrenaline kinetics 
Table 4.4 Coefficient of Variation and Intra-Class correlation results. 
 Cold Pressor 70° Head-
up Tilt 
Stand Test Stroop task Average 
CV 
Intra-class correlation 
(LB UB) Indices BL Test BL Test BL Test BL Test 
TVSymp 0.66 0.48 0.76 0.33 1.33 0.33 1.13 0.34 0.67 0.96 (0.9 0.99) 
SCL 6.04 1.68 2.12 1.28 1.96 0.69 3.07 0.64 2.18 0.87 (0.67 0.97) 
NS.SCR 1.09 0.91 1.50 0.76 1.11 0.48 1.56 0.40 0.98 0.92 (0.8 0.98) 
EDASympn 0.68 0.47 0.90 0.45 0.59 0.48 0.72 0.37 0.58 0.81 (0.46 0.95) 
HRVLF 0.90 0.69 0.82 1.32 1.02 0.91 0.85 0.69 0.90 0.84 (0.58 0.96) 
HRVLFn 0.39 0.52 0.28 0.34 0.22 0.29 0.42 0.20 0.33 0.89 (0.72 0.97) 
BL: baseline; LB and UB are upper and lower bounds, respectively, of the intra-class correlation with a level of 
significance of 0.05; TVSymp, Time-varying index of sympathetic tone; SCL, skin conductance level; NS.SCRs, 
non-specific skin conductance responses; EDASympn, normalized sympathetic component of the EDA; HRVLF, 
low frequency components of HRV; HRVLFn, normalized low frequency components of HRV 
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[35], [36], HRV analysis [9], [37], [38] or imaging techniques [39].  However, hemodynamic measurements 
and pharmacological blockade are invasive and present limited reproducibility. Noradrenaline 
measurement provides only a ‘static’ picture of sympathetic function.  Microneurography is the only 
method for directly and continuously recording efferent postganglionic muscle sympathetic nerve activity; 
however, it is an invasive technique.  Imaging techniques, including positron emission tomography and 
single photon emission computed tomography scanning, have been applied to visualize the sympathetic 
innervation of human organs with good success, but neuroimaging techniques are costly and require 
specialized technical support. 
HRV analysis has been widely employed because it is a low-cost noninvasive continuous method 
to evaluate cardiac sympathetic regulation.  The low-frequency components of HRV (0.045-0.15 Hz) are 
commonly used as a marker of sympathetic control, even though such components are known to be 
influenced by both the sympathetic and parasympathetic nervous systems.  Such influence reduces the 
accuracy of the technique.  Time-domain analysis of EDA has also been used as a noninvasive marker of 
sympathetic nervous system regulation.  The main advantage of EDA over HRV is that there is no 
parasympathetic innervation of eccrine sweat glands.  However, a drawback to using time-domain measures 
of EDA is that they are highly variable between subjects [15].   
A recent study suggests that sympathetic function influences the EDA spectrum mainly in the range 
from 0.045 to 0.25 Hz [16].  This is in agreement with what we found, specifically, that the spectral 
amplitudes with frequencies of 0.08 to 0.24 Hz are the most responsive to sympathetic control, with the 
improvement in consistency and sensitivity shown by the time-frequency index, the TVSymp.  We also 
performed VFCDM decomposition using sampling frequencies of 1 Hz and 0.8 Hz (not shown), in order to 
explore the effect of a higher frequency resolution on the signal decomposition.  This allowed us to compute 
the percentage of spectral power with higher spectral resolution and calculate the TVSymp index at 
frequencies between 0.04 and 0.08 Hz, which was part of the frequency-domain index in our previous study 
[16].  Although this frequency band comprised about 10 to 15% of the total power, it was not as responsive 
to induced stimuli in this study, and its inclusion in computing the TVSymp resulted in lower sensitivity 
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and performance of the index (assessed by signal detection theory).  Performing time-invariant spectral 
density calculations on time-variant dynamics has been known to cause spectral distortion in the form of 
broadening of the spectral density [40], hence, we surmise that this may have caused the difference between 
the lower bound of the sympathetic dynamics found in this and our previous study [16].  We believe that fs 
= 2 Hz is the most suitable sampling frequency, and that TVSymp index based on the frequency band 0.08 
to 0.24 Hz is the most appropriate for capturing the sympathetic dynamics. 
The responses of HRV dynamics and EDA to cold stress are also poorly understood, however, this 
stimulus has been increasingly used in clinical practice to evaluate autonomic function in cardiovascular 
regulation, because stressful cooling evokes an increase in sympathetic neurotransmissions via activation 
of cold thermoreceptors and nociceptors [41].  HRVLF and HRVLFn are known to be insensitive detectors 
of stress induced by cold pressor, as various studies have reported increases [42], [43], decreases or 
insignificant changes [44]–[47].  This is in agreement with our results, as HRVLF and HRVLFn exhibited 
no differences between baseline and test for this stressor.  Other studies found increases in SCL and 
NS.SCRs in healthy subjects when cold pressor was applied [48], [49].  Despite the high variability (CV) 
for this test, we also found significant differences in NS.SCRs and SCL indices when comparing cold 
pressor to baseline.  EDASympn index also exhibited sensitivity to this test, as reported previously [16].  
The time-frequency analysis index in this study, TVSymp, was able to discriminate between baseline and 
cold pressor.  Indeed, although we observed that cold pressor was the most challenging test for detection, 
TVSymp performed the best among the various indices (highest J, AUC and Acc). 
HUT testing has been widely used to elicit sympathetic activation, as evidenced by increases in the 
low frequency components of HRV, mainly in normalized units [47], [50]–[52].  We were in agreement, as 
we found significant differences only in the normalized index, HRVLFn.  EDA data during HUT are scarce, 
as only one study has tested skin conductance during HUT [53], showing an increase in the SCL in the tilt-
negative group.  In addition to the increase in SCL and NS.SCRs, the novel findings for the current study 
were the EDASympn and TVSymp responses, both of which have never been tested during HUT.  
EDASympn was able to discriminate between supine baseline and HUT, and TVSymp not only showed 
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differences between baseline and HUT, but was the most sensitive, accurate and responsive index at 
detecting when the subjects were under orthostatic stress induced by HUT. 
Sympathetic tone normally increases with postural stimulation (e.g. stand test) [5], [54], [55].  
However, HRV has been shown to have poor reproducibility during an orthostatic challenge in healthy 
subjects, and even poorer reproducibility in a clinical population [56]. In the supine position, HRVLF and 
HRVLFn were shown to have poor relative reliability (i.e. high inter-subject variability).  In this study we 
found significant differences in both HRV indices during the stand test.  Indeed, HRVLFn showed the 
highest performance in distinguishing between supine and standing position.  For its part, EDA has not 
 
 
Figure 4.5 – ROC curves (sensitivity vs. 1-specificity) for the four tests, (a) cold pressor, (b) head-up 
tilt, (c) stand test and (d) Stroop task. 
The indices of sympathetic control are: TVSymp, Time-varying index of sympathetic tone; SCL, skin 
conductance level; NS.SCRs, non-specific skin conductance responses; EDASympn, normalized 
sympathetic component of the EDA; HRVLF, low frequency components of HRV; HRVLFn, 
normalized low frequency components of HRV 
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been used often for assessing the stress induced in a stand test [14], [16].  In this study we found significant 
differences in SCL and NS.SCRs between supine and standing.  EDASympn, the time-invariant frequency-
domain index, was also different between body postures, with a much lower variability than SCL and 
NS.SCRs.  The time-frequency domain index, TVSymp, was significantly different between supine and 
upright positions.  Even though the best detector for stand test was the HRVLFn, TVSymp exhibited a 
similarly good performance. 
Low-frequency components of HRV have been shown to increase significantly during Stroop task 
[57]–[59].  We found that HRVLF, but not HRVLFn, significantly increased between baseline and Stroop 
test.  Regardless of their high variability during this test, SCL and NS.SCRs indices were significantly 
higher during the Stroop test when compared to baseline.  EDASymp also exhibited a significant increase.  
The performance and sensitivity of the TVSymp index was nearly perfect for the Stroop task.  Beyond the 
significant differences encountered between baseline and the induced cognitive stress, TVSymp detected 
such stress with the maximum possible accuracy (Acc = 1) and performance (J = 1). 
As shown in Table 4.2, the greatest change in the EDA indices to induced stimuli occurred for the 
Stroop task for TVSymp, SCL and NS.SCR, which are then sequentially followed by stand and head-up tilt 
tests.  For these three indices, the cold pressor stimuli induced the least change in their EDA responses.  For 
HRVLF index, the greatest change was noted for the stand test followed by the Stroop test.  While the 
EDASympn showed significant differences between the baseline and all stimuli, the induced changes in the 
amplitude of the EDA responses were similar for all tests.  For TVSymp, SCL and NS.SCR indices, the 
EDA responses are most sensitive to cognitive followed by orthostatic and cold pressor tests.  However, 
further studies are needed to quantify and validate these findings using direct measures of the sympathetic 
activity.  
The SCL index and NS.SCRs are consistent with sympathetic arousal, as they are elevated by 
administration of dextroamphetamine, caffeine, and threatening instructions [60]–[62].  They also have 
relatively low within-subject variability (correlation of test-retest ranges from 0.50 to 0.70) but high 
variability between subjects [15]. In this study, we also found SCL to be a sensitive, but very highly variable 
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index.  Although NS.SCRs are a consistent and fairly sensitive index, frequency-domain and time-
frequency domain (EDASympn and TVSymp) indices do not rely on either manual or automatic SCR 
detection, which is usually more complex and time consuming.  Because of its high sensitivity to four 
different types of stimuli and relatively low variability, the frequency-domain EDASympn index was 
recognized as a promising index of sympathetic function under multiple stressors in healthy individuals.  
However, it lacks consistency between subjects and has an inability to detect postural stimulation (stand 
test) and cognitive stress, compared to SCL and NS.SCRs.  TVSymp uses time-varying dynamics, an 
inherent characteristic of all biological systems, hence, it was shown to be a highly sensitive index of the 
sympathetic autonomic nervous system activity. 
Time-varying analysis of EDA not only overcomes the well-known lack of consistency limitation 
of traditional time-domain analysis of EDA, it was also shown to be highly sensitive measure of the 
sympathetic dynamics.  Moreover, time-varying analysis of EDA was found to be more sensitive measure 
of the sympathetic dynamics than the low frequency component of the heart rate variability.  While this 
work explored cognitive, physical and orthostatic stress, the time-varying analysis of EDA along with HRV 
could be extended to host of other studies to better characterize and discriminate dynamics of the autonomic 
nervous system that may be indicative of impending fatigue and stress.  An accurate understanding of the 
autonomic nervous system’s dynamics pertaining to the situation at hand can lead to better guidance and 
interventions to improve human health and performance.   
 
4.5 Conclusion 
The TVSymp index is a suitable discriminator of the stress induced by cold pressor, HUT, stand 
test, and Stroop task, and has the potential to be used as a reliable marker of quantitative assessment of 
sympathetic function.  Although HRVLFn was slightly more sensitive to postural stimulation from the stand 
test, it was not as sensitive to HUT, cold pressor and Stroop task compared to TVSymp. Overall, TVSymp 
was found to be more reliable and sensitive than indices based on low-frequency components of HRV, was 
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highly consistent between subjects, and exhibited a lower variability compared to the time-domain 
measures of EDA.  Finally, the frequency bands of the sympathetic nervous activities in healthy subjects 
can be defined to be most responsive in the frequencies between 0.08 and 0.24 Hz.  More research is needed 
to determine whether these characteristics extend to patient populations.  
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Chapter 5: Electrodermal Activity Suggests a Change in Frequencies of 
Sympathetic Control During Exercise 
(Posada-Quintero, H. F., Reljin, N., Mills, C., Mills, I., Florian, J. P., VanHeest, J. & Chon, K. H. 
Electrodermal Activity Suggests a Change in Frequencies of Sympathetic Control During Exercise.  
American Journal of Physiology - Exercise.  Submitted) 
 
5.1 Introduction  
Traditionally, two frequency bands are considered in the spectral analysis of HRV during stationary 
conditions: high frequency (HF) band (0.15 to 0.4 Hz), for which the parasympathetic nervous system 
activity is the major contributor [1], [2]; and low frequency (LF) band (0.045 to 0.15 Hz), whose 
interpretation is more complex, but it has been demonstrated that it reflects both sympathetic and 
parasympathetic influences [1], [3].  Intuitively the LF and HF bands should increase with exercises as the 
heart rates are higher, however, the precise frequency bandwidths are not well established.  Previous studies 
have shown inconsistent results if the prescribed bands of frequencies associated with the ANS are kept 
unmodified during exercises [4]–[7].  Other studies have made attempts to characterize the sympathetic and 
parasympathetic dynamics during exercises, especially taking into account influences of higher respiratory 
rates and other physiological effects of physical activity [8]–[11].  In particular, adjustments to the original 
HF band were made, either by extending the upper frequency bound (originally 0.4Hz) to about 1.2Hz to 
1.5Hz, or defining HF as a time-varying or constant bandwidth around respiratory frequency, but LF 
bandwidth was fixed at the stationary prescribed range [8], [9], [11]–[18].  The LF bandwidth during 
exercise is difficult to establish due to the nature of the HRV as it is not able to separate contributions of 
the sympathetic and parasympathetic dynamics. 
We hypothesize that the frequency bandwidth of the sympathetic dynamics should also be modified 
under physical activity.  Exploring this hypothesis has been technically difficult using only HRV because 
 71 
 
the increase in the upper frequency bound of LF band can potentially result in the overlap of the frequencies 
associated with the parasympathetic tone in the HF portion of the HRV spectrum [19].  Moreover, given 
that the LF band consists of both parasympathetic and sympathetic tones, it is not clear if the frequency 
range needs to be adjusted to higher frequencies or remain the same for exercise conditions.  Given these 
scenarios, a novel approach is needed to overcome these limitations of HRV. 
Electrodermal activity (EDA) has recently garnered interest as an alternative to HRV for assessing 
sympathetic dynamics given that sweat glands are only innervated by sympathetic nerves.  EDA as a 
reflection of autonomic innervation of sweat glands [20], has shown strong correlation to sweat production, 
and is thought to provide a quantitative functional measure of sudomotor activity [21], [22].  EDA is 
technically defined as a measure of the changes in electrical conductance of the skin. In a recent studies, 
we have used power spectral density (PSD) and time-varying spectral analysis of EDA to obtain information 
of sympathetic arousal.  We found that dynamics of the sympathetic dynamics estimated from the EDA 
signal under non-exercise conditions were found to be in the low-frequency range, from 0.045 to 0.25 Hz, 
when subjects underwent stress invoking tests [23, p.], [24].  This frequency range is similar to HRV’s LF 
band albeit the upper limit frequency of 0.25 Hz from EDA is higher than 0.15 Hz.  Hence, to test the ANS 
under physical activity, specifically the possible shifting of the frequency band of sympathetic tone to 
higher frequencies, we conducted submaximal physical tests on a treadmill and data collection of both 
electrocardiogram and EDA signals from healthy subjects. 
5.2 Materials and Methods 
5.2.1 Protocol 
Subjects for which exercise represents a low risk level, based on standardized guidelines from the 
American College of Sports Medicine (ACSM) [25], were asked to participate in the study.  Eighteen 
healthy subjects, 11 males and 7 females, age 21 ± 3 years old were enrolled.  Participants were asked to 
avoid caffeine and alcohol during the 48 hours preceding the test, and were instructed to fast for at least 3 
h before testing. The study was conducted in a quiet, comfortable room (ambient temperature, 26-27 °C, 
 72 
 
and a relative humidity between 30-50%).  All participants signed a consent form approved by the 
Institutional Review Board of UConn.  
Before the exercise test begun, the subjects were asked to lay in the supine position for 5 min to 
procure hemodynamic stabilization. ECG and EDA were measured simultaneously for each subject 
throughout the whole experiment. HP ECG monitor (HP 78354A) and GSR ADInstruments module were 
used.  Three hydrogel Ag-AgCl electrodes were employed for ECG signals collection on the torso, placed 
on the shoulders and lower left rib.  In addition, a pair of stainless steel electrodes were placed on index 
and middle fingers to collect EDA signal.  The skin was cleaned with alcohol before placing the ECG and 
EDA electrodes.  All leads were taped to subject’s skin using latex-free tape, to avoid movement of the 
cables, which can corrupt the signals.  All signals were acquired through the ADInstruments analog-to-
digital converter, and a compatible PowerLab software, while sampling frequency was fixed to 400 Hz for 
all signals.  Participants were asked to wear their own active wear/gym clothes during the protocol with the 
shirt covering the electrodes and cables during the experiment. 
Experimental protocol resembles the procedure utilized in [8]  (sketched in table 1).  Notice that 
this study involves only moderate intensity physical activity, as the stopping criteria is achieving 85% of 
subjects’ maximal heart rate (HRmax).  Subjects were first monitored for 5 min at rest (supine, without any 
movement or talking) to measure resting heart rate (HR) and EDA. The subjects then performed an 
incremental test on a motorized treadmill (Life Fitness F3), reaching 85% of their HRmax, calculated from 
the equation [25]: 
  𝐻𝑅𝑚𝑎𝑥 = 206.9 − (0.67 ∗ 𝑎𝑔𝑒),  
The incremental running began with an initial warm-up walking at 3mi/h (about 4.82 km/h). Then 
the speed was increased to 5 mi/h (about 8 km/h) and increased 0.6 mi/h (about 1 km/h) every minute until 
the subjects were stopped due to reaching 85% of their HRmax. Thereafter, subjects were required to remain 
running at 5mi/h (about 8 km/h) for another 4 min to start the recovering phase, followed by walking at 
3mi/h (about 4.82 km/h) for 5 minutes and a final 10 min (or more if needed to achieve baseline HR) period 
 73 
 
in the supine position to procure adequate recovering. The duration of the experiment lasted approximately 
one hour. 
5.2.2 Signal processing  
Time-invariant and time-variant spectral analysis have been employed recently on EDA data [23, 
p.], [24].  The criteria to define the maximum frequency (Fmax) or the upper frequency bound of the 
sympathetic components of EDA is to find a frequency greater than Fmax such that the integration of the 
spectral power from it to Fs/2 (half of sampling frequency or the Nyquist’s frequency) consists of less than 
5% of the total power.  Using this criterion, our previous time-invariant and time-varying analyses found 
that in the non-exercise conditions, the upper bound or Fmax was found to be 0.25 Hz.  Similarly, in this 
study, we analyzed Fmax for all subjects, to test the effects of physical activity on the possible increase of 
spectral power for frequencies beyond 0.25 Hz. 
We define six exercise stages of data collection: stage 1, subjects are lying down on their back, 
labeled “supine”; stage 2, the subject is asked to move to the treadmill, named “going-to-walk”; stage 3, 
subject starts moving on the treadmill, called “walking”; subject has been walking on the treadmill at 3 mi/h 
for three minutes, the “end-of-walking”; speed is set to 5 mi/h and the increasing test starts, labeled 
“running”; and finally subject is running “at-85%-HRmax”.  Two-minute segments of every stage were 
utilized for data analysis. 
 
Table 5.1 Experimental protocol. 
Action (details) Speed Duration 
Rest (supine)  5 min 
Warm up (walking) 3 mi/h (~4.82km/h) 5 min 
Running 5 mi/h (~8 km/h) 1 min 
Running 
(until the subjects stopped due to reaching 
85% of their HRmax) 
+ 0.6 mi/h (+ ~1km/h) 
Every  
1 min 
Running (recovery starts) 5 mi/h (~8 km/h) 4 min 
Recovery (walking) 3 mi/h (~4.82km/h) 5 min 
Rest (supine)  10 min 
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Using these various exercise stage signals, we tested how Fmax evolves under the exercise protocol 
using both time-invariant and time-varying approaches.  The time-invariant power spectra of EDA signals 
were calculated using Welch’s periodogram method with 50% data overlap.  A Blackman window (length 
of 128 points) was applied to each segment, the Fast Fourier Transform was calculated for each windowed 
segment, and the power spectra of the segments were averaged.  
To compute the time-frequency representation (TFR) of EDA we employed the variable frequency 
complex demodulation (VFCDM), a time-frequency spectral (TFS) analysis technique that provides 
accurate amplitude estimates and one of the highest time-frequency resolutions.  The technique has been 
previously described [26], [27].  We used the instantaneous spectral estimate for every time point of the 
TFR to compute an Fmax series.  We averaged the Fmax series over the time segments defined previously 
for the six stages. 
To test the differences on Fmax between stages we have utilized the Dunn's test, a non-parametric 
pairwise multiple comparisons procedure based on rank sums, often used as a “post hoc” procedure 
 
Figure 5.1 – Raw EDA signal for a given subject throughout different body positions and 
exercise conditions. 
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following rejection of a Kruskal–Wallis test. As such, it is a non-parametric analog to multiple pairwise t-
tests following rejection of an ANOVA null hypothesis [28]. 
 
5.3 Results 
This section comprises the results of this study, including a general description of the signals 
obtained during the experiment, their main characteristics, the parameter computed using spectral analysis, 
and the statistical analysis carried out to evaluate the significance of the results. 
 
Figure 5.2 – Twenty seconds of raw EDA for a given subject during different events.  Note the 
high-frequency oscillations increase with exercise intensity. 
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 Figure 5.1 shows the EDA signal for a representative subject, showing the time progression from 
lying on the table until the moment the heart rate reached 85% of HRmax.  The EDA signal’s dynamics as 
shown in Figure 5.1 were found to be similar for all subjects. Changes in the conduction levels of EDA, 
termed skin conductance level (SCL) in the literature [29], are seen with the progression of various exercise 
stages.  For example, for this subject in the supine posture, the SCL is low, with an immense increase in 
conductance when the subject stood up to go to the treadmill.  There is also a considerable increase in SCL  
when the subject started walking.  The mean conductance level tends to increase during exercise (walking 
and running).  Lines in the Figure 5.1 denote the time when the subject started walking and running, 
respectively. 
 
Figure 5.3 – Power spectral density of EDA for a given subject during different events and computed 
Fmax (to account for 95% of the total power).  Fmax values increase concomitantly with exercise 
intensity. 
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 In addition to the increase in conductance level, there is also an increase in high-frequency 
components, as shown in Figure 5.2.  A good indicator of the quality of the EDA signals is the smoothness  
of the raw waveform [29].  These waves are called skin conductance responses (SCRs).  Since these SCRs 
 
Figure 5.4 – Time-frequency representation of EDA for a given subject. Red lines demarcate when the 
subject started walking and running. Instantaneous Fmax (white line) is computed for each time point. 
 
Table 5.2 Fmax (Hz) for different stages. 
 
Time-invariant 
analysis 
Time-varying 
analysis 
Supine 0.11 ± 0.07 0.11 ± 0.07 
Going to walk 0.16 ± 0.12 0.14 ± 0.08 
Walking 0.22 ± 0.12 0.22 ± 0.08 
End of walking 0.28 ± 0.09 0.27 ± 0.07 
Running 0.27 ± 0.12 0.31 ± 0.12 
At 85% HRmax 0.31 ± 0.15 0.37 ± 0.11 
Values are mean ± standard deviation 
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we obtain in this experiment are not due to any specific instantaneous stimuli, in contrast to startle-like  
experiments, they are called non-specific skin conductance responses (NS.SCRs). Note that the occurrence 
of NS.SCRs is more frequent when the intensity of the exercise is increased.  Although NS.SCRs have been 
traditionally quantified in time domain, by counting them and providing an index of number of NS.SCR’s 
per unit of time, these high-frequency oscillations have shown to be an even more sensitive index of 
sympathetic arousal when analyzed in the frequency or time-frequency domain [23], [24]. 
 
 
Figure 5.5 – Box plots for estimated Fmax for all exercise stages and subjects using time-invariant 
(top panel) and time-varying (bottom panel) approaches. 
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Power spectra of EDA signal segments were computed for all subjects and for every exercise stages.  
For each spectrum the Fmax was computed and is noted as the blue vertical line.  Figure 5.3 includes 
representative results for one subject.  For this representative subject, when the subject is at the supine 
posture, most of the spectral power is concentrated in the very-low frequency range.  As the subject stands 
up (the second panel: “going to walk”), the Fmax is increased to about 0.25 Hz.  After the subject has 
walked for about 5 minutes, spectral power shifts towards higher frequencies, reaching an Fmax value of 
about 0.35 Hz to 0.4 Hz; these frequencies do not shift higher for greater exercise intensities.   
For the time-varying approach [27], instantaneous Fmax was computed for every time point.  
Figure 5.4 shows an example of how higher-frequency power is increased over time.  Red and yellow lines  
are more visible as the subject undergoes to a walk and run, and the Fmax (shown as white line in Figure 
5.4) moves upward.   
Table II includes the results for Fmax for both time-invariant and time-varying analysis.  Both 
approaches show an increase of Fmax for higher exercise intensities.  The Fmax was lower during the 
running period when compared to the supine stage.  Figure 5.5 consists of the box plot for the estimates of 
Fmax using time-invariant and time-varying approaches.  Mean value of Fmax is stable for the first two 
 
Table 5.3 Summary of Dunn’s test for time-invariant and time-varying analysis 
 
 Time-invariant  Time-variant 
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Supine 0 0 1 0 1  0 0 1 1 1 
Going to walk - 0 1 0 1  - 0 1 1 1 
Walking - - 0 0 0  - - 0 0 0 
End of walking - - - 0 0  - - - 0 0 
Running - - - - 0  - - - - 0 
 “1” indicates statistical significance p < 0.05.  Left: results using time-invariant spectra (power spectral density); 
Right: results using time-varying analysis (time-frequency representation).  Time-varying analysis provided a 
more clear difference on Fmax between the higher-intensity exercise and the lower levels of physical activity. 
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stages, then increases to a medium level when subjects start walking, and finally increases to a value 
between 0.3 to 0.4 Hz when subjects undergo higher-intensity exercises.   
 Table III shows the outcome of Dunn’s test.  These results suggest an increase in Fmax at higher 
intensities of exercise, starting when the subjects have walked for about 5 minutes, until the subjects are 
running at 85% of their HRmax.  No statistical differences were found between stages one, two and three 
(supine, going to walk and walking) using either approach.  PSD showed differences on Fmax between the 
time the subjects were walking before starting to run and the time the subjects were running at 85% of their 
HRmax, compared to the supine stage and right before subjects were going to walk. As mentioned, time-
invariant PSD approach’s estimated Fmax during the running stage is lower than the preceding stage (end 
of walking), resulting in non-significant difference when compared to end of walking stage.   
The TFR approach was able to find differences more consistently for the three highest levels of 
physical activity, compared to the first two stages.  This suggests that Fmax is significantly higher at the 
time the subjects have walked for about 5 minutes to any level of exercise, compared to the very low and 
 
Figure 5.6 –  Ensemble average of power spectral density of HRV during different events. Vertical 
lines are Fmax values computed via EDA.  Note that Fmax is an estimation of the upper bound of LF 
band. 
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medium levels of exercise.   The stage when the subject was starting to walk showed some increase on 
Fmax, but such increase was not significant.  
Figure 5.6 shows averaged PSD of HRV derived from surface ECG obtained from 18 subjects 
during various body positions and exercise conditions.  The vertical dotted lines in Figure 5.6 represent 
Fmax values determined from EDA.   Note the shift of the respiratory rates to higher frequencies 
concomitant to the increased levels of exercise difficulty.  When accounting for the respiratory frequencies 
in Figure 5.6, we observe that the Fmax demarcation lines are good approximations of the LF dynamics of 
the HRV derived from ECG.  This result lends support to the following two observations.  First, we observe 
that the sympathetic dynamics do shift to higher frequencies as the level of strenuous exercise increases.  
Second, the EDA derived upper frequency bounds, Fmax values, are good surrogate measures of the LF 
dynamics of the ECG derived HRV.  Hence, when only the HRV values are available (e.g., no EDA data), 
our derived Fmax bounds from EDA may be confidently used as the demarcation of the upper limit of the 
sympathetic dynamics.  
5.4 Discussion 
We have found evidence of an increase of the maximum frequency of the sympathetic tone 
concomitant with the exercise intensities, termed Fmax, based on both time-invariant and time-varying 
spectral analysis of EDA, albeit more significant shifts were found with the latter approach.  The 
implications of the current finding are twofold.  First, the current practice of fixed frequency band of 0.04-
0.15 Hz, termed, the low frequency via HRV analysis of RR intervals for all conditions can lead to 
inaccurate capture of the sympathetic dynamics especially during exercise conditions.  Second, Fmax values 
obtained via EDA can be used as a good surrogate measure of the sympathetic dynamics even for HRV 
analysis.  In other words, it is our view that even when EDA signals are not available, the derived Fmax 
from our study can be reliably used as the upper bound of the LF range of the HRV analysis based on RR 
intervals derived from electrocardiogram signals.      
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The relative role of the two branches of the ANS depends on the exercise intensity [30], [31].  In 
resting conditions, heart rate fluctuations are driven by homeostatic cardiovascular control systems [32]–
[34].  On the contrary for the exercise condition, heart rate increases to a steady-state value due to both 
parasympathetic withdrawal and augmented sympathetic activity. However, HRV has shown to be an 
inconsistent means to assess sympathetic and parasympathetic tone especially during exercise conditions.  
For example, there have been reports of an unexpected decrease of HRVLF during exercise of high intensity 
[7], [10], [35], [36].  Some studies have proposed saturation of the sympathetic activity during physical 
activity of high intensity as a possible cause [36], [37].  In simulated data, a group of researchers indicated 
that the cause for the reduction of HRVLF and HRVHF with high-intensity exercise was likely due to the 
decrease of the mean heartbeat variability which would consequently result in decreased spectral power of 
HRV [38].   
HRVHF (0.15 to 0.4 Hz) is widely accepted to be a measure of the parasympathetic activity at 
resting conditions [33]. Given that respiratory frequency is not restricted to the fixed frequency range during 
exercise, studies have been conducted to redefine the HRVHF band [8], [9], [11]–[18].  HRVHF band has 
been extended to include the entire physiologically relevant range of respiratory frequencies [39], [40], or 
centered on the respiratory frequency with a constant or time-dependent bandwidth [40], [41, p.], [42]–[44].  
However, none of the referenced studies above, have adjusted HRVLF bound, mainly because HRV cannot 
separate dynamics of the sympathetic and parasympathetic dynamics in the low frequency range [19], [45].   
The consequence of this is perhaps even greater inaccuracy of purported representation of the sympathetic 
dynamics in the LF as we show in Figure 5.3 and Figure 5.6, the sympathetic dynamics’ upper frequency 
band does shift to higher frequencies with increasing exercise intensities.   
In this study we used EDA to evaluate the sympathetic function under exercising conditions, as 
EDA represents only the sympathetic activity.  We encountered no significant difference between the 
walking and the supine posture conditions.  This is in agreement with the literature [31], because it has been 
reported that during mild exercise intensities heart rate rises primarily by a decrease on parasympathetic 
activity, whereas the increase in the sympathetic tone is minimal.  With medium and high exercise intensity 
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the sympathetic tone also contributes to the cardiac acceleration [31].  We have found that such increase on 
the sympathetic tone, due to high-intensity exercise, is noticeable and statistically significant on the EDA 
signal.   
The sympathetic dynamics’ upper frequency bound shifted higher to 0.25 Hz when subject 
transitioned from supine to upright and started walking (Table II) stages.  The walking stage corresponds 
to low-intensity exercise, where the main contribution of the ANS is the result of withdrawal of the 
parasympathetic tone.  In our previous study using EDA, we found that the sympathetic control was 
confined to the range 0.045 to 0.25 Hz, when subject underwent cold pressor test, tilt table test, cognitive 
stress and orthostatic stress [23], [24].  It can be noted that low-intensity exercise produces similar 
sympathetic tone as seen with various stressor induced in our previous study [23].  When subjects undergo 
moderate stress, (e.g., after the subject was walking on the treadmill for 5 minutes), the increase of Fmax 
was found to be significant with respect to the first two stages (supine and going to walk).   The upper 
frequency bound in this stage was located around 0.3 to 0.35 Hz.  When the subjects went for running (not 
at 85% of HRmax), we did not observe Fmax shifting higher than 0.35 Hz.  However, the mean Fmax 
increased to about 0.4 Hz when subjects were running at 85% of HRmax, but such increase was not 
significant compared to the previous two stages.  These last three stages of moderate and high-intensity 
exercise are characterized by the increase of the sympathetic tone, however we found that the dynamics of 
the sympathetic tone also moved towards frequencies of 0.35 to 0.4 Hz. 
The time-domain measures of EDA, e.g. SCL and NS.SCRs, are commonly utilized as markers of 
sympathetic arousal in response to tonic stimuli [29].  However, computing NS.SCRs relies on either 
manual or automatic SCR detection, which is usually more cumbersome and time consuming.  Furthermore, 
these measures are highly variable and less sensitive than indices based on frequency or time-frequency 
analysis of EDA [23], [23], [24], [46].  More importantly, these measures do not provide dynamic 
characteristics of the ANS. 
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5.5 Perspectives and Significance 
Spectral analysis of EDA can lead to a better understanding of the effect of physical exercise on 
humans and their autonomic nervous system.  EDA, possibly along with HRV, could be extended to other 
studies to better characterize and discriminate dynamics of the autonomic nervous system that may be 
indicative of fatigue, stress or exercise intolerance.  An accurate understanding of the autonomic nervous 
system’s dynamics under exercise can lead to better guidance and interventions to improve human health 
and performance.   
5.6 Conclusion 
Previous studies have shown that in resting conditions most of the sympathetic spectral power of 
EDA is confined to a similar frequency band as that of HRVLF.  In this study, we have found that when 
subjects undergo moderate to high-intensity exercises, the upper band of the sympathetic dynamics shift to 
0.35 to 0.4 Hz.  Moreover, we found that the low frequency bounds derived via EDA can be good surrogate 
measures of the sympathetic dynamics especially during moderate to high-intensity exercises, hence, the 
upper bound of HRVLF needs to shift to higher frequencies.  The varying upper frequency band of the 
sympathetic dynamics to be taken into account to provide a better understanding on the functioning of the 
branches of autonomic nervous system especially under high-intensity physical activity. 
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Chapter 6: Electrodermal Activity Can Track the Effects of Sleep Deprivation 
on Reactiveness and Vigilance 
(Posada-Quintero, H. F., Bolkhovsky, J. B., Reljin, N. & Chon, K. H.. Electrodermal Activity Can Track 
the Effects of Sleep Deprivation on Reactiveness and Vigilance.  To be published) 
 
6.1 Introduction  
This study analyzes the variations in electrodermal activity (EDA) and heart rate variability (HRV, 
see chapter 2) measures during a 24-hour period of sleep deprivation.  Understanding the effects of sleep 
deprivation on humans’ physiology is key to comprehending and mitigating the performance impairment 
produced by drowsiness. Human performance deterioration causes accidents in jobs like the military, health 
care, computer operations, and many more, that frequently require working long hours or late at night [1]. 
Occupational accidents result in a large social and economic cost [2], [3].  
Drowsiness has a remarkable effect on the autonomic nervous system (ANS) [4]–[6].  The ANS 
compensates for increased levels of stress by modulating the balance between parasympathetic and 
sympathetic nervous system traffic within the body’s regulatory network. A predominant sympathetic 
response to fatigue stressors is appropriate and beneficial. In contrast, a predominant parasympathetic 
response to the same fatigue stressor reflects an inappropriate response, indicating a progression toward a 
state of decompensation and failure of physiological function [5], [7]–[10].  Drowsiness induces such state 
of decompensation in humans.  Given the high-sensitivity of ANS to drowsiness, the ANS is an attractive 
target for the development of an objective physiological measure of the effects of sleep deprivation.   
Many studies have used indices of HRV to track the effects of sleep deprivation on humans [6], 
[11]–[18], with different levels of success.  These studies suggest that HRV has the potential to track several 
effects of sleep deprivation. On the other hand, the effect of sleep deprivation on humans’ EDA has been 
scarcely explored.  However, recent studies suggested the important contribution of EDA and the 
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sympathetic function assessment to better understand the altered reactivity in sleep deprived persons [4], 
[19].  Surprisingly, those studies only looked at the very slow components of EDA, i.e., change in SCL, 
and did not explore the occurrence of rapid shifts, which are common in the EDA signal. We hypothesize 
that higher-frequency components of EDA contain valuable information to better understand the effects of 
sleep deprivation.  We expect the changes found on the EDA and HRV due to prolonged sleep deprivation 
can be used to prevent the inconvenient (many times fatal) consequences of sleep deprivation.  To test this, 
we have employed a simple yet robust test that requires the subject to maintain vigilance. We have collected 
measurements of HRV and EDA through a 24-hour sleep deprivation period, and deployed analysis on the 
results. 
 
6.2 Materials and Methods 
6.2.1 Subjects 
Ten healthy volunteers (seven males and three females; ages ranging from 25 to 35) were enrolled 
in this study.  Participants were asked to remain awake for at least 24 hours, and various precautions were 
taken to ensure the validity of this study as well as the safety of the participants (i.e., experimenter 
observation). Seven days prior to the experiment, participants were given a data sheet to record their sleep 
patterns, to indicate compliance and explain potential outliers. 
6.2.2 Protocol 
Participants were asked to halt all consumption of stimulants and depressants beginning 48 hours 
prior to the start of the experiment. Food was provided to ensure it adhered to the restrictions of this study. 
Within two hours of waking up participants arrived at the experimental facility located at the University of 
Connecticut. Participants remained in the building for approximately 25 hours to allow for the completion 
of all trials. Within the first hour of arrival participants completed a set of learning trials for the experimental 
task. They then proceeded to perform the task every other hour for the duration of the 24-hour period.  
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Five minutes before each task session, stainless steel electrodes were placed on the participants’ 
middle and index fingers of their non-dominant hands to collect EDA signals. A set of three standard 
Ag/AgCl electrodes were placed on participant’s chest for recording ECG. ECG and EDA signals were 
simultaneously recorded every run.  An HP 78354A (Hewlett-Packard, FDA approved) and a GSR 
amplifier FE116 (fully isolated AC excitation and automatic zeroing low voltage amplifier, 22 mVrms @75 
Hz, ADINSTRUMENTS) were used to collect ECG and EDA, respectively.  No on-line filtering was 
applied during the signal recording.    EDA device was adjusted to zero to assure a consistent level at the 
start of every run to avoid baseline differences in EDA that may arise from homeostatic and circadian 
processes [19], [20], allowing changes specific to the EAT to be isolated.  The study protocol was approved 
by the Institutional Review Board of The University of Connecticut and all volunteers consented to be 
subjects for the experiment. 
6.2.2.1 Error awareness task 
To examine the effect of sleep deprivation on subjects’ performance, we used the error awareness 
task (EAT).  The EAT involves presenting a serial stream of single color words in congruent fonts, where 
each word is presented for 900 ms followed by a 600 ms inter-stimulus interval.  Participants were trained 
to respond to each of the words with a single ‘Go trial’ button press and withhold this response (‘No go 
trial’) when either of two different circumstances arose.  The first withhold condition occurred if the same 
word was present on two consecutive trials, while the second was caused if the word and color of the word 
did not match (see Figure 6.1) [21].  Notice that the latter situation utilizes the Stroop effect (using a 
keyboard in lieu of verbal responses), which induces cognitive stress to the subjects [22].  The two rules 
we induced to the subject brought about the need to be attentive rather than repetitive, because of the 
overlearned human behavior of reading the word over recognizing its color predisposed subjects to monitor 
for the repeat rather than the Stroop no-gos.  In presence of these constrains, we have computed the ‘Go 
trial’ response time for every trial, as a measure of subjects’ performance, to be able to examine the effects 
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of sleep deprivation on such a simple measure and correlate with the various available physiological 
parameters.  
6.2.3 Physiological indices of autonomic nervous system 
Measures to assess the autonomic nervous system (ANS) based on analysis of HRV and EDA were 
computed using data collected while the subject was performing the EAT. 
6.2.3.1 Indices of heart rate variability 
For HRV analysis, ECG signals were band-pass filtered (0.05-40 Hz) to reduce noise and motion 
artifacts.  The R-waveform peaks were detected using the detection algorithm that defines a delineation 
function based on the envelope of the ECG signal [23], [24].  All the segments were visually inspected to 
ensure that no beat was missed.  After accounting for the missed R-wave beats, the HR time series were 
computed.  The power spectra of HRV were then calculated using Welch’s periodogram method with 50% 
data overlap.  The RR interval series were converted to an evenly time-sampled signal (4 Hz) by cubic 
spline interpolation.  A Blackman window (length of 256 points) was applied to each segment and the fast 
 
Figure 6.1 – The error awareness task (EAT). 
EAT required subjects to respond pressing the space bar to a stream of color words and withhold their 
response when either a word was repeated on consecutive trials or the color and word were 
incongruous.  
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Fourier transform was calculated for each windowed segment.  Finally, the power spectra of the segments 
were averaged.  The low-frequency index (HRVLF [ms2], 0.045 to 0.15 Hz), high-frequency index 
(HRVHF [ms2], 0.15 to 0.4 Hz), and normalized versions of these two (HRVLFn, HRVHFn, dividing by 
total power of HRV, in normalized units [n.u.]) were computed [25].   
Four minutes of clean (subjects were asked to remain still) ECG signals were used to compute HRV 
indices.  Indices from the LF range (HRVLF and HRVLFn) of HRV are used as indices of sympathetic 
control although they have proven parasympathetic influence, and indices from the HF power (HRVHF and 
HRVHFn) are used as indices of parasympathetic control, even though parasympathetic tone is present in 
both, the LF and HF range. 
6.2.3.2 Indices of electrodermal activity 
Indices of EDA were computed in time and frequency domain.  In time domain, EDA signal is 
traditionally decomposed into two measures: skin conductance level (SCL) and skin conductance responses 
(SCRs) [26].  SCL (expressed in microsiemens, µS) is a measure related to the slow shifts of EDA, and 
specifically refers to the level of skin conductance.  SCL was computed as the mean value of EDA taken 
during the given period.  The skin conductance responses (SCRs) are the rapid transient events contained 
in the EDA signals.  The non-specific SCRs (NSSCRs) is an index measured as the number of SCRs per 
minute [26].  In this study, for each run, two minutes of EDA was collected while the subject was 
performing the EAT, to compute SCL and NSSCRs. 
The same two minutes of EDA extracted to compute time-domain indices were also used for 
spectral indices.  The time-invariant spectra of EDA were calculated using Welch’s periodogram method 
with 50% data overlap.  A Blackman window (length of 128 points) was applied to each segment, the fast 
Fourier transform was calculated for each windowed segment, and the power spectra of the segments were 
averaged.  The power spectral index of EDA, EDASymp [µS2], was computed by integrating the power in 
the range from 0.045 to 0.25 Hz, as it was found before to be sensitive to cognitive stress [27]. 
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To compute the time-varying index of EDA, TVSymp, time-frequency representation (TFR) of 
EDA was computed using the variable frequency complex demodulation (VFCDM), a time-frequency 
spectral (TFS) analysis technique that provides accurate amplitude estimates and one of the highest time-
frequency resolutions [28].  The components comprising the frequency power in the range from 0.08 to 
0.24 Hz were used to compute TVSymp.  
6.2.4 Statistics 
The set of physiological indices tested in this study included: HRVLF, HRVLFn, HRVHF, 
HRVHFn, SCL, NSSCRs, EDASymp and TVSymp.  As a measure of subjects’ performance, average ‘Go 
trial’ reaction time (Go_RT), Stroop No-Go and Repeat No-Go accuracies (Stroop_NoGo_acc and 
Repeat_NoGo_acc, respectively) were computed for every run of every subject.  Go_RT exhibits an inverse 
relationship to subjects’ performance, as a higher reaction time represents lower performance.  We explored 
the differences caused by the sleep deprivation on the physiological indices.   
6.2.4.1 Changes on indices due to sleep deprivation 
The impairment on participants’ performance due to sleep deprivation was tested.  In a similar 
manner, all the computed physiological indices of ANS were analyzed to test for significant differences 
due to sleep deprivation.  In both cases (performance and physiological indices) we utilized the Dunn's test, 
a non-parametric pairwise multiple comparisons procedure based on rank sums, used as a “post hoc” 
procedure following rejection of a Kruskal–Wallis test.  As such, it is a non-parametric analog to multiple 
pairwise t-tests following rejection of an ANOVA null hypothesis [29].  The analysis is meant to test the 
relationship between performance deterioration and changes to physiological indices, allowing us to 
understand the effect of prolonged wakefulness on subjects’ EDA.  
 
6.3 Results 
For clarity and simplicity, we will refer to the run number to express the results, and the reader can 
easily abstract the relationship between run number and hours of sleep deprivation (hours of deprivation = 
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2* run number). The changes in performance and ANS indices as a result of sleep deprivation are shown 
on Figure 6.2, Figure 6.3 and Figure 6.4.  The figures display the results for Go_RT, HRV and EDA indices, 
respectively.  Measures of Go_RT during run 3 and 4 were significantly different to the measurement during 
run 1.  Measurements of Go_RT during runs 6 and 7 exhibited significantly lower values than those in run 
2.  The average reaction time increased after these two runs, but the increase was not significant. The results 
of Go_RT can be described in the following manner: the two runs performed during learning (2 hours) 
followed by the subjects reaching a plateau where the average reaction time stabilized for runs 3 through 8, 
ending in a final increase in average reaction time.  Stroop_NoGo_acc and Repeat_NoGo_acc indices 
exhibited stable values for most of the test, followed by a sustained drop in value after 18 hours.  
 
Figure 6.2 – Go_RT, Stroop_NoGo_acc and Repeat_NoGo_acc values through 24 hours of sleep 
deprivation.  
Numbers on the figure represent the runs it was significantly different to.  Whiskers account for one 
standard deviation. 
 96 
 
Repeat_NoGo_acc showed a significant decrease in runs 11 and 12 compared to run 7; in this run  
Repeat_NoGo_acc exhibited a peak value.  Differences in Stroop_NoGo_acc were not significant. 
HRVLF exhibited a significant increase in run 10, compared to run 1. None of the other HRV 
indices, HRVLFn, HRVHF, and HRVHFn, showed a significant difference during the 24-hour period.  
As for EDA measures, we found significant differences in SCL values during runs 5 and 8, 
compared to run 1.  SCL profile looks similar to Go_RT for runs 1 through 8, in the sense that there are 
two runs similar to learning, followed by a plateau.  The NSSCRs were significantly diminished on runs 9 
and 11 compared to run 1 and 3.  Values of the normalized EDASymp (EDASympn) were different at run 
 
Figure 6.3 – Values through 24 hours of sleep deprivation for HRV indices: HRVLF (top left), 
HRVLFn (top right), HRVHF (bottom left) and HRVHFn (bottom right).  
Numbers on the figure represent the runs it was significantly different to.  Error bars account for one 
standard deviation. 
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9 compared to run 1.  TVSymp, similarly to NSSCRs and EDAsympn, exhibited a continuous decrease in 
magnitude over time.  However, that decrease was not significant for TVSymp at any point of time.  
TVSymp was the only EDA index with differences between runs 2 and 1, which were found in the 
Go_RT index.  Interestingly, this index exhibited more significant differences between runs than any other 
index.  Values of runs 2, 5, 8 and 11 were significantly different to run 1, similar to the observed for HRVLF 
and HRVHFn indices.  Runs 2, 5, 8 and 11 were different to runs 1, 4, 7 and 10, if the runs from the latter 
fall prior than those of the first set (e.g. run 5 was only different to 1 and 4).  Values of run 4 were 
significantly different to run 2.  Values of run 10 were different to runs 2, 5 and 8. During the 24-hour test, 
 
Figure 6.4 – Values through 24 hours of sleep deprivation for EDA indices: SCL (top left), NSSCRs 
(top right), EDASymp (bottom left) and TVSymp (bottom right).  
Numbers on the figure represent the runs it was significantly different to.  Whiskers account for one 
standard deviation. 
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there was a pattern of significant decrease on TVSymp every 3 runs (6 hours). Also, there were significant 
increases at runs 4 and 10 (8 and 20 hours).   
6.4 Discussion 
We have observed how indices accounting for higher frequencies of EDA follow a trend similar to 
indices of vigilance, measured by accuracy in performing an attention task, whereas the index that 
represents the slow changes of EDA resemblances more the changes in reactiveness, measured by reaction 
time. Our results suggest that indices of EDA can complement approaches using HRV, to predict the effect 
of sleep deprivation on humans’ autonomic response and performance. 
Many studies have studied the ANS using HRV under sleep deprivation. A group studied 
participants under 40-hour under constant routine conditions and determined that HRV was in general 
diminished during recovery sleep after sleep deprivation [18] .  Analysis of these results revealed a decrease 
in HRV due to sleep deprivation, but with less intensity than during sleep.  Another group found, in persons 
with over 36 h of sleep deprivation, a progressive increase during daytime in sympathetic, and a decrease 
in parasympathetic cardiac autonomic modulation [6]. This was demonstrated by reduced HRV values in 
the frequency domain for healthy participants while test persons performed a cognitive task repetitively.  In 
contrast, another study could not find increased sympathetic drive expressed during daytime by diminished 
HRV values after one night of sleep deprivation [16].  Another investigation revealed a correlation of HRV 
spectral values with subjects’ performance in a psychomotor vigilance test during sleep deprivation [11]. 
Information on the effect of sleep deprivation on humans’ electrodermal activity is scarce.  A 
classical review reported contradictory results on changes on SCL and SCRs during sleep deprivation [30].  
However, that review highlighted that many of these studies suffered from methodological limitations 
(single case studies, measurements taken only once or twice during the test, or lack of statistical analysis).  
A study later reported an increased latency and reduced amplitude in event-related SCRs after 36 hours of 
sleep deprivation [31].  There are very few recent investigations.  A study reported an increase of skin 
resistance level (inverse to SCL) that correlates with deterioration of reaction time, using a simple reaction 
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time test (mean correlation = 0.425) [19].  A recent study looked at the SCL to probe how the sympathetic 
nervous system might contribute to altered reactivity in sleep deprived persons [4].  Note that these two 
recent studies only analyzed the SCL, not including the information of the more rapid transients of EDA, 
where this signal has shown great sensitivity.   
We found a significant reduction in Go_RT (learning effect) in runs 3 and 4 compared to run 1, and 
an increase after about 16 hours of sleep deprivation.  Stroop_NoGo_acc and Repeat_NoGo_acc (indices 
of vigilance) were decreased towards the end of the 24-hour period.  These results were expected, as human 
brain is able to maintain stable cognitive performance during certain period of time, but after prolonged 
wakefulness the level of arousal and performance tend to diminish [32]–[37]. In agreement to the affected 
level of arousal, indices of sympathetic control should ideally exhibit a decreasing trend.  In this study, 
values of HRV indices of sympathetic control steadily increased with sleep deprivation (with some 
fluctuations), whereas NSSCRs, EDASymp and TVSymp tend to lower values by the end of the test.   
EDAsymp exhibited a significant decrease in run 9 with respect to run 1, which coincided with an 
increase in mean Go_RT, and preceded the decrease in mean Stroop_NoGo_acc and Repeat_NoGo_acc 
noticeable in run 10.  A similar peak in run 9 was also detected by NSSCRs index, with a repeated peak in 
run 11.  The profiles of NSSCRs, EDASympn and TVSymp were similar, although EDASympn was 
somewhat smoother.  In terms of significant change, it is noticeable that indices of  higher-frequency 
components of EDA provide more information to understand and possibly predict the effects of sleep 
deprivation on the sympathetic nervous system. 
There is an apparent relationship between the evolution of performance indices (Go_RT, 
Stroop_NoGo_acc and Repeat_NoGo_acc) and the indices of EDA.  First, Go_RT and SCL showed a 
remarkable inverse relationship, showing a training period (the first two runs), a stable plateau for a long 
part of the test (top performance, when subjects learned the task), and a period where the indices went back 
close to training values.  We hypothesize this final period, characterized by a drop in reactiveness (higher 
reaction time), is due to fatigue induced by sleep deprivation.  This means that tonic SCL relates with 
subjects’ reactiveness, which is in agreement with previous studies [4], [19], [38].  Second, the evolution 
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of indices that account for higher frequencies, NSSCRs, EDASymp and TVSymp, related to the measures 
of No-Go accuracy.  These indices, Stroop_NoGo_acc and Repeat_NoGo_acc, which represent vigilance, 
remain stable for a part of the test (5 to 6 runs) then constantly degrade to low values.  NSSCRs, EDASymp 
and TVsymp exhibited a behavior similar to the indices of vigilance, but at 20 hours they presented a large 
overshoot, followed by final return to low values. We believe that this high peak at the end of the test 
suggests that at such time subjects make an attempt to stay focused and vigilant.  However, improved 
accuracy is not achieved.  The results are in agreement with the classic studies that reported decrease in 
amplitude of SCRs after sleep deprivation [31], and with the classic report that related SCRs to attention, 
noting that such responses are sensitive to stimulus novelty [38].  
The only available indices of parasympathetic control, HRVHF and HRVHFn indices, were stable 
throughout the test, with an increase in mean value towards the end of the 24 hours.  These indices, 
especially HRVHFn, resembles the sleepiness of subjects at the start of the test, and the increased sleepiness 
by the end of the study.   
6.5 Conclusion 
We evaluated the effects of sleep deprivation on reactiveness, vigilance, HRV and EDA, every two 
hours during a 24-hour period.  We found notable differences in the effects of sleep deprivation on lower 
and higher frequencies of EDA.  Information confined to the higher frequency components of EDA relates 
to subjects’ level of attention or vigilance. For its part, changes on tonic SCL, exhibited a relationship with 
subjects’ reactiveness.  This information can be utilized for developing tools to prevent the effects of 
prolonged wakefulness in jobs that require a high number of work hours, along with significant 
concentration to perform well, to assess and predict impaired cognitive performance. 
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Chapter 7: Low Impedance Carbon Adhesive Electrodes with Long Shelf Life 
(Posada-Quintero, H., Reyes, B., Burnham, K., Pennace, J., & Chon, K.. Low Impedance Carbon 
Adhesive Electrodes with Long Shelf Life. Annals of BME, 2374-2382 (2015)) 
 
7.1 Introduction  
The electrocardiogram (ECG) provides a graphical representation of the electrical activity of the 
heart, and to properly monitor the cardiac health of a patient, it is crucial to obtain an ECG signal with a 
high signal-to-noise ratio (SNR).  In a typical ECG setup, depending on the particular application, three to 
twelve signal receptive electrodes are attached to the patient’s body.  These electrodes are able to measure 
minute changes in potential that occur as a consequence of the propagation of electrical signal from atria to 
ventricles during each heartbeat cycle, thus rendering it possible to produce the characteristic ECG 
waveforms that can then be used for diagnostic purposes.  The ECG can also be further quantified by 
computing the heart rate variability (HRV) indices, as these have been shown to provide a good estimate 
of  the dynamics of the autonomic nervous system[1].  To ensure optimal signal strength of the electrode, 
it is imperative to minimize the impedance of the electrode-skin interface by lowering the impedance of the 
electrode.  High impedance levels at the skin-electrode interface can result in significant loss in signal 
strength and low SNR, which will lead to poor quality ECG waveforms. 
The current industry gold standard for electrodes is the Silver/Silver Chloride (Ag/AgCl) wet 
(hydrogel) electrode, which has been proven to provide accurate ECG waveforms[2].  These electrodes 
consist of a layer of silver chloride, often in the form of a paste-like hydrogel surrounding a silver disc.  
While the hydrogel layer significantly improves the signal quality by effectively lowering the impedance 
that exists at the electrode-skin interface, it is also the principal reason behind the relatively short shelf life 
of these electrodes. The hydrogel layer that exists in the skin-electrode interface degrades with time as it 
dehydrates, producing high impedance.  This leads to a loss of signal quality [3] and an increased incidence 
of motion artifacts and noise in the ECG[4].  Moreover, the electrodes need to be carefully packaged to 
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ensure prolonged retention of the hydrogel layer.  Due to finite shelf life and electrode dehydration, these 
electrodes can only be used to record signals for a few days at maximum[5].  Also, Ag/AgCl electrodes are 
limited to short-term use because they are known to cause irritation to the skin especially after their removal.  
Moreover, Ag/AgCl electrodes are also relatively expensive since silver is an expensive commodity.  For 
these reasons, dry electrodes have been developed in recent years to substitute traditional wet Ag/AgCl 
electrodes [4], [6], [7]. 
A novel type of electrode that does not require a hydrogel layer has been developed to address the 
issue of dehydration with the current industry gold standard electrodes. The new dry electrodes are designed 
by combining a visco-elastic polymeric adhesive[8], [9] with carbon black powder and a quaternary salt.  
This mixture is potentially much more economical than Ag/AgCl.  The objective of this paper is to 
demonstrate and detail the fabrication process of our new Carbon/Salt/Adhesive (CSA) electrodes and 
compare their ECG morphologies to the standard Ag/AgCl wet electrodes. 
First, a brief description of the fabrication of the CSA electrodes is provided. After the CSA 
electrodes are fabricated, they need to be activated by a procedure known as electrophoresis[10].  Once 
activated, the electrodes must meet the Association for the Advancement of Medical Instrumentation 
(AAMI) requirement for defibrillation overload recovery & impedance.  The AAMI states that for 
electrodes such as hydrogel, the average post-activation impedance must remain equal to or below 2 kΩ, 
and no single electrode pair can have impedance greater than 3 kΩ after activation.  
To ensure that dry CSA electrodes meet the AAMI standard for electrodes, we designed and 
implemented an activation circuit which is capable of providing various levels of activation voltage and 
amperage with varying discharge times.  This allowed us to obtain the best parameters required for the 
activation.  This procedure was also used to discern the optimal concentration of carbon by measuring pre- 
and post-activation impedance values.  
Once the activation parameters as well as the carbon concentration were determined, several 
comparisons between CSA and Ag/AgCl electrodes were carried out.  First, electrode-skin contact 
impedance was measured for each type of electrode.  Subsequently, simultaneous ECG data acquisition 
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was performed using the two electrode types on human subjects in order to ensure similarities in the ECG 
waveforms.  Finally, heart rate variability analyses were performed with the hypothesis that the CSA will 
provide statistically similar indices as that of the Ag/AgCl electrodes.    
7.2 Materials and Methods 
7.2.1 Carbon/Salt/Adhesive electrode fabrication 
The base material used is a .001" thick polyester film with a conductive carbon ink coating on one 
surface which gives approximately 100 Ohms per square of measured surface resistivity. Silver/silver 
chloride coatings (which are commonly used in hydrogel based electrodes to provide electro-chemical 
stability) are not needed due to the characteristics of the waterless adhesive.  Using a polar organo salt is a 
way to introduce into the adhesive composition a very polar molecule (electro-physically aligns with the 
applied electric filed) that orientates with a time varying signal, which can be alternating current, ramped, 
pulsed DC, mixed waveform or ECG.  The salt in this case is a quaternary ammonium salt [hydrogenated 
tallowalkyl (2-ethylhexyl) dimethyl ammonium methylsulfate] that exhibits excellent compatibility with 
the chosen waterless adhesive by virtue of its organic functionality.   
 
 
Figure 7.1 – Hydrogel Ag/AgCl electrode (left) and Carbon/Salt/Adhesive electrode (right).  
The circular piece of carbon in the center is the conductivity enhancing feature (bridge).   
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Since the adhesive is not in a very polar solvent (like water) to stabilize its disassociated ions (the 
solvent here instead being an acrylic polymer), there is little ionic formation and thus it does not contribute 
much (if any) ionic conductivity. The alignment response of the polar salt molecule to an applied electric 
field facilitates a displacement current which is a different mechanism than the ionic current arising from 
the movement of dissociated salt ions. The greater that the concentration of the polar salt is, the greater the 
number of available parallel current pathways there are, thus leading to lower impedance.  By contrast, salts 
(such as NaCl) in a hydrogel composition break down to Na +and Cl- (hydrolytic stabilized disassociated 
ions). It is the formation of these ions that is the basis for ionic conductivity in hydrogels but not in the 
waterless adhesive used here. Thus, there is no similarity in the mechanism of signal detection between the 
salt in a hydrogel and the salt used in the CSA electrode. 
To create electrodes, 30 g total of the dopant and the visco-elastic polymeric adhesive are added to 
a beaker.  The amount of carbon and salt added is dependent on the percent to be used out of 30 g.  A 
magnetic mixer is used for 40 minutes to stir the adhesive and dopant.  The mixture is spread onto a liner 
using a 12 mil spreading tool, and then placed into a 160° F oven for 10 minutes.  The dried adhesive is 
covered with a 2nd liner and is cut into 4.45 cm wide pieces, the Carbon electrode film is cut into 5.08 cm 
wide pieces and the adhesive is placed onto the film, leaving a small amount of carbon film exposed.  
Electrodes were cut to a size of 4.45cm X 3.81cm.   
A feature for enhancing surface conductivity is then applied.  The conductivity enhancing feature 
(the bridge) is a low impedance electrically conductive material that produces a lower electrode ohm value 
by connecting in parallel multiple isolated Z direction (out of plane) conductive pathways in the adhesive.  
 
Table 7.1 Variable parameters for electrode activation. 
Parameter Values to test Units 
Voltage (DC) 5, 20, 45, 75, 120, 200 V 
Current 1, 2, 5, 10, 20, 50, 100 mA 
Frequency DC, 60, 1000 Hz 
Time 1, 10, 100, 1000 ms 
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This can be described by 1/Rtotal = (1/R1)+(1/R2)+1/R3)+....(1/Rn)  where R represents each isolated Z 
direction pathway. The bridge is specifically designed to balance electrical, mechanical and electrode 
adhesion properties: its conductive loading level provides electrical conductivity, its polymeric content and 
thinness provide mechanical flexibility, and its large open area pattern minimizes reduction in adhesive 
bonding. 
In general higher salt concentration leads to higher conductance, but it would also increase the risk 
of eliciting a reaction in subjects’ skin.  For the purposes of this study, salt concentration was fixed to 25%, 
given that such concentration produced very low to minimal skin irritation.  A representative CSA electrode 
is shown on the right panel of Figure 7.1 and the left panel shows a standard Ag/AgCl ECG electrode.   
7.2.2 Carbon black concentration  
The ideal concentration of carbon powder in CSA electrodes was determined by minimizing post 
activation impedance.  The carbon concentration ranged from 2% to 12% loading levels with an increment 
of 2% and we measured pre-activation and post-activation impedance using an impedance meter.  Initially, 
for each carbon load level, 5 different sample electrodes were used.  Subsequently, for the 3 carbon levels 
with the lowest post-activation impedance, 30 additional samples for each level were further analyzed.  
Impedance measurements were taken at 10 Hz as reference because this is within the ECG frequency range 
of interest. 
7.2.3 Activation process  
An activation device with variable parameters was designed and built in order to determine the best 
parameters to activate the electrodes.  The test parameters are listed in Table 7.1.  All permutations of 
parameter values were tested, in order to determine the optimum activation (i.e., lowest impedance).  The 
design of the activation circuit was determined based on the AAMI standard defibrillation overload circuit.  
In order to vary parameters as listed in Table 7.1, dip switches were used to change values of resistors and 
capacitors.  The power supply used provides an AC voltage from 0-240 Volts, but the circuit based on the 
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AAMI standards is typically used with a DC voltage.  In order to address this, a diode rectifier was designed 
at the input to the circuit to convert the voltage from AC to DC.  
Activation was obtained by applying electrophoresis through the Z direction of each electrode. 
Carbon columns formed in the Z-direction were an indication that the activation was successful which was 
verified in many samples using the scanning electron micrograph (see Figure 7.2).   A voltage meter was 
applied across the activation capacitor to examine if the electrode pair was shorted during application of 
the two electrode adhesives.  The electrodes were then removed and two impedance testing clips from a 
Hiroki IM 3570 were attached to the activation points of the material.  The electrode’s impedance was 
tested at 10 Hz by using a 1 V amplitude signal from the impedance testing device.  The impedance of each 
electrode pair was measured before and after activation.  In order to meet the Association for the 
Advancement of Medical Instrumentation (AAMI) standards, the average post-activation impedance is 
required to be under 2kΩ with no single value over 3kΩ.  
7.2.4 Electrode-skin contact impedance measurements 
The study protocol was approved by the Institutional Review Board of Worcester Polytechnic 
Institute and all volunteers consented to be subjects for the experiment. 
 
 
Figure 7.2 – Scanning electron micrograph image of an activated electrode.   
Notice that in the depletion zone the carbon particles moved in from the surrounding area and form 
vertical columns in the Z-direction.  
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Activated CSA electrodes were used to carry out over-skin impedance measurements and compare 
to Ag/AgCl electrodes.  The skin of the test subject was cleaned before each measurement by wiping with 
a 2%-alcohol impregnated cotton pad, which was allowed to evaporate before applying the electrodes.  Two 
electrodes were mounted on the right forearm, one on the palm side of the wrist, and the second 5 cm apart 
from the first but situated towards the elbow. These electrodes were connected to the Hiroki IM3570 
impedance analyzer, and each measurement is the result of averaging 20 measurements.  The signal voltage 
amplitude was set to 1 V and the frequency range from 4 to 100 KHz, as used in previous studies [4], [11].  
N = 7 pairs of electrodes were used.  To keep skin properties as constant as possible, all measurements were 
performed in a single day. 
7.2.5  Collection of electrode comparison data 
A simultaneous set of 3 CSA (post-activation and optimal-mixture) and wet Ag/AgCl electrodes 
was used to collect ECG signals from 17 healthy subjects (12 males, 5 females, 28 ± 5 years old).  An 
electrode was placed on xiphoid process (ground), a second one in the center of the manubrium (1−), and 
the third under the left pectoral near V6 electrode position (1+).  These placements mimics lead II ECG 
configuration [12].  Subjects were seated for 7 minutes followed by standing for the same duration 
(Rozinn® Holter @ 180 Hz).  The ECG signals were band-pass filtered (0.05-40 Hz) offline to reduce noise 
and motion artifacts.  Throughout all the experiments for this study, the skin area was cleaned with 70% 
isopropyl alcohol prior to each measurement. 
7.2.6 HRV indices 
Heart Rate Variability (HRV) series were obtained from the ECG signals.  The R-waveform peaks 
were detected using a widely-used peak detection algorithm[13].  Time and frequency domain HRV indices 
were then calculated from the HRV series.  
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7.2.6.1 Time domain indices. 
Temporal measures of the HRV considered in this study were: mean RR interval (millisecond 
units), SDNN (standard deviation of all RR intervals; millisecond units), RMSSD (square root of the mean 
of the sum of the squares of differences between adjacent RR intervals; millisecond units), NN50 count 
(number of pairs of adjacent RR intervals differing by more than 50 ms in the entire recording; unitless), 
and pNN50 (NN50 count divided by the total number of all RR intervals; percentage). 
7.2.6.2 Frequency domain indices. 
The power spectra of HRV were calculated using Welch’s periodogram method with 50% data 
overlap.  The RR interval series were converted to an evenly time sampled signal by cubic spline 
interpolation.  A Blackman window was applied to each segment and the Fast Fourier Transform was 
calculated for each windowed segment.  Finally, the power spectra of the segments were averaged.  From 
spectral analysis, two frequency bands were considered: low frequency (LF) band (0.045 to 0.15 Hz) and 
high frequency (HF) band (0.15 to 0.4 Hz)[1].  The very low frequency (VLF) band was not taken into 
account because the physiological correlates are still unknown[1]. 
Spectral powers were designated as the Total, LF, HF, LF/HF ratio and are presented as the absolute 
(square milliseconds, ms2) units.  The spectral contents of the LF and HF are known to reflect dynamics of 
the autonomic nervous system.  Parasympathetic nervous system activity is the major contributor to the HF 
component[14], [15]. The interpretation of the LF component is more difficult, but previous works have 
demonstrated that it reflects both sympathetic and parasympathetic dynamics[14], [16].  Consequently, the 
LF/HF ratio is considered as a reasonable estimate of the sympatho-vagal balance[1].  The paired t-test was 
used to compare all of the obtained parameters. 
7.2.7 ECG morphology comparison 
Out of the group of 17 subjects, 5 were enrolled to collect 5-lead ECG signals in order to perform 
ECG morphology (lead I, HP 78354A ECG) comparison between CSA and Ag/AgCl electrodes; data were 
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sampled at 1000 Hz for 2 minutes.  With the subjects standing still, either a set of Ag/AgCl or CSA 
electrodes were placed and ECG signals were collected.  Upon immediately after data collection involving 
a set of electrodes, a second set of electrodes which were not previously used  were placed in the same exact 
position and ECG signals were acquired.  The skin area was cleaned with 70% isopropyl alcohol prior to 
each measurement. 
7.2.8 Motion artifacts 
One of the disadvantages of dry electrodes compared to gel electrodes is the lack of flexible contact 
provided by the gel.  This produces variations in contact during motion, and tend to introduce motion 
artifacts to the ECG signal.  We presume that Z-direction formation of carbon columns after activation 
provides a better reaction to shifting against skin, as the electrodes should be less sensitive to X- and Y-
direction potentials.  Same 5 subjects enrolled for ECG morphology comparison were used to perform a 
motion artifacts evaluation (lead I, Chroma® Holter @512 Hz sampling rate).  Subjects were requested to 
perform horizontal movements (HM; torso rotations), vertical movements (VM; squats-like up and down 
movements) and random walking (RW).  Each subjects wore both types of electrodes (Ag/AgCl and CSA) 
and simultaneous ECG measurements were collected using two Holter monitors. 
 
7.3 Results 
7.3.1 Optimum carbon concentration 
Table 7.2 shows three different levels of carbon powder concentration from a sample size of 35.  
As shown in Table 7.2, the most consistent results (e.g., smallest standard deviation values) were obtained 
for carbon loads at 10% and 12%.  According to AAMI standards, the mean post activation impedance is 
required to be under 2 kΩ and no single electrode pair can have impedance greater than 3 kΩ.  Based on 
this criterion, only the 10% and 12% carbon concentration levels meet the AAMI criterion.  Note that 2%, 
4% and 6% carbon concentration data are not shown because their post-activation impedance values were 
significantly higher than 2 kΩ.  
 113 
 
In order to verify that the data gathered for pre-activation and post-activation impedances are 
statistically significant, two-tailed t-tests were performed using MATLAB.  Only the 12% and 10% carbon 
concentrations were found to be comparable.  Given that there was no statistical difference between 10% 
and 12% carbon powder concentration, we selected the former as the optimal value.  Notice that a slightly 
higher carbon loading of 15% would be comparable to 10% & 12%. 
7.3.2 Activation Parameters 
Pre-activation and post-activation impedances were recorded for 840 electrodes. Each parameter 
value shown in Table 7.1 was permuted with the other parameters to determine the optimal activation of 
electrodes. Table 7.3 details the mean and standard deviation values of the pre- and post-activation 
 
Table 7.2 Electrode impedance test results 
Carbon Load Pre-activation impedance (MΩ) Post-activation impedance (Ω) 
8%  10.5 ± 6.01 1,170 ± 1,170 
10%  2.09 ± 2.79 256 ± 51.4 
12%  3.96 ± 2.39 286 ± 56.5 
Values are expressed as mean ± standard deviation. 
 
 
Table 7.3 Electrode impedance test results 
Parameters  
Voltage Capacitance Current Pre-Activation [MΩ] Post-Activation [kΩ] 
200V .1µF 20mA 18.83 ± 3.70 3.68 ± 1.87 
200V .1µF 100mA 17.17 ± 8.40 6.04 ± 6.67 
200V 1µF 10mA 20.86 ± 2.34 2.41 ± 1.34 
120V 1µF 10mA 7.82 ± 9.83 1.24 ± 0.26 
200V 1µF 100mA 20.71 ± 2.77 0.443 ± 0.189 
120V 1µF 100mA 20.63 ± 3.32 0.829 ± 0.296 
200V 10µF 10mA 21.57 ± 3.22 1.67 ± 0.49 
200V 10µF 20mA 15.64 ± 8.89 1.19 ± 2.16 
120V 10µF 20mA 21.09 ± 1.96 1.05 ± 1.51 
Values are expressed as mean ± standard deviation. 
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impedances based on some of the chosen voltage, capacitance and current parameter values. We only show 
those data with the lowest post-activation impedance values.  
As shown in Table 7.3, the optimum activation parameters are 200 V, 1 µF and 100 mA since this 
choice provides the lowest post-activation impedance. The post-activation values are well under the AAMI 
requirements of the mean value being no more than 2 kΩ and no single impedance exceeding 3 kΩ.  
 
 
Figure 7.3 – Impedance of Carbon/Salt/Adhesive and Ag/AgCl electrodes.  
 
 
Figure 7.4 – Segment of interpolated HR time series signal from ECG signals acquired by using Ag/AgCl 
(a) and Carbon/Salt/Adhesive electrodes (b).  
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7.3.3 Electrode-skin contact Impedance  
Figure 7.3 shows the comparison of skin impedance between Ag/AgCl and CSA electrodes as a 
function of varying frequencies. As shown, activated CSA electrodes exhibit much lower electrode-skin 
contact impedance than Ag/AgCl electrodes for the frequency band of 4 to 100 KHz.   
Note that the measured Ag/AgCl impedance shown in Figure 7.3 is in agreement with previously 
reported studies[4].  
 
7.3.4 HRV indices  
For quantitative HRV analysis, R-wave peak detection was applied[13] and the resultant RR 
segments were used to calculate time- and frequency-domain indices were calculated, for sitting and 
standing positions.  A summary of time- and frequency domain indices is presented in Table 7.4.  Figure 
7.4 shows a short duration HR time series obtained by both media. 
 
Table 7.4 HRV indices 
Time domain 
 Sitting Standing 
 Carbon/Salt/Adhesive Ag/AgCl Carbon/Salt/Adhesive Ag/AgCl 
meanNN (ms) 1186.103 ± 205.9* 1186.11 ± 205.8* 1330.76 ± 238* 1330.77 ± 238* 
SDNN (ms) 100.5 ± 62.2 99.9 ± 60.2 107.1 ± 41.3 106.9 ± 40.6 
RMSSD (ms) 30.38 ± 48.24 30.003 ± 46.75 26.08 ± 34.14 25.77 ± 33.13 
NN50 61.5 ± 126.3 61.5 ± 126.6 41.6 ± 67.6 41.6 ± 67.1 
pNN50 0.039 ± 0.077 0.039 ± 0.07 0.025 ± 0.040 0.025 ± 0.040 
Frequency domain 
 Sitting Standing 
 Carbon/Salt/Adhesive Ag/AgCl Carbon/Salt/Adhesive Ag/AgCl 
LF (ms2) 2701 ± 2149 2696 ± 2150 3981 ± 3153 3983 ± 3154 
HF (ms2) 3151 ± 8179 3040 ± 7716 1463 ± 1956 1438 ± 1846 
Total (ms2) 12208 ± 21116 11921 ± 19957 11074 ± 10979 10958 ± 10520 
LF/HF 2.80 ± 2.57 2.82 ± 2.62 4.59 ± 3.84 4.61 ± 3.87 
Values are expressed as mean ± standard deviation. 
*Statistically significant difference. 
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These indices are similar to those reported by the HRV task force[1]. Non-significant differences 
were found for all indices except for the mean NN interval index for both body positions. While the mean 
NN interval index is significantly different, the actual difference is quite small and it is physiologically 
insignificant.  
7.3.5 ECG morphology comparison  
Figure 7.5 represents the average of an ensemble template of ECG aligned by the R-wave peak, 
using the two media in the same body locations (not simultaneous measurement, however), for a given 
subject.  Such ECG ensemble was computed for each subject during sitting and standing positions.  Note 
the similarity in the morphologies of the ECG waveforms between the two media.  The R-wave peak 
amplitude, ST-segment elevation and QT interval duration time were computed for each ensemble and two-
tail paired t-test was performed to compare between CSA and Ag/AgCl results.  Table 7.5 includes these 
results.   We found only the R-wave peak amplitude of the Ag/AgCl electrodes showed significantly higher 
 
 
Figure 7.5 – Averaged ensembles of ECG signals acquired using Ag/AgCl and Carbon/Salt/Adhesive 
electrodes, for the same subject.   
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value than the CSA electrodes.  There was no significant difference in the ST-segment elevation and QT 
interval time duration between the two electrode media.   
7.3.6 Motion artifacts 
Figure 7.6 shows an example of the data collected during introduction of motion artifacts. Data 
from both types of electrodes were simultaneously collected using 2 Holter monitors for each subject.  Note 
that motion artifacts affect differently to CSA and Ag/AgCl electrodes.  For comparison of motion artifacts 
on both types of electrodes, the R-wave peak amplitude misdetections were computed.  Table 7.4 shows 
the percentage of R-wave peak misdetections found for each type of motion.  In general, we found that 
CSA electrodes exhibited a similar performance to the wet Ag/AgCl electrodes in terms of miss-detected 
R-wave peak.   
7.4 Discussion 
Novel CSA electrodes were developed and their characteristics were compared to the standard 
Ag/AgCl electrodes.  It was found that our dry electrodes are comparable to the industry gold standard 
 
Table 7.5 ECG morphology measurements over ensemble averages 
  CSA Ag/AgCl 
R-peak amplitude [ADC counts] 151.2 ± 37.6* 165.99 ± 13.06 
ST segment elevation [ADC counts] 0.45 ± 6.12 -0.17 ± 4.97 
QT time segment [s] 0.24 ± 0.02 0.24 ± 0.018 
Values are expressed as mean ± standard deviation. 
*Statistically significant difference. 
 
 
 
Table 7.6 R-wave peak misdetection percentage for CSA and Ag/AgCl electrodes in the presence of 
motion artifacts. 
  
No movement 
N = 249 beats 
Torso rotation 
N = 261 beats 
Vertical movement 
N = 267 beats 
Random walking 
N = 255 beats 
 CSA Ag/AgCl CSA Ag/AgCl CSA Ag/AgCl CSA Ag/AgCl 
R-wave peak misdetection % 0% 0% 1% 3.43% 6.67% 3% 9.06% 7.91% 
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Ag/AgCl electrodes in terms of impedance and ECG morphological characteristics. The optimal mixture to 
fabricate electrodes was determined to be 10% carbon when combined with 90% visco-elastic polymeric 
adhesive. This mixture resulted in the lowest post-activation impedance, which also meets AAMI 
requirements.  These electrodes need to be activated prior to use in order to reduce their impedance; pre-
activation impedance is in the range of mega ohms.  Once the electrodes are activated, they are permanent. 
The optimal activation parameters were found to be 200 V, 100 mA current and a 100 ms discharge time 
using 1μF capacitor.  CSA electrodes address two of Ag/AgCl electrode’s issues: dehydration and high 
cost.  The CSA electrodes are theoretically more economical than Ag/AgCl electrodes since carbon is 
cheaper than silver.  Further, the CSA electrodes have an infinite shelf life whereas the Ag/AgCl electrodes 
dry out and the standard practice is to discard them after 1 month of storage.  Finally, our CSA electrodes 
meet all AAMI requirements.  
Electrode-skin impedance measurements showed much lower values for CSA electrodes when 
compared to wet Ag/AgCl electrodes.  Moreover, the impedance of our CSA electrodes is even lower than 
those reported for carbon nanotube-polydimethylsiloxane (CNT-PDMS) flexible electrodes [5]. 
 
 
Figure 7.6 – Simultaneous ECG signals to show CSA and Ag/AgCl electrodes’ motion artifact response.   
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All HRV indices derived from the CSA electrodes were found to be no different than Ag/AgCl 
derived indices.  Statistically significant differences were found only for the mean NN interval index for 
both body positions.  However, the differences are minimal and not physiologically significant.   
ECG morphological waveforms are well captured with CSA electrodes.  ST segment elevation and 
QT segment time showed no significant differences. However, statistically significant differences in R-
wave peak amplitudes were found between ECG signals collected using CSA and Ag/AgCl electrodes.  
Although CSA electrodes exhibited lower impedance than Ag/AgCl, amplitude and morphology of the 
ECG signals seem to be influenced by capacitive components of the impedance.  The elimination of such 
reduction is an aim for future generations of CSA electrodes.  During stable conditions (no movement), 
such amplitude reduction did not affect the R-wave peak detection (see Table 7.6).   
We examined the quality of both types of electrodes during body movements.  Specifically, we 
examined miss-detection of R-wave peak amplitudes during various body movements consisting of side-
to-side and up-and-down torso movements as well as ECG data collection during normal walking condition.  
In general, CSA electrodes performed comparably to the wet Ag/AgCl electrodes in correct identification 
of R-wave peaks.  During torso rotations, CSA electrodes presented less problems for R-wave peak 
detection.  For vertical movements and random walking, CSA electrodes produced more misdetections than 
Ag/AgCl electrodes, but such differences were not dramatic.  These findings involving CSA show better 
results with respect to other dry electrodes, which have been reported to have poor performance in 
comparison to Ag/AgCl in the presence of motion artifacts [4]–[7], [17].  However, more thorough side-
by-side comparison of CSA to other dry electrodes will be needed to make such definitive claim.  
Based on 30 minutes of exposure to CSA electrodes, none of the 17 subjects showed any negative 
reactions to electrode-skin contact.  Further, in our previous study involving development of hydrophobic 
ECG electrodes based on a mixture of carbon-black powder and polydimethylsiloxane (CBPDMS), it was 
shown that CB/PDMS electrodes are not cytotoxic to L929 connective tissue fibroblasts or neonatal human 
keratinocytes [11].   Given that our current electrodes are also composed of carbon, we do not expect that 
they are cytotoxic to skin.  Certainly, further experiments will need to be performed to determine the long-
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term biocompatibility of the CSA electrodes.  Moreover, CSA electrodes will need to be tested in the future 
for their sensitivity to moisture as it is well known that perspiration can lead to degradation of the quality 
of ECG signals.  While we have not tested our electrodes after storing them for more than a year, we have 
found no ECG signal degradation with 2-month old CSA electrodes (not shown).  For future work, we aim 
to test CSA electrodes after storing them for more than 1 year. 
7.5 Conclusion 
In summary, we demonstrated that dry ECG electrodes can be fabricated from a mixture of carbon 
powder, salt, and visco-elastic polymeric adhesive.  All ECG morphological waveforms and HRV indices 
were found to be nearly identical to Ag/AgCl electrodes.  Moreover, the CSA electrodes can also be 
applicable for defibrillation usage but the main advantage is their infinite shelf life which lowers both supply 
chain handling costs and scrap costs when compared to Ag/AgCl electrodes since the latter have a shelf life 
of only a month.  Hence, our CSA electrodes have the potential to be a viable and cost-effective alternative 
to standard Ag/AgCl electrodes. 
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Chapter 8: Assessment of Carbon/Salt/Adhesive Electrodes for Surface 
Electromyography Measurements 
(© 2016 IEEE. Reprinted, with permission, from Posada-Quintero, H., Rood, R., Burnham, K., Pennace, 
J., & Chon, K.. Assessment of Carbon/Salt/Adhesive Electrodes for Surface Electromyography 
Measurements. IEEE Journal of Translational Engineering in Health and Medicine, PP (99), 2016) 
 
8.1 Introduction  
Orthopedics, rehabilitation, sports medicine, stress assessment and neurology are some of the many 
fields where electromyography (EMG) measurements are employed.  EMG aims to measure muscle activity 
by assessing the electrical activity elicited during muscle contraction. EMG measurements can be acquired 
directly on the muscle fibers through needle electrodes, but most EMG signals are collected by the use of 
superficial electrodes applied on the skin, corresponding to the part of the muscle that is of interest.  This 
type of EMG measure is normally called surface electromyography (sEMG).   
The current industry gold standard for sEMG is the Silver/Silver Chloride (Ag/AgCl) wet 
(hydrogel) electrode.  These electrodes consist of a layer of silver chloride, often in the form of a paste-like 
hydrogel surrounding a silver disc.  While the hydrogel layer significantly improves the signal quality by 
effectively lowering the impedance that exists at the electrode-skin interface, it also degrades with time as 
it dehydrates, producing high impedance.  This leads to a loss of signal quality [1] and an increased 
incidence of motion artifacts and noise.  Ag/AgCl electrodes have a number of other disadvantages: they 
need to be carefully packaged to ensure prolonged retention of the hydrogel layer; they are limited to short-
term use because they are known to cause irritation to the skin with prolonged use, especially after their 
removal [2]; they are also relatively expensive since silver is an expensive commodity.   
FLEXcon has developed a novel electrode that does not require a hydrogel layer, to address the 
issue of dehydration with most of the current industry gold standard electrodes. The new dry electrodes are 
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designed by combining a viscoelastic polymeric adhesive [3] with carbon black powder and a quaternary 
salt.  This mixture is potentially much more economical than Ag/AgCl.  We recently demonstrated and 
detailed the fabrication process of our new Carbon/Salt/Adhesive (CSA) electrodes and compared their 
performance to the standard Ag/AgCl electrodes’ when acquiring electrocardiographic morphologies [4]. 
The purpose of this study was to assess the surface electromyography (sEMG) measuring 
capabilities of the newly-developed CSA electrodes compared to traditional Ag/AgCl electrodes.  First, a 
brief description of the fabrication of the CSA sEMG electrodes is provided. Then the experimental protocol 
is explained.  The experimental protocol, which covered measurements on muscles of various sizes, was 
meant to compare the impedance of CSA and Ag/AgCl EMG electrodes, evaluate how well the CSA 
electrodes can replicate Ag/AgCl electrodes for the task of sEMG signal collection, and evaluate the quality 
of sEMG signals obtained using each media.  Measures related to sEMG signals, like “linear envelope” 
estimation, RMS value, on and off contraction times, and power spectral density were used to evaluate the 
interchangeability of EMG signals acquired with CSA and Ag/AgCl electrodes.  Quality assessment, noise 
power, motion-artifact corruption, sensitivity to EMG activity and distortion were evaluated using 
previously-reported and validated indices.    
8.2 Materials and Methods 
8.2.1 sEMG CSA electrode fabrication 
To create the testable CSA sEMG electrodes, the conductive base layer, the adhesive, and the bridge 
were prepared beforehand.  Details about preparation of those components are provided below.  After that, 
a description of the CSA electrode assembly process is included. 
8.2.1.1 Conductive Base layer   
A polyethylene foam carrier is coated with an electrically conductive material consisting of a 
polymeric binder loaded with conductive fillers. The conductive coating consists of 50% polymeric binder 
and 50% conductive filler based on the total solids weight of the mixture.  The wet coating is prepared by 
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weighing out the desired amounts of each component and smoothly blending them together for about 10 
minutes until a uniform appearance is obtained.  The wet mixture is then coated onto the carrier using a #60 
Mayer rod, and then placed into a 71.1 °C oven for 10 minutes to dry.  The electrical conductivity of the 
dried coating is easily checked by measuring its surface resistance to confirm that approximately 150 Ohms 
per square has been achieved.  
8.2.1.2 Adhesive   
A releasable carrier is coated with a doped adhesive such as an acrylic pressure sensitive type 
loaded with conductive carbon filler & a quaternary ammonium salt.  The wet adhesive mixture is prepared 
by weighing out the desired amounts of each component and smoothly blending together for about 10 
minutes until a uniform appearance is obtained.  The resulting wet mixture is then coated onto a release 
liner using a # 18 gap drawdown blade and then placed into a 71.1 °C air flow oven for 10 minutes to dry.  
The dried adhesive is covered with a second liner to facilitate easy handling.  
8.2.1.3 Bridge   
A releasable carrier is coated with an electrically-conductive material such as a polymeric binder 
loaded with conductive fillers. The conductive coating consists of 50% polymeric binder and 50% 
conductive filler based on the total solids weight of the mixture.  The wet coating mixture is prepared by 
 
           
(a)                                                                        (b) 
 
Figure 8.1 – Connector and contact sides of Ag/AgCl (left) and CSA (right) sEMG electrodes. (a) 
Connection side; (b) Contact side. 
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weighing out the desired amounts of each component and smoothly blending together for about 10 minutes 
until a uniform appearance is obtained.  The wet mixture is then coated onto the carrier using a #60 Mayer 
rod, and then placed into a 71.1 °C oven for 10 minutes to dry.  The electrical conductivity of the dried 
coating is easily checked by measuring surface resistance to confirm that approximately 150 Ohms per 
square has been achieved.  Discs of the conductive bridge (3/8" diameter) coating/carrier are cut out using 
a die punch. 
8.2.1.4 Electrode Assembly and Activation  
A 2 mm round die is used to punch holes in the base layer material every 1-1/2".  The bottom half 
of an electrode snap is inserted through the hole from the side with the conductive coating. The top half of 
the snap is assembled to the bottom half using sufficient pressure so that the snap halves are securely mated.  
After removing one release carrier from the adhesive, the adhesive layer is laminated to the conductive base 
layer so that it covers the bottom halves of the electrode snaps. The remaining release carrier is removed.  
The discs of conductive bridge coating/carrier are applied to the adhesive with the bridge against the 
adhesive so that each snap is covered by a bridge. The bridge's release carrier is removed.  The lamination 
 
Figure 8.2 – Sample images of where the electrodes were placed for each muscle-contraction test. 
Note that the electrodes presented in these images were not the ones that were used for the actual tests. (a) 
Biceps brachii; (b) Triceps brachii (long head); (c) Tibialis anterior; (d) Quadriceps femoris (rectus 
femoris). 
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is then applied to a release carrier to facilitate easy handling.  The lamination is trimmed into 1-1/2" x 7/8" 
electrodes to complete the process.  After the CSA electrodes are fabricated, they are activated by 
electrophoresis [5]. This produces multiple isolated Z direction (out of plane) conductive pathways in the 
adhesive.  The resulting test electrodes were used for all testing described. 
8.2.2 Electrode-skin contact impedance measurements  
CSA-EMG electrodes were used to carry out electrode-skin impedance measurements and were 
compared to Ag/AgCl EMG electrodes (GS28 Solid Gel - Foam Electrode - 7/8" X 1-1/2", low impedance, 
disposable Ag/AgCl sensors).  Figure 8.1 shows the Ag/AgCl and CSA electrodes used in this study.  The 
skin of the test subject was cleaned before each measurement by wiping with a 2%-alcohol impregnated 
cotton pad, which was allowed to evaporate before applying the electrodes.  Two CSA electrodes were 
mounted on the left forearm, one on the palm side of the wrist, and the second 5 cm apart from the first but 
situated towards the elbow.  These electrodes were connected to a Hioki IM3570 impedance analyzer, and 
each measurement was the result of averaging 20 measurements.  The signal voltage amplitude was set to 
1 V and the frequency range from 4 to 2 KHz.  N = 7 pairs of CSA electrodes were used.  Once the testing 
of CSA electrodes were completed, we performed the same experiments as described above using only one 
pair of Ag/AgCl electrodes.  To keep skin properties as constant as possible, all measurements were 
performed in a single day. 
8.2.3 Protocol 
N = 20 subjects were enrolled to take part in this test.  The experiments were carried out in a quiet, 
comfortable room (ambient temperature 26-27 °C, relative humidity between 30-50%).  To ensure accurate 
comparison between the electrodes, simultaneous measurements were recorded. To do this, CSA and 
Ag/AgCl (GS28) electrodes were placed side-by-side.  sEMG measurements are largely dependent on 
location, since proximity to the muscle has a great effect on signal strength.  Hence, to eliminate any benefit 
from being on either side, the CSA and the Ag/AgCl electrodes were assigned a lateral position (left or 
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right on the same muscle) that alternated from subject to subject.  This should have reduced any error 
resulting from one of the side-by-side positions having a stronger sEMG signal than the other. 
We had subjects lift a weight of 3 lb. (1.36 kg) for testing triceps brachii and tibialis anterior 
muscles.  For biceps brachii and quadriceps femoris, they used a weight of 6 lb. (2.72 kg).  These weights 
were chosen considering the size of the muscles and to ensure effective stress on the muscle during 
contraction time.  Before performing every test, we made sure that the locations where the electrodes were 
placed did not exhibit excessive hair and had been wiped with alcohol and then allowed to dry.  If the 
subject presented thick or abundant hair, they were provided with a disposable razor and asked to shave the 
hair from the site where the electrodes were placed.  Figure 8.2 shows the areas where the electrodes were 
placed, for each muscle.  The electrodes were placed with the subjects in resting condition.  Surface EMG 
measurements of the biceps brachii, triceps brachii (long head), tibialis anterior, and quadriceps femoris 
(rectus femoris) were recorded while subjects performed four muscle contraction maneuvers during the 
experiment, one for each muscle.  These specific muscles were chosen based on their variance in size.  It 
has been observed that muscles of varying sizes will produce sEMG signals of varying amplitudes.   
EMG signals were acquired using a dual-channel bioelectric amplifier (Nikon Kohden) and 
digitized through an ADInstruments analog-to-digital converter, with a sampling frequency of 1 kHz, and 
we used compatible PowerLab software.  
The completion order of the four maneuvers should not influence the results because the muscles 
are independent, so for this study they were performed in an arbitrary numerical order that we assigned. 
While different motions and weights were involved for each muscle, the same time limit for each maneuver 
was followed for EMG signal recording (Figure 8.3).  The contraction maneuvers were kept as clear of 
motion artifacts as possible by allowing the subject 2 seconds to perform the required movement.  Subjects 
practiced the maneuvers prior to every test until they felt comfortable with the procedure.  This was 
important given the time constraint for the movements in the tests.  A visual tool with timing signals was 
used to guide the subjects throughout the tests. 
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Subjects were asked to perform these maneuvers: 1) to contract their biceps, bringing the elbow to 
a 90 degree angle, with the forearm in supination; 2) to contract their triceps and extend their elbow joint 
so that the weight was suspended backwards; 3) to contract their tibialis anterior muscle and lift the weight 
off the floor without extension of the great toe; and 4) to lift their leg up (extend their knee) to procure 
contraction of the quadriceps. The protocol was approved by the Institutional Review Board of the 
University of Connecticut.  
8.2.4 Signal processing 
In the acquisition device the sEMG signals were filtered using an analog bandpass filter (5-300 Hz) 
and a Notch filter at 60 Hz.  We also processed the signals offline to quantify their quality and to compare 
the performance of the CSA EMG electrodes to the Ag/AgCl EMG electrodes.  Several time- and 
 
 
Figure 8.3 – Time frame for movements while recording EMG signal. 
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frequency-domain indices of correlation and the sEMG signals’ quality were computed.  In the time domain, 
the linear envelope of each sEMG signal was computed using rectification and a low pass filter (7th-order 
Chebyshev, cut-off frequency = 16.66 Hz), and an RMS approach was also applied. From the linear 
envelope, on and off contraction times were estimated.   
For frequency domain analysis, the power spectral density (PSD) of each sEMG signal was 
calculated using Welch’s periodogram method with 50% data overlap.  A Blackman window (length of 256 
data points) was applied to each segment and the Fast Fourier Transform (FFT) was calculated for each 
windowed segment.  Finally, the power spectra of the segments were averaged.  An FFT segment size of 
1024 data points was used.  PSD correlation was computed between CSA and Ag/AgCl signals.  Time- and 
frequency-domain correlations, along with the interchangeability of on- and off-time measures, were 
intended to prove whether or not CSA electrodes are able to match the functionality of Ag/AgCl electrodes 
in the task of sEMG signal collection.  
To measure quality of the collected sEMG signals, signal-to-noise (SN) ratio (SNR), signal-to-
motion (SM) ratio, the spectrum maximum-to-minimum drop in power (DP ratio) density and the power 
spectrum deformation (Ω ratio) indices were computed.  All computations, including the statistical analyses 
of these indices, are explained below. 
 
8.2.4.1 Time domain measures 
8.2.4.1.1 Linear envelope   
sEMG signals are rectified (by taking their absolute value), low-pass filtered at 10 Hz, and down-
sampled to 41.66 Hz (a rate that is closer to motion frequencies) to get a linear envelope.  The resulting 
envelope is an estimate of the standard deviation of the sEMG signal, which is in turn a measure of the 
muscles’ power.  The Pearson’s correlation between CSA and Ag/AgCl electrodes’ sEMG envelopes was 
computed, for each muscle and in the overall, to test the similarity between the two simultaneously-acquired 
signals.  Correlation gives us an index of similarity, independent of the amplitude of the signals which were 
collected with the two types of electrodes side by side. 
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8.2.4.1.2 Amplitude   
Mean value of the linear envelope was computed as an amplitude estimation of sEMG signals.  This 
index was computed for relaxation and contraction stages, to evaluate the statistical differences in amplitude 
between the signals obtained using CSA and Ag/AgCl electrodes.  
8.2.4.1.3 RMS value  
The sEMG signals were divided into multiple windows of 25 ms [6]. RMS values were computed 
from the signals before rectification since the values have both negative and positive values.  As with the 
linear envelope, the Pearson’s correlation between CSA and Ag/AgCl electrodes’ sEMG RMS values was 
computed, for each muscle and in the overall. 
8.2.4.1.4 On- and off-time   
Muscles’ on and off contraction times were estimated using the linear envelope of sEMG signals. 
On and off detection is based on determining the times at which the envelope of the signal exceeds a 
threshold.  In this study the threshold was calculated by: 
 
Figure 8.4 – Illustration of SM ratio and SN ratio estimation. 
Gray area corresponds to motion artifact. Power on the thick black line (upper 20% of the range) is 
considered noise. 
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𝑇ℎ𝑟𝑒𝑠ℎ𝑜𝑙𝑑 =  𝜇 + 𝐽𝜎                                                                                      (1) 
Where µ and σ are the mean and standard deviation of the linear envelope during a period of 
inactivity, and J is a constant.  J was fixed to 3 [7] and it was required that the mean of the points in a sliding 
window of 25 ms exceed the threshold to label a point as an on- or off-time [8].  This approach provides a 
suitable on- and off-time detection.  Agreement between the on and off estimations using CSA and Ag/AgCl 
sEMG signals was evaluated using Bland and Altman analysis and the Pearson’s correlation.  
 
8.2.4.2 Frequency domain measures 
8.2.4.2.1 PSD correlation  
The raw sEMG data were used to perform frequency domain analysis.  To test the similarity 
between CSA and Ag/AgCl sEMG signals in the frequency domain, the Pearson’s correlation coefficient 
of PSD representations was computed.  
8.2.4.2.2 SN Ratio  
This index takes into account all kinds of noisy disturbances as well as low signal levels. In this 
case, noise is defined as any signal of unrecognizable source present in the high-frequency range of the 
PSD [9]. For the SN ratio calculation we assumed that noise had a constant power density over the 
frequency region of interest in sEMG recordings and that no muscular activity-related power was present 
above 400 Hz (upper 20% of the frequency range). So, first, the power for the frequency range above 400 
Hz was calculated. The predicted total power of the noise is this power summed over the whole frequency 
range. The SN ratio was then calculated as the ratio of the total sEMG power to the total power of the noise. 
8.2.4.2.3 SM Ratio  
For this study, motion artifacts are defined as low-frequency fluctuations of the signal induced by 
mechanical alteration of the electrode-skin interface.  Use of the SM ratio is based mainly on two 
assumptions: 1) the frequency of motion-induced artifacts of the signal stays well below 20 Hz, and 2) the 
shape of the non-contaminated sEMG power spectrum is fairly linear between 0 and 20 Hz [10].  As a 
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consequence, the motion artifacts’ spectral power will be mixed in with the true signal dynamics at 
frequencies between 0 to 20 Hz.  According to Sinderby et al., the motion artifacts’ power (grey area in 
Figure 8.4) can be reasonably estimated by summing the PSD area below 20 Hz that exceeds a straight line 
between the origin and the highest mean power density.  The highest mean power density (the red dot in 
the averaged spectral plot of Figure 8.4) was defined as the largest mean spectral value within a window 
length of 12.7 Hz starting from 35 Hz to 500 Hz.  Finally, the sum of the area under the PSD for all 
frequencies divided by motion artifact power was computed to obtain the SM ratio. 
8.2.4.2.4 DP ratio  
The spectrum maximum-to-minimum drop in power (DP ratio) was obtained by computing the 
quotient between the highest and lowest mean PSD values.  The mean PSD is obtained by averaging a 
spectral window length of 12.7 Hz (13 consecutive points).  The DP ratio is an indicator of whether the 
spectral frequency contents of interests are adequately peaked and is sensitive to the signal’s amplitude and 
can detect the absence of sEMG activity.  DP ratio is not sensitive to power below 35 Hz (in contrast to the 
SN ratio) and will not provide falsely high values because of the power induced by motion artifacts.  A 
higher DP ratio is desirable. 
8.2.4.2.5 Ω ratio.  
The spectral deformation is computed in terms of spectral moments, as follows: 
Ω =  (𝑀2 𝑀0⁄ )
1
2/(𝑀1/𝑀0),                                                                                     (2) 
where 
 𝑀𝑛 = ∑ 𝑝𝑜𝑤𝑒𝑟 𝑑𝑒𝑛𝑠𝑖𝑡𝑦𝑖 ∙ 𝑓𝑟𝑒𝑞𝑢𝑒𝑛𝑐𝑦𝑖
𝑛𝑖𝑚𝑎𝑥
𝑖=0                                                          (3) 
Ω ratio is sensitive to changes in symmetry and peaking of the PSD and to additive disturbances in 
the high- and low-frequency regions [9].  This index identifies all dynamics of spectral changes except 
those caused by pure translations along the frequency axis.  In this manner it adapts to myoelectric changes 
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due to muscle fatigue but not to additive disturbances.  The feature is also sensitive to motion artifacts, 
which give an excess of low-frequency power.   A lower Ω is desirable.  
The SN, SM and DP ratios are presented in decibels, and the Ω ratio is unitless.  These four indices 
obtained for CSA and Ag/AgCl electrodes were compared for each muscle and in the overall, by testing for 
statistically significant differences, to check whether there is an electrode media that collects the signal with 
lower noise power, lower motion-artifact corruption, more sensitivity to EMG activity and lower distortion, 
respectively.  Quality indices were computed using a myoelectric signal processing toolbox developed by 
Chan and Green [11].  
 
 
Figure 8.5 – Electrode-skin contact impedance measurements for CSA and Ag/AgCl electrodes. 
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8.3 Results  
Results for electrode-skin contact measurements are presented in Figure 8.5. Ag/AgCl sEMG 
electrodes exhibited lower impedance compared to CSA sEMG electrodes throughout the range of 
frequencies of interest (4 Hz to 2 kHz).   Representative sEMG signals acquired with Ag/AgCl and CSA 
electrodes are shown in Figure 8.6.  It is clearly evident that on the Figure 8.6 (biceps of a given subject), 
 
 
Figure 8.6 – Sample sEMG measures using Ag/AgCl (top) and CSA electrodes (bottom). 
 
Table 8.1 Results for evaluation of signals’ interchangeability 
Index Stage Biceps Triceps Tibialis Quadriceps Overall 
Amplitude Ag/AgCl (V) 
Relaxation 0.16 ± 0.17 0.42 ± 0.27 0.064 ± 0.101 0.072 ± 0.068 0.18 ± 0.22 
Contraction 0.99 ± 0.42 1.47 ± 0.53 0.98 ± 0.7 0.72 ± 0.36 1.04 ± 0.58 
Amplitude CSA (V) 
Relaxation 0.17 ± 0.26 0.48 ± 0.46 0.06 ± 0.11 0.051 ± 0.041 0.19 ± 0.31 
Contraction 0.99 ± 0.38 1.48 ± 0.66 1.01 ± 0.68 0.71 ± 0.31 1.05 ± 0.59 
Contraction time 
correlation 
on 0.95 0.96 0.96 0.97 0.96 
off 0.96 0.98 0.91 0.90 0.94 
Envelope correlation 0.91 ± 0.07 0.92 ± 0.038 0.95 ± 0.029 0.93 ± 0.05 
0.93 ± 
0.052 
RMS correlation 0.91 ± 0.06 0.91 ± 0.038 0.95 ± 0.029 0.93 ± 0.05 0.93 ± 0.05 
PSD correlation 0.98 ± 0.02 0.95 ± 0.034 0.95 ± 0.046 0.97 ± 0.04 0.96 ± 0.04 
Values are expressed as mean ± standard deviation. 
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the CSA electrodes exhibited a lower noise level than Ag/AgCl during the relaxation phases of the signal 
while both types of electrodes exhibited similar signal amplitude during the contraction phase.   
Table 8.1 contains the results for our interchangeability analysis.  No significant differences in 
amplitude were found between CSA and Ag/AgCl sEMG signals either for relaxation or for contraction 
stages, for any muscle or in the overall which combines all four types of muscles denoted in Table 8.1.  The 
CSA electrodes exhibited lower amplitude for most of the muscles during muscle relaxation, with the 
exception of the Tibialis, and higher amplitude during the contraction time for all the muscles.  The 
differences in the relaxation and contraction amplitudes are also present in the overall comparison 
(gathering results for all muscles together), but they are not found to be statistically significant.   
The linear envelope, the RMS value envelope, and the sEMG PSD were highly correlated.  The 
linear envelope and RMS value envelope exhibited a correlation higher than 0.91 for all muscle. Lower 
correlation was found for the smaller muscles (biceps and triceps), and a stronger correlation was found for 
the bigger muscles (tibialis and quadriceps).  The PSD of the sEMG signals achieved a correlation higher 
than 0.95 for all the muscles.  Figure 8.7 shows the RMS value envelope for a given subject.  
 
Figure 8.7 – RMS value envelope estimation for a given signal. 
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On- and off-time contraction time estimations were highly correlated between the two electrodes.  
Figure 8.8 exemplifies the on- and off-time estimation using the linear envelope and the threshold.  We did 
not use a single value of the sEMG but the mean value of a 25 ms window to determine if a threshold of 
the occurrence of the muscle contraction or relaxation had occurred.  For all the muscles, the correlation of 
off-time detection was above 0.9.  Correlation for on-time estimations was always very high (above 0.95). 
Notice that the threshold was computed using the same signal during the relaxation stage, i.e. for Ag/AgCl 
electrodes the threshold was computed using a segment of Ag/AgCl sEMG signal during the relaxation 
stage. The same time frame of the relaxation stage was used to compute the threshold for CSA and Ag/AgCl 
signals.  Figure 8.9 presents the Bland-Altman plot and a scatter plot of the results for on- and off-time 
estimation, allowing us to test the interchangeability of the signals for this purpose.  Notice the small bias 
and variance of the error for on- and off-time estimation.   
Table 8.2 includes the frequency-domain indices for quality assessment of sEMG signals.  The SN 
ratio was significantly different between the two media for biceps and quadriceps, and in the overall.  CSA 
electrodes showed a higher SN ratio, compared to Ag/AgCl.  The SM ratio was different for all the muscles, 
with CSA electrodes always exhibiting a better response to motion artifacts.  The DP ratio was higher for 
Ag/AgCl electrodes only in the overall, compared to CSA electrodes.  Finally, the Ω ratio indicates a 
significantly higher spectral deformation for the Ag/AgCl electrodes.  
 
Table 8.2 Indices of EMG signal quality estimated using frequency domain measures 
  Biceps Triceps Tibialis Quadriceps Overall 
SN ratio (dB) 
Ag/AgCl 41.6 ± 14.9 35.2 ± 9.62 24.4 ± 17.3 29.8 ± 15 32.7 ± 15.6 
CSA 50.01 ± 5.89* 34.93 ± 11.9 30.42 ± 5.44 37.83 ± 6.27* 38.3 ± 10.6* 
SM ratio  (dB) 
Ag/AgCl 15.9 ± 7.26 18.4 ± 7.17 19.3 ± 9.49 12.9 ± 9.08 16.6 ± 8.52 
CSA 21.5 ± 12* 22.6 ± 9.56* 30.6 ± 14.5* 21.9 ± 9.95* 24.1 ± 12.1* 
DP ratio (dB) 
Ag/AgCl 82.8 ± 6.61 62.2 ± 11.7 58.9 ± 13.5 67.7 ± 9.26 67.9 ± 13.9 
CSA 82.9 ± 7.79 60.6 ± 15.3 55.3 ± 9.6 62.8 ± 6.73 65.4 ± 14.6* 
Ω ratio (relative 
units) 
Ag/AgCl 1.48 ± 0.14 1.39 ± 0.27 1.42 ± 0.6 1.56 ± 0.38 1.46 ± 0.39 
CSA 1.39 ± 0.12* 1.31 ± 0.12 1.28 ± 0.31 1.3 ± 0.173* 1.32 ± 0.2* 
Values are expressed as mean ± standard deviation. *p<0.05. 
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8.4 Discussion 
First, CSA and Ag/AgCl electrodes were compared by means of impedance measurements.  Then, 
measures of similarity were deployed to evaluate whether CSA sEMG electrodes could replicate dynamics 
of the Ag/AgCl electrodes.  Finally, both time- and frequency-domain indices of sEMG signal quality were 
introduced to highlight the advantages of using CSA electrodes for the task of sEMG signal collection.  
Despite the higher electrode-skin contact impedance exhibited by the CSA electrodes, no 
significant amplitude differences were found between the signals obtained by the two media.  Hence, the 
impact of the electrode-skin contact impedance on the collected signal amplitude was found to be 
negligible.  Note that impedance results between Ag/AgCl and CSA electrodes are in agreement with what 
has been reported previously [4], [12]–[14].  Higher impedance was found for CSA electrodes in the current 
work than in our previous study [4], but this is because the salt concentration was substantially reduced to 
minimize possible skin irritation.  One way to lower the impedance of CSA electrodes is to use higher salt 
concentrations, but this can lead to possible skin irritation as found in our previous study [4]. 
 
Figure 8.8 – Top: Estimated on and off contraction time for a given subject.  Bottom: linear envelope 
and threshold used to estimate the times. 
 
(a)                                       (b) 
Figure 8.9 – Bland-Altman plot. 
(a) On-time estimation (bias = -0.005, variance = 0.1);  (b) Off-time estimation (bias = -0.061, variance 
= 0.23).  
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The analysis of interchangeability comprises amplitude comparison, linear envelope, on- and off-
time estimation, RMS value envelope and PSD correlation.  Differences in amplitude estimation during 
relaxation and contraction stages were not significant, demonstrating that CSA electrodes are at least as 
sensitive to collect sEMG signals as the Ag/AgCl electrodes. All the correlation values were high and the 
biases of the measures were low, indicating that CSA electrodes can be used as functional substitutes for 
Ag/AgCl electrodes for sEMG signal collection. 
EMG signal waveforms are more irregular than others (e.g. ECG) and motion artifacts and noise 
corruption are more difficult to assess by visual inspection of the signal in time or frequency domains.  
Given this complication, previously-reported and validated indices for automatic evaluation of EMG signal 
quality were employed.  With the only exception of DP ratio (which was higher for Ag/AgCl electrodes 
only in the overall), the quality indices SN, SM and Ω ratios were in favor of CSA electrodes.  These indices 
suggest that CSA electrodes are more resistant to noise and motion artifact corruption, two highly relevant 
issues for sEMG signal collection.  These are significant benefits of CSA electrodes considering that one 
of the disadvantages of past dry electrodes, compared to gel electrodes, was the lack of flexible contact 
provided by the gel. This rigidity produced variations in contact during motion, and tended to introduce 
motion artifacts to the EMG signal. However, for the CSA electrodes, the Z-direction formation of carbon 
columns after activation provides a better resistance to shifting against skin, as the electrodes should be less 
sensitive to X- and Y-direction potentials.  Specifically, the main advantage of the CSA electrode is that 
the conductivity enhancing feature (the bridge) is a low impedance electrically conductive material that 
produces a lower electrode ohm value by connecting in parallel multiple isolated Z direction (out of plane) 
conductive pathways in the adhesive. This can be described by  
 
1
𝑅𝑡𝑜𝑡𝑎𝑙
=
1
𝑅1
+
1
𝑅2
+
1
𝑅3
+ ⋯ +
1
𝑅𝑛
                                                                                      (4) 
where R represents each isolated Z direction pathway. The bridge is specifically designed to 
balance electrical, mechanical and electrode adhesion properties: its conductive loading level provides 
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electrical conductivity, its polymeric content and thinness provide mechanical flexibility, and its small area 
does not significantly reduce the adhesive bonding.  
Finally, the lower Ω ratio demonstrates that CSA electrodes are more able to adapt to muscular 
activity changes derived from muscle fatigue but not from additive disturbances like motion artifact and 
noise, compared to Ag/AgCl.  The higher DP ratio of Ag/AgCl electrodes suggests that the PSD of sEMG 
signals obtained with such electrodes are more sensitive to detecting the absence of sEMG activity. 
 
8.5 Conclusion 
CSA and Ag/AgCl electrodes were quantitatively compared for the task of collecting sEMG 
signals.  It was found that our dry CSA electrodes are comparable to the gold standard Ag/AgCl electrodes 
in that there were no significant differences in the sEMG amplitude and activation times.  Further, CSA 
electrodes were more resistant to noise and motion artifacts and delivered signals with lower spectral 
distortion, compared to Ag/AgCl.  This is primarily an exciting result because of the two salient 
disadvantages of Ag/AgCl electrodes that are not a problem for CSA: dehydration with storage or prolonged 
use, and higher cost.  The results of the current work indicate that CSA electrodes represent a suitable and 
cost-effective alternative to standard Ag/AgCl electrodes for sEMG signal collection.  For point-of-care 
applications, CSA electrodes can be used to monitor the progression of muscular dystrophies or control 
muscle activities via signal processing of the electromyogram data.  Certainly, with the advent of 
sophisticated machine learning algorithms and robotics, rehabilitation engineering of muscles and limbs 
will be a good opportunity for more noise-resistant and cost-effective surface EMG electrodes than the 
current standard hydrogel-based electrodes. 
 
 
 
 140 
 
8.6 References 
[1] A. Searle and L. Kirkup, “A direct comparison of wet, dry and insulating bioelectric recording 
electrodes,” Physiol. Meas., vol. 21, no. 2, pp. 271–283, May 2000. 
[2] J.-Y. Baek, J.-H. An, J.-M. Choi, K.-S. Park, and S.-H. Lee, “Flexible polymeric dry electrodes for the 
long-term monitoring of ECG,” Sens. Actuators Phys., vol. 143, no. 2, pp. 423–429, May 2008. 
[3] I. Benedek, Pressure-sensitive adhesives and applications. CRC Press, 2004. 
[4] H. F. Posada-Quintero, B. A. Reyes, K. Burnham, J. Pennace, and K. H. Chon, “Low Impedance 
Carbon Adhesive Electrodes with Long Shelf Life,” Ann. Biomed. Eng., vol. 43, no. 10, pp. 2374–2382, 
Oct. 2015. 
[5] K. L. Lerner and B. W. Lerner, The Gale Encyclopedia of Science. Cengage Gale, 2008. 
[6] C. J. De Luca, “The Use of Surface Electromyography in Biomechanics,” J. Appl. Biomech., vol. 13, 
no. 2, pp. 135–163, May 1997. 
[7] R. P. Di Fabio, “Reliability of computerized surface electromyography for determining the onset 
of muscle activity,” Phys. Ther., vol. 67, no. 1, pp. 43–48, Jan. 1987. 
[8] P. W. Hodges and B. H. Bui, “A comparison of computer-based methods for the determination of 
onset of muscle contraction using electromyography,” Electroencephalogr. Clin. Neurophysiol., vol. 101, 
no. 6, pp. 511–519, Dec. 1996. 
[9] A. Arvidsson, A. Grassino, and L. Lindström, “Automatic selection of uncontaminated 
electromyogram as applied to respiratory muscle fatigue,” J. Appl. Physiol., vol. 56, no. 3, pp. 568–575, 
Mar. 1984. 
[10] C. Sinderby, L. Lindström, and A. E. Grassino, “Automatic assessment of electromyogram 
quality,” J. Appl. Physiol. Bethesda Md 1985, vol. 79, no. 5, pp. 1803–1815, Nov. 1995. 
[11] A. D. Chan and G. C. Green, “Myoelectric control development toolbox,” in Proceedings of 30th 
Conference of the Canadian Medical & Biological Engineering Society, 2007, vol. 1, pp. M0100–1. 
[12] A. Gruetzmann, S. Hansen, and J. Müller, “Novel dry electrodes for ECG monitoring,” Physiol. 
Meas., vol. 28, no. 11, pp. 1375–1390, Nov. 2007. 
[13] B. A. Reyes, H. F. Posada-Quintero, J. R. Bales, A. L. Clement, G. D. Pins, A. Swiston, J. Riistama, J. 
P. Florian, B. Shykoff, M. Qin, and K. H. Chon, “Novel electrodes for underwater ECG monitoring,” IEEE 
Trans. Biomed. Eng., vol. 61, no. 6, pp. 1863–1876, Jun. 2014. 
[14] Y. Noh, J. R. Bales, B. A. Reyes, J. Molignano, A. L. Clement, G. D. Pins, J. P. Florian, and K. H. 
Chon, “Novel Conductive Carbon Black and Polydimethlysiloxane ECG Electrode: A Comparison with 
Commercial Electrodes in Fresh, Chlorinated, and Salt Water,” Ann. Biomed. Eng., vol. 44, Jan. 2016. 
 
 141 
 
Chapter 9: Dry Carbon/Salt Adhesive electrodes for recording Electrodermal 
Activity 
(Posada-Quintero, H. F., Rood, R., Noh, Y., Burnham, K., Pennace, J. and Chon, K. H.. Dry Carbon/Salt 
Adhesive electrodes for recording Electrodermal Activity.  Sensors & Actuators: A. Physical. In process 
of revision for publication) 
 
9.1 Introduction  
This paper describes the evaluation of carbon/salt adhesive (CSA) electrodes for measuring 
electrodermal activity (EDA). CSA electrodes’ performance was compared to Silver/Silver Chloride 
(Ag/AgCl) hydrogel electrodes, the gold standard for electrodermal recording [1]. EDA measures have been 
traditionally used to assess psychophysiological stress [1], [2], but recently have also been used to assess 
sympathetic nervous system arousal under stressors of many kinds [3]–[7]. The increasing relevance and 
popularity of EDA and the ease of data acquisition via wearable devices necessitates the development of 
better electrodes and instrumentation. 
The EDA is a measure of the change in conductance of the skin [1]. When the body is experiencing 
stressful situations the sympathetic nervous system (SNS) is activated. Sympathetic innervation of sweat 
glands results in sweat production. As sweat production increases, the conductance of the skin increases, 
due to high conductivity of the sodium chloride in the sweat. EDA is measured as the modulation produced 
by such conductivity changes on a power (DC or AC) source [8]. EDA has many potential applications in 
society. For instance, it could be used for monitoring the stress which the US Navy personnel are 
experiencing when working in harsh conditions (e.g. battlefield, underwater, prolonged surveillance, etc.). 
Another possible application could be the use of these electrodes in the automobile industry to alert drivers 
when they are too tired to be driving because their EDA levels indicate that the driver is falling asleep. In 
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wearable devices, EDA signals could be used to develop alarms of high or increasing levels of cognitive 
(related to workload), physical (during workout) or emotional stress, among other things.  
EDA data acquisition with Ag/AgCl electrodes requires the application of a paste-like hydrogel 
over a silver disc. While the hydrogel layer significantly improves the signal quality by effectively lowering 
the impedance that exists at the electrode-skin interface, impedance increases when the hydrogel layer 
degrades with time as a result of dehydration. This leads to a loss of signal quality and an increased 
incidence of motion artifacts and noise [9]. Also, Ag/AgCl electrodes are expensive since silver is an 
expensive commodity. The Ag/AgCl electrodes we used for this study needed to be taped to the subject’s 
fingers, because they don’t have any self-attaching system similar to ECG Ag/AgCl that have an adhesive 
surrounding the hydrogel. 
The most salient advantages of CSA electrodes are their consistently low impedance and no shelf 
life limitations without the use of a hydrogel layer [10]. These electrodes are cheap to make, and because 
of their ease of fabrication and flexibility they can be designed, tuned and configured depending on the 
application. For this study, we have made electrodes in such a way that they wrap around the fingers, with 
electrode-skin contact surface of around 2 cm2 and a little circular conduction bridge placed directly on a 
fingertip. We expected these dimensions and characteristics to be suitable for EDA measurements, because 
of the finger’s anatomy and the nature of the EDA signal. 
Most EDA devices involve the application of an external constant current or voltage source via 
electrodes on the skin, either direct current (DC) or alternating current (AC). These are termed exosomatic 
methods. EDA devices measure the modulated current or voltage (depending on whether the constant 
source is voltage or current, respectively) to compute the skin conductance. Although AC-source devices 
have shown advantages over DC-source devices (mainly, avoiding electrode polarization [1]), both types 
are still widely used.  
We aimed to compare CSA to Ag/AgCl electrodes for the task of acquiring EDA signals. First, the 
electrode-skin impedance was measured for CSA and Ag/AgCl electrodes. The electrodes were tested with 
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representative types of stressors for which EDA is used, namely physical, emotional, and cognitive stress. 
The same protocol was followed using DC- and AC-source devices.  
  
9.2 Materials and Methods 
Figure 9.1 shows CSA and Ag/AgCl electrodes used to collect EDA signals during this study. 
FLEXcon developed CSA electrodes to address the issue of dehydration with the current industry gold 
standard electrodes for collecting bioelectric signals [10]. They were designed by combining a visco-elastic 
polymeric adhesive [11] with carbon black powder and a quaternary salt. This mixture is potentially much 
more economical than Ag/AgCl. The process of fabrication of CSA electrodes, and the implemented 
methods to compare them to Ag/AgCl electrodes are described below. 
9.2.1 Fabrication of CSA electrodes for EDA 
To create the testable CSA electrodes for EDA measurements, the conductive base layer, the 
adhesive, and the bridge were prepared beforehand.  Details about preparation of the components and a 
description of the CSA electrode assembly process are included below. 
9.2.1.1 Conductive Base layer.   
 
  
Figure 9.1 – Ag/AgCl hydrogel electrodes (left) and CSA electrodes (right) for EDA 
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A polyethylene foam carrier is coated with an electrically conductive material consisting of a 
polymeric binder loaded with conductive fillers. The conductive coating consists of 50% polymeric binder 
and 50% conductive filler based on the total solids weight of the mixture.  The wet coating is prepared by 
weighing out the desired amounts of each component and smoothly blending them together for about 10 
minutes until a uniform appearance is obtained.  In the design of CSA electrodes to collect EDA, 
concentrations of 2% carbon and 15% salt were used. The wet mixture is then coated onto the carrier using 
a #60 Mayer rod, and then placed into a 71.1 °C oven for 10 minutes to dry.  The electrical conductivity of 
the dried coating is easily checked by measuring its surface resistance to confirm that approximately 150 
Ohms per square has been achieved.  
9.2.1.2 Adhesive.   
A releasable carrier is coated with a doped adhesive such as an acrylic pressure sensitive type 
loaded with conductive carbon filler & a quaternary ammonium salt.  The wet adhesive mixture is prepared 
by weighing out the desired amounts of each component and smoothly blending together for about 10 
minutes until a uniform appearance is obtained.  The resulting wet mixture is then coated onto a release 
liner using a # 18 gap drawdown blade and then placed into a 71.1 °C air flow oven for 10 minutes to dry.  
The dried adhesive is covered with a second liner to facilitate easy handling.  
9.2.1.3 Bridge.   
A releasable carrier is coated with an electrically-conductive material such as a polymeric binder 
loaded with conductive fillers. The conductive coating consists of 50% polymeric binder and 50% 
conductive filler based on the total solids weight of the mixture.  The wet coating mixture is prepared by 
weighing out the desired amounts of each component and smoothly blending together for about 10 minutes 
until a uniform appearance is obtained.  The wet mixture is then coated onto the carrier using a #60 Mayer 
rod, and then placed into a 71.1 °C oven for 10 minutes to dry.  The electrical conductivity of the dried 
coating is easily checked by measuring surface resistance to confirm that approximately 150 Ohms per 
square has been achieved.  Discs of the conductive bridge coating/carrier are cut out using a die punch. 
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9.2.1.4 Electrode Assembly and Activation.  
After removing one release carrier from the adhesive, the adhesive layer is laminated to the 
conductive base layer so that it covers the bottom of the electrodes. The remaining release carrier is 
removed.  The discs of conductive bridge coating/carrier are applied to the adhesive with the bridge against 
the adhesive. The bridge's release carrier is removed.  The lamination is then applied to a release carrier to 
facilitate easy handling.  The lamination is trimmed into 1-1/2" x 3/8" electrodes to complete the process.  
We cut the material in this shape so the electrode can be wrapped around the finger, with the bridge in 
contact with the fingertip, providing stability.  After the CSA electrodes were fabricated, they were 
activated by electrophoresis [12]. This produces multiple isolated Z direction (out of plane) conductive 
pathways in the adhesive. The bridge, or conductivity-enhancing feature, is a low impedance electrically 
conductive material that produces generally lower electrode impedance by connecting in parallel the Z 
direction conductive pathways. This can be described by 1/Rtotal = (1/R1)+(1/R2)+(1/R3)+....(1/Rn) where 
R represents each isolated Z direction pathway. The bridge is specifically designed to balance electrical, 
mechanical and electrode adhesion properties: its conductive loading level provides electrical conductivity, 
its polymeric content and thinness provide mechanical flexibility, and its small footprint minimizes 
reduction in adhesive bonding.  
9.2.2 Protocol  
The study protocol was approved by the Institutional Review Board of The University of 
Connecticut and all volunteers provided written informed consent to participate in the experiment. 
Electrode-skin contact impedance was measured for both media. For procuring a fair comparison, skin 
properties were kept as constant as possible by doing all measurements in a single day, on a single subject. 
The skin of the test subject was cleaned before each measurement by wiping with a 70% alcohol-
impregnated cotton pad, which was allowed to evaporate before applying the electrodes. Two electrodes 
were mounted, one each on the index and middle fingers. These electrodes were connected to the Hiroki 
IM3570 impedance analyzer, and each measurement is the result of averaging 10 measurements. The signal 
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voltage amplitude was set to 1 V and the frequency range from 4 to 200 Hz. N = 7 pairs of CSA electrodes 
were used for impedance measurements. 
To evaluate CSA electrode performance on measuring EDA, three types of stress were monitored 
throughout this study: physical, emotional, and cognitive. The physical testing consisted of electrical 
stimulation (shocks), which is a startle-like test; the emotional testing consisted of watching a disturbing 
video; the cognitive testing consisted of the Stroop test. The latter two are considered tonic-stress tests. 
With an overall experiment length of just above 40 minutes, subjects experienced each type of stress after 
a resting period to procure hemodynamic stabilization, and 5 minutes of baseline measurement.  
First, the subject went through the electrical stimulation phase. This phase required the use of a 
commercially available dog collar [13]. The contact points of the receiver were placed on the inside of the 
subjects forearm. The power level on the transmitter was set to a level just enough to elicit a response on 
the subjects (amperage of less than 1.5 mA) without any risk, and remained at this level throughout the 
entire period of electrical stimulation (5-min baseline plus 5-min stimulation). This level of power was 
chosen because it was just above the threshold of feeling of 1 mA [14]. This also was chosen to adhere to 
UConn IRB recommendations and reduce any unnecessary discomfort to subjects. After the baseline 
recordings, there were 5 minutes of test during which the subjects were stimulated twice, at minutes 1 and 
4. Subjects were not told when the shocks were going to be given. Each shock lasts about 100 ms. At the 
end of the five minutes the dog collar was taken off the subject. 
The second stage consisted of emotional stimulation by presenting to the subjects a disturbing video 
(adapted from [15]). After 5 minutes of baseline recordings, subjects were presented a video including 
images and sounds intended to elicit emotional stress on the subjects (the video was approved by the IRB 
at The University of Connecticut). Finally, the Stroop test was applied in the same manner as in [16]. Stroop 
tests induce cognitive stress on subjects. Five minutes of baseline measurements were also recorded for the 
subject before the Stroop task took place.  
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9.2.3 Subjects 
N= 16 subjects (5 female, 11 male, age 25 ± 7.7 years old) were selected. CSA and Ag-AgCl 
electrodes were used simultaneously on every subject to collect EDA signals. Subjects were screened to 
participate in the experiment based on their answers to a preliminary questionnaire. This was a screening 
process to make sure that candidates who use drugs frequently, sweat often and easily, or have a pre-existing 
condition that puts them in harm during the experiment were excluded. Subjects were not allowed to drink, 
smoke or use any other type of drug (excluding daily prescriptions) for a 48 hour period before testing. This 
eliminated any variables that may affect the response the body has to certain stressful scenarios. Some drugs 
and daily medications have a direct correlation with skin conductance changes, hence, subjects with these 
scenarios were excluded. Any candidates that have metal implants, pacemakers, or other implants were not 
allowed to enter this study to avoid harmful effects of the electrical shock experiment. In addition to this, 
candidates with severe anxiety problems or cardiac and circulatory conditions such as chronic hypertension 
or frequent heart palpitations were excluded from this study. Also, candidates who are pregnant or have a 
past history of seizures did not meet criteria. All other subjects who completed the questionnaire were 
allowed to participate. 
9.2.4 Devices 
Data were collected using both DC- and AC-source EDA devices (N=8 for each). AC-source EDA 
measurement has been documented to be superior to DC-source measurement with respect to electrode 
polarization and also possible effects of the applied voltage on biological membranes [17]. Despite its 
known advantages compared to DC, AC has been infrequently used so far [1]. For this reason, we decided 
to compare CSA and Ag/AgCl electrodes using both types of devices.  
Two identical DC-source EDA devices were implemented to perform a fair comparison between 
the two media. Figure 9.2 shows the schematic diagram of the circuit for the DC-source EDA devices 
fabricated for this study. It is powered by a source of 3.3 volts. The current source applied a constant current 
to the subjects’ fingers through the electrodes. The signal variations on the resulting voltage were acquired 
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through a differential op-amp. Lastly, a filter was used to obtain the EDA signal. Similarly, two identical 
AC-source fully isolated galvanic skin response amplifiers with low voltage (22 mVrms, 75 Hz AC, FE116, 
ADInstruments) were employed to collect EDA signals. All EDA signals were digitized through the 
PowerLab ADC (ADInstruments), sampled at 400 Hz.  
In order to collect signals simultaneously from two different media, two pairs of fingers were 
employed: (1) middle and index, and (2) ring and little. To procure a fair comparison, fingers were 
interchanged from subject to subject, for both types of devices (for instance, CSA electrodes were placed 
on middle and index fingers on half of the subjects). 
Electrodermal activity is usually measured in conductance units, microsiemens [µS]. In our study, 
the AC-source devices provided values in µS. However, for the DC-source circuits used in this experiment, 
the raw voltage signal modulated by changes in subjects’ skin conductance was acquired [mV]. Therefore, 
instead of a conductance increasing when the subject became stressed, we obtained a voltage that decreased 
at the same rate. This is why for the DC measurements the onset is determined by a drop in magnitude (as 
shown in the left panel of Figure 9.4).  
 
 
 
  
Figure 9.2 – Schematic of circuit used for measuring EDA using DC current source. 
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9.2.5 Signal processing 
Once all data were collected, data were separated into the corresponding electrode and task. All 
EDA signals were down-sampled to a frequency of 2 Hz, which is enough to maintain all the frequency 
components of the signal (< 0.5 Hz). EDA incorporates both rapid transient events and slow shifts. Rapid 
transients, called skin conductance responses (SCRs), are elicited through startle tests like the one we 
implemented in the present study to induce physical stress (electric shocks).  The SCR rise time (onset-to-
peak time) and amplitude for both signals were measured, for further analysis and comparison.  
Amplitude is defined as the absolute value of the difference in level between the onset and the peak 
of the SCR. Rise time is the difference in time between the same two points. Onset-difference is defined as 
the time of SCR’s onset obtained using Ag/AgCl electrodes minus the time of the onset of the corresponding 
(ideally simultaneous) SCR obtained through the CSA electrodes, as a reaction to the same stimulus.  
Emotional and cognitive stress are elicited to evaluate slow shifts of the EDA signals. Signals for 
these tests were high-pass filtered to remove any low frequency trend or baseline wander (Butterworth, 
cutoff frequency = 0.01 Hz). In order to obtain a frequency domain representation of the EDA signals, the 
power spectra were calculated using Welch’s periodogram method with 50% data overlap. A Blackman 
window (128) was applied to each segment, the Fast Fourier Transform was calculated for each windowed 
segment, and the power spectra of the segments were averaged. Also, the recently-reported indices of 
sympathetic control based on frequency-domain and time-frequency domain analysis of EDA (EDASympn 
and TVSymp) were computed [18], [19]. These indices utilize the spectral power within the band of 0.045 
to 0.25 Hz. Frequency and time-frequency domain indices exhibited lower variability compared to time-
domain measures of EDA, and acceptable consistency and sensitivity to cognitive stress.  
9.2.6 Statistics 
Acquired EDA signals using CSA and Ag/AgCl electrodes were compared independently for startle 
(shocks) and tonic (disturbing video and Stroop task) tests. The resulting SCRs from the electric shocks 
were compared in terms of their amplitude, onset-to-peak time and onset-differences between simultaneous 
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recordings obtained using CSA and Ag/AgCl electrodes. T-test analysis was used to determine the 
significance of the differences in SCRs’ amplitude and onset-to-peak time values obtained with the two 
media, and to evaluate the null hypothesis that the mean of the onset-differences is equal to zero.  
EDA signals during emotional and cognitive stress, from CSA and Ag/AgCl electrodes, were 
compared on each subject by computing the Pearson’s Correlation Coefficient in time and frequency 
domain. Pearson’s correlation coefficient mean and standard deviation throughout the subjects for each test 
were calculated. Difference in values of EDASympn and TVSymp obtained for baseline and test were 
compared between CSA and Ag/AgCl electrodes by means of t-test. Also, the differences between baseline 
and test values of EDASympn and TVSymp obtained using each type of electrode were tested to see if they 
have the same power to distinguish between the two stages. The same analysis was performed for signals 
obtained with the DC and AC source devices.  
 
 
9.3 Results  
Results for electrode-skin contact measurements are presented in Figure 9.3. Ag/AgCl electrodes 
exhibited lower impedance compared to CSA electrodes for the range of frequencies of interest (4 Hz to 
200 Hz). For an example of what an individual SCR looks like right after electrical stimulation, for the two 
 
 
Figure 9.3 – Electrode-skin contact impedance measurements for CSA and Ag/AgCl EDA electrodes. 
 
 151 
 
types of electrodes using the two DC- and AC-source devices, see Figure 9.4. The vertical line is the time 
when the shock was applied. Notice in the Figure 9.4 that there is a delay of about three to five seconds 
from the actual shock time to the SCR onset. This delay time is in agreement with what has been reported 
in the literature [1], [8]. For the DC-source devices, given that we acquired the potential produced by a 
constant current to the skin, an increase in skin impedance is transduced to subsequent reduction in the 
voltage. Therefore, each time a shock occurs the voltage signal drops significantly. For the AC-source 
devices, the readings are in µS, so the shock produces an increase in subjects’ skin conductivity. Every 
shock can be recognized fairly easily. The trends are very similar and each shock is well captured by both 
types of electrodes.  
Figure 9.5 displays the results for rise time (left) and amplitude (right) correlation analysis, for DC- 
(top) and AC-source (bottom) devices. The two most commonly observed waveforms of the SCRs, the 
uniphasic and biphasic [8], were considered in the analysis. N = 13 and N = 12 SCRs were selected from 
the DC-source and AC-source data respectively, out of a total of 16 (2 shocks times 8 subjects). Unused 
shocks either saturated the SCR of one of the electrodes (in all three cases it was the Ag/AgCl) or elicited 
an SCR that was not distinguishable or was overlapped with other waves (4 times). It is worth mentioning 
 
  
Figure 9.4 – Example of SCR for Ag/AgCl (top) and CSA (bottom) electrodes. Left: DC-source (mV); 
right: AC-source (µS). 
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that many times Ag/AgCl electrodes tended to polarize with the DC-source device, making it temporarily 
impossible to measure any EDA values.  
Using the DC-source device, an overall correlation of 0.97 for the onset-to-peak time measure was 
found between the measurements performed using CSA and Ag/AgCl EDA signals. This indicates that both 
media exhibited a similar time for going from the onset to the peak on the elicited SCRs. Moreover, SCR 
amplitudes were also highly correlated between CSA and Ag/AgCl electrodes (0.93). With the AC-source 
 
 
 
Figure 9.5 – Left: correlation analysis of onset-to-peak time; right: amplitude.  Top: DC-source device; 
bottom: AC-source device.  The blue line represents the unitary slope straight line. 
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devices, the obtained correlation values were lower, 0.87 for the onset-to-peak time and 0.69 for the 
amplitude.  
Table 9.1 includes the results for DC- and AC-source EDA devices. In general, CSA electrodes 
seemed to obtain slightly lower SCR amplitudes, due to higher impedance than Ag/AgCl electrodes. 
Nevertheless, CSA electrodes appeared to capture the transit from onset to peak in a faster manner 
(somewhat lower onset-to-peak time). However, none of these differences are significant. For both 
materials the mean of the onset-differences is not statistically different from zero. 
The Stroop test elicited noticeable reactions on the subjects’ EDA, with both types of electrodes 
and devices. Figure 9.6 shows representative EDA for a subject undergoing the Stroop task. Responses to 
disturbing video were more variable, ranging from negligible reaction (common within male subjects), to 
highly noticeable reaction (noticeable in some female subjects). CSA and Ag/AgCl electrodes demonstrated 
this same trend, throughout the experiment. The frequency-domain index, EDASympn, was not 
significantly different between the two types of electrodes, for both emotional and cognitive stress. The 
index was able to distinguish the differences between baseline and test when subjects underwent cognitive 
Table 9.1 Results for comparing CSA electrodes to Ag/AgCl electrodes using DC and AC-source devices 
  DC-source devices AC-source devices 
  Electric Shocks (physical stress) 
  Ag/AgCl CSA Ag/AgCl CSA 
Onset-to-peak time (sec)  4.12 ± 3.52 3.94 ± 3.66 6.67 ± 3.56 5.82 ± 3.22 
Amplitude (mV for DC, µS for AC)  37.62 ± 53.29 29.3 ± 37.4 1.94 ± 1.09 1.66 ± 1.81 
Onset-difference (sec)  0.0026 ± 0.13 0.31 ± 0.72 
  Disturbing video 
  Baseline Emotional Stress Baseline Emotional Stress 
Time-domain correlation  0.96 ± 0.06 0.84 ± 0.23 0.6 ± 0.35 0.59 ± 0.37 
Frequency-domain correlation  0.94 ± 0.08 0.96 ± 0.05 0.64 ± 0.33 0.84 ± 0.25 
EDASympn 
Ag/AgCl 0.12 ± 0.074 0.15 ± 0.085 0.14 ± 0.09 0.15 ± 0.082 
CSA 0.26 ± 0.22 0.19 ± 0.16 0.39 ± 0.33 0.33 ± 0.29 
TVSymp Ag/AgCl 0.3 ± 0.18 0.62 ± 0.45# 0.29 ± 0.47 0.47 ± 0.44 
 CSA 0.12 ± 0.027* 0.19 ± 0.087*# 0.17 ± 0.05 0.37 ± 0.4 
  Stroop test 
  Baseline Cognitive Stress Baseline Cognitive Stress 
Time-domain correlation  0.92 ± 0.14 0.87 ± 0.14 0.63 ± 0.37 0.54 ± 0.45 
Frequency-domain correlation  0.96 ± 0.04 0.91 ± 0.14 0.73 ± 0.34 0.92 ± 0.07 
EDASympn 
Ag/AgCl 0.1 ± 0.096 0.31 ± 0.21# 0.11 ± 0.068 0.37 ± 0.23# 
CSA 0.16 ± 0.088 0.32 ± 0.14# 0.16 ± 0.14 0.38 ± 0.25# 
TVSymp Ag/AgCl 0.37 ± 0.22 0.96 ± 0.44# 0.23 ± 0.17 1.1 ± 0.78# 
 CSA 0.13 ± 0.06* 0.23 ± 0.081*# 0.18 ± 0.12 0.48 ± 0.35# 
Values are mean ± standard deviation. EDASympn: normalized spectral index of sympathetic control; TVSymp: 
time-varying index of sympathetic control. 
* represents significant differences between Ag/AgCl and CSA 
# represents significant differences between baseline and test, for the given type of electrodes. 
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stress, and as expected, was not sensitive to the elicited emotional stress. Nevertheless, high correlation, 
with low standard deviation, was found for baseline and test stages of emotional and cognitive stress tests 
(Table I).   
The time-varying spectral index, TVSymp, exhibited significant differences from baseline to 
cognitive stress, using any type of EDA electrode and device. Beyond that, it was able to detect differences 
from baseline to emotional stress with both kinds of electrodes, using the DC-source devices. When AC-
source devices were used, the index was also insensitive to emotional stress, similar to EDASympn. 
Interestingly, there are noticeable differences in the TVSymp index computed using signals from Ag/AgCl 
and CSA electrodes, when the DC-source devices were employed.  
 
 
 
 
  
Figure 9.6 – EDA measurements (µS) during baseline (before the line) and cognitive stress test (Stroop 
task), for Ag/AgCl and CSA electrodes, for a given subject. AC-source device was used for this specific 
subject. 
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9.4 Discussion 
The CSA electrode has demonstrated its ability to detect EDA dynamics similarly to Ag/AgCl 
hydrogel electrodes, using DC- and AC-source devices, in various stressful scenarios. This is in agreement 
with previous studies that showed how the CSA electrodes are suitable to detect bio potentials [10], [20]. 
Figure 9.4, Figure 9.5 and Figure 9.6 all illustrate the direct correspondences between the measurements 
for both media. The results are similar for both media. The effect of the stimulus on the subject, for both 
the CSA and Ag/AgCl electrodes, can be clearly seen in the figures. Figures show differences in the 
amplitude of the responses and in the magnitude of the baseline wander of the signals, but the differences 
are circumstantial, because the measures are simultaneous, with the electrodes placed in different fingers. 
The comparison showed no significant differences and a high correlation of the results between the two 
media. It seems that a CSA electrode should be a valid replacement when it comes to recording EDA. This 
could save a substantial amount of money for hospitals due to the infinite shelf life the CSA electrode has 
to offer [10]. The CSA electrodes can also be more economical since carbon is cheaper than silver as well 
as the cheaper fabricating and manufacturing process mentioned earlier.  
Electrode-skin impedance was higher for CSA electrodes, compared to Ag/AgCl hydrogels. The 
difference is more noticeable in the low frequency range, but is consistent throughout the frequency band 
of interest (4 to 200 Hz). Even though at very low frequencies CSA electrodes exhibited about two times 
the impedance of Ag/AgCl electrodes (600 compared to 350 Ω), those differences are reduced to less than 
100 Ω on average as the frequency increases. We noticed that such difference in electrode-skin impedance 
did not affect the measures significantly.  
Furthermore, as mentioned before, the Ag/AgCl electrodes made it impossible to collect EDA 
signals on many occasions. The signal was very noisy and in some cases, there was no signal at all. This 
was due to polarization of the electrodes, impeding the use of the electrodes for a period of time. However, 
CSA electrodes worked properly when the Ag/AgCl electrodes failed to work. Even though the use of 
sintered Ag/AgCl electrodes is the standard in order to minimize polarization of the electrode [1], [21], 
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[22], we have found it to polarize and fail many times during the development of this study. Moderate 
correlation (>0.5) values found between the two signals (Table 1), can be also explained in the eventual 
failure of Ag/AgCl electrodes to properly collect EDA signals.  
Three different types of stress were induced to verify that the electrodes worked for each type of 
stress someone may undergo. For the electric-shocks test no significant differences were found for onset-
to-peak time, amplitude, or onset-time, for any type of EDA devices. The onset differences were calculated 
by simply subtracting the values of Ag/AgCl SCR onsets from CSAs’ SCR onset times, providing a 
difference value. If this value was negative then the hydrogel electrode responded first, and vice versa. 
Once all the values were recorded the mean value was taken, providing a value of 0.0026 ± 0.13 for DC-
source devices and 0.31 ± 0.72 for AC-source devices. The mean of these onset differences are not 
significantly different from zero.  
The disturbing video induced negligible changes in participants’ stress levels, on average. The main 
characteristic that subjects reported from the emotional stress test was the subjectivity of the stress induced 
by the images, which highly varied depending on the novelty of the information, gender, cultural 
background, and other factors. For our purpose, we found high correlation between Ag/AgCl and CSA 
recordings. As expected, we found no differences in EDASympn from baseline to test during this test, for 
any type of electrodes, using either kind of device. Only TVSymp, a highly sensitive index of sympathetic 
arousal [19], exhibited significant differences from baseline as a result of the exposure to the disturbing 
video, exclusively when the DC-source devices were used. For its part, Stroop test results were in agreement 
with previous studies [18], [19]. The computed EDASympn and TVSymp indices were able to distinguish 
differences between baseline and test using both CSA and Ag/AgCl electrodes, for DC and AC source 
devices.  
Between the two media, there were significant differences only in the computed TVSymp index 
for the DC-source devices, both for emotional and for cognitive stress. This significant difference resulted 
from lower standard deviation values and greater sensitivity of the CSA electrodes with stimuli when 
compared to Ag/AgCl electrodes. 
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9.5 Conclusion 
Overall, CSA electrodes had similar readings to the Ag/AgCl electrodes. The correlation between 
the signals obtained using the two types of electrodes was moderate to very high and there were only 
significant differences in the highly sensitive time-varying index of sympathetic control. The electrodes 
worked using DC- and AC-source EDA devices, for all three different types of stress: emotional, physical, 
and cognitive. Signals were slightly more correlated in the frequency domain, compared to the time domain. 
The amplitude and onset-to-peak time testing also verified that the two electrodes were comparable to 
collect SCRs and there were no significant differences in their characteristics. In conclusion, CSA 
electrodes for collecting EDA signals are suitable surrogates of Ag/AgCl electrodes. 
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Chapter 10: Conclusions and Future Work 
10.1 Conclusions  
In this thesis we have used signal processing techniques to evaluate how EDA can contribute to 
better understanding of the dynamics of the sympathetic nervous system.  We started with introduction of 
the power spectral analysis to EDA processing, in order to develop a less variable and more sensitive index 
of sympathetic control. The EDASymp (chapter 3) index is a suitable discriminator of orthostatic, physical 
and cognitive stress, and has the potential to be used as a reliable marker of quantitative assessment of the 
sympathetic function.  It was found to be more reliable and sensitive than the LF index of HRV, consistent 
between the subjects, and exhibited a lower variability compared to the time-domain measures of EDA.  
Moreover, we established for the first time that frequency bands of the sympathetic nervous activities can 
be defined to be within 0.045-0.25 Hz based on spectral analysis of EDA.  
Subsequently, we used a time-varying approach to analyze the spectrum of EDA. We computed a 
time-varying index, TVSymp, which proved to be a suitable discriminator of the stress induced by cold 
pressor test, 70° head-up tilt (HUT) test, stand test, and Stroop task, and has the potential to be used as a 
reliable marker of quantitative assessment of the sympathetic function.  Overall, TVSymp was found to be 
more reliable and sensitive than indices based on low-frequency components of HRV (commonly used to 
assess sympathetic tone), was highly consistent between subjects, and exhibited a lower variability 
compared to the time-domain measures of EDA.  Using this time-frequency domain approach, we 
concluded that the band of frequencies between 0.08 and 0.24 Hz is the most responsive to the sympathetic 
nervous activities in healthy subjects.   
Using the analysis techniques developed in previous stages, along with others available in the 
literature (i.e. HRV and time-domain EDA), we explored the effects of sleep deprivation on the ANS. We 
collected EDA and ECG (for HRV) every two hours during a 24-hour period.  We found notable differences 
in the effects of sleep deprivation on lower (SCL) and higher frequencies (NS.SCRs, EDASymp and 
TVSymp) of EDA.  We encountered that information confined to the higher frequency components of EDA 
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relates to subjects’ level of attention or vigilance. For its part, changes on tonic SCL, exhibited a relationship 
with subjects’ reactivity.  This information can be utilized for developing tools to prevent the effects of 
prolonged wakefulness in jobs that require a high number of work hours, along with significant 
concentration to perform well, to assess and predict impaired cognitive performance. 
To better understand what happens to sympathetic and parasympathetic control under exercising 
conditions, we studied HRV and EDA in subjects undergoing increasing level of exercise.  We stablished 
that the upper band of the sympathetic dynamics shift to 0.35 to 0.4 Hz as a result of moderate to high-
intensity exercise.  Moreover, we found that the low frequency bounds derived via EDA can be good 
surrogate measures of the sympathetic dynamics especially during moderate to high-intensity exercises, 
hence, the upper bound of HRVLF needs to shift to higher frequencies.  The varying upper frequency band 
of the sympathetic dynamics needs to be taken into account to provide a better understanding of the 
functioning of the branches of autonomic nervous system especially under high-intensity physical activity. 
In the field of sensing media, our ultimate goal was to evaluate novel CSA electrodes for the task 
of recording EDA signals. In the pursuing of such goal, we deployed a comprehensive assessment of CSA 
electrodes’ performance.  CSA electrodes were used to collect several biopotential signals and the results 
were evaluated using suitable measures of signal quality.  We started with the most common application, 
the ECG.  First, we demonstrated that dry ECG electrodes can be fabricated from a mixture of carbon 
powder, salt, and visco-elastic polymeric adhesive.  All ECG morphological waveforms and HRV indices 
were found to be nearly identical to Ag/AgCl electrodes.  Moreover, based on CSA electrode’s 
characteristics we determined that they are applicable for defibrillation usage, but the main advantage is 
their infinite shelf life which lowers both supply chain handling costs and scrap costs when compared to 
Ag/AgCl electrodes since the latter have a shelf life of only a month.   
Subsequently, we carried out a quantitative comparison of CSA and Ag/AgCl electrodes for the 
task of collecting sEMG signals.  It was found that our dry CSA electrodes are comparable to the gold 
standard Ag/AgCl electrodes in that there were no significant differences in the sEMG amplitude and 
muscle activation times.  CSA electrodes were more resistant to noise and motion artifacts and delivered 
 161 
 
signals with lower spectral distortion, compared to Ag/AgCl.  The results of the current work indicate that 
CSA electrodes represent a suitable and cost-effective alternative to standard Ag/AgCl electrodes for sEMG 
signal collection.   
When comparing CSA and Ag/AgCl electrodes for collecting EDA, both media achieved similar 
results. The correlation between the signals obtained using the two types of electrodes was moderate to very 
high, and there were only significant differences in the highly sensitive time-varying index of sympathetic 
control. The electrodes worked using DC- and AC-source EDA devices, for all three tested types of stress: 
emotional, physical, and cognitive. Signals were slightly more correlated in the frequency domain, 
compared to the time domain. The amplitude and onset-to-peak time testing also verified that the two 
electrodes were comparable to collect SCRs and there were no significant differences in their 
characteristics. In conclusion for this part of the study, CSA electrodes for collecting EDA signals are 
suitable surrogates of Ag/AgCl electrodes. 
The results on evaluation and comparison of CSA electrodes to Ag/AgCl electrodes are exciting 
because the two salient disadvantages of Ag/AgCl hydrogel electrodes are not a problem for CSA: 
dehydration with storage or prolonged use, and higher cost.  Hence, CSA electrodes have the potential to 
be a viable and cost-effective alternative to standard Ag/AgCl electrodes for collecting ECG, sEMG and 
more importantly for us, EDA.   
Table 10.1 includes a list of the remarkable results, while providing some details about them.  It 
can be better interpreted when the chapters have been read, and is meant to serve as quick reference if the 
reader wants to have access to summarized information of the results without the need of searching for 
them in the specific chapter. 
10.2 Future Work 
We expect many benefits to arouse from the techniques and sensors reported in this thesis.  
However, many things need to be studied to potentiate the applicability of EDA.  For example, the effects 
of motion is a common concern for many physiological signals and have been poorly explored in the EDA 
[1]–[3].  We consider that in the near future, digital processing techniques to identify corrupted data, remove 
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the adverse effects and reconstruct the signal when possible, and determine the usability of the affected 
EDA data, are needed. 
 
 
  
Table 10.1 Summary of results. 
 
Study Remarkable results Comments 
Power spectral 
density analysis of 
EDA.  
Chapter 3. 
 Frequency bands of the sympathetic nervous 
activities on EDA signal. 
 EDASymp is a suitable discriminator of 
orthostatic, physical and cognitive stress. 
 EDASymp exhibited a lower variability compared 
to the time-domain measures of EDA 
0.045 to 0.25 Hz 
 
p < 0.05 (t-test) 
 
CV = 0.55 
Time-varying 
spectral analysis.   
Chapter 4. 
 The components of time-frequency 
decomposition most sensitive to sympathetic 
nervous activities in healthy subjects 
 TVSymp is a suitable discriminator of the stress 
induced by cold pressor, 70° head-up tilt (HUT) 
test, stand test, and Stroop task 
 TVSymp is more reliable and sensitive than HRV 
indices, was highly consistent between subjects, 
and exhibited a lower variability compared to the 
time-domain measures of EDA. 
0.08 and 0.24 Hz 
 
 
AUC = [0.8 to 0.92] 
J = [0.75 to 1.0] 
Acc = [0.88 to 1.0] 
ICC = 0.96 (0.9 0.99) 
CV = 0.67 
Exercise.   
Chapter 5. 
 Significant increase in high-frequency bound 
(Fmax) due to moderate to high-intensity exercise 
 
Dunn's test between stages (p<0.05) 
~0.35 Hz for moderate 
~0.4 for high-intensity exercise 
Sleep Deprivation. 
Chapter 6. 
 Indices accounting for higher frequencies of EDA 
exhibited more significant differences during 24-
hour sleep deprivation experiment 
 Higher frequencies of EDA relate to attention or 
vigilance 
 
 
 Lower frequencies of EDA relate to reactiveness 
Dunn's test between runs (p<0.05) 
 
 
Relation found between NSSCRs, 
EDASymp, TVSymp and 
Stroop_No_Go, Repeat_No_Go 
accuracy indices 
Relation found between SCL and 
Go_RT index 
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The deployment of indices of EDA on clinical and daily use environments require a systematical 
exploration of repeatability and robustness of the measures. High inter-subject variability of time-domain 
measures of EDA has been reported [4], [5].  Indices that account for spectral information of EDA 
(EDASymp and TVSymp) exhibited less variability and higher consistency.  We expect these novel indices 
to exhibit also lower intra-subject variability and higher consistency than time-domain EDA measures.  This 
has to be evaluated.  Repeatability, consistency and variability are important concepts for the applicability 
of the technique. 
Another potential application of EDA is to use it jointly with HRV to develop indices of autonomic 
function. For instance, as reported in chapter 5, EDA can be used to adjust the bands for spectral analysis 
of HRV under exercise.  Also, adaptive filtering approaches are able to use the information of EDA to filter 
out sympathetic content of HRV, in order to obtain a pure parasympathetic index, can be also explored.   In 
the past, we have utilized the nonlinear nature of HRV with respect to the ANS dynamics, to separate 
parasympathetic and sympathetic tones from HRV [6].  The order (i.e., linear or nonlinear) of the 
Table 10.1 Continuation 
Study Remarkable results Comments 
CSA electrodes. 
Chapters 7 through 
9. 
 All ECG morphological waveforms and HRV 
indices can be obtained using CSA electrodes, 
nearly identical to Ag/AgCl electrodes 
 CSA electrodes are applicable for defibrillation 
usage, but the main advantage is their long 
(theoretically infinite) shelf life. 
 For sEMG, amplitude and muscle activation times 
were not significantly different between CSA 
electrodes and the gold standard Ag/AgCl 
electrodes 
 Dry CSA electrodes were more resistant to noise 
and motion artifacts than Ag/AgCl, for sEMG 
signals collection. 
 EDA signals collected using CSA and Ag/AgCl, 
were similar using DC- and AC- source devices. 
 
 
 CSA electrodes for collecting EDA signals are 
suitable surrogates of Ag/AgCl electrodes. 
p > 0.05 
 
 
impedance < 2 kΩ 
Carbon instead of Ag 
No hydrogel layer 
p > 0.05 
 
 
 
SM ratio = 24.1 ± 12.1 
SN ratio = 38.3 ± 10.6 
Moderate to high correlation of EDA 
signals collected using CSA and 
Ag/AgCl, for both devices, for all 
tests. 
No significant differences on 
measures of SCRs. 
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relationship between EDA and the sympathetic tone need to be determined, for being able to successfully 
carry out studies like the adaptive filtering suggested above. 
Furthermore, the possible contributions of EDA for the assessment of sympathetic nervous system 
in clinical applications need to be explored.  The correct diagnosis of many diseases requires more sensitive 
and reliable measures of sympathetic function. An important example is the diabetic cardiovascular 
autonomic neuropathy (DCAN), which is present in at least 25% of diabetics. DCAN is a remarkable 
example of the need for sensitive measures of sympathetic tone [6], [7] because the gold standard procedure 
for sympathetic assessment in DCAN is the cardiovascular autonomic reflex tests (CARTs) [8], which has 
low sensitivity (50%) [9].  New quantitative and accessible methods for assessment of sympathetic nervous 
system are needed. Hence, the analysis techniques for assessing sympathetic control developed in this thesis 
can contribute to the diagnosis of cardiovascular diseases and conditions (like DCAN) by taking advantage 
of unique characteristics of EDA signals.  
From the sensing point of view, the most efficient way to collect EDA signals have to be 
established.  The proper sensing approach also depends on the specific application and environment to be 
used.  For example, if continuous monitoring needs to be deployed, skin irritation and signal degradation 
are the key factors.  In wearables, the fabrication process and durability of the sensor are more relevant.  
We found CSA electrodes to be a suitable surrogate of Ag/AgCl electrodes to collect EDA. These electrodes 
can theoretically be cheaper and last longer.  However, they are not reusable.  Alternatives like stainless 
steel electrodes and other carbon-based sensors have to be evaluated for the task of collecting EDA data. 
10.3 Envisioned applications 
Considering that the ability of the humans’ body to respond to a stimulus is linked to the 
sympathetic nervous system (it is also called the “fight or flight” system), we foresee the deployment of 
wearable devices as tools to assess stress of many kinds (cognitive, physical, orthostatic, etc.).  For instance, 
in the automobile industry to alert drivers when they are too tired to be driving because their bodies are 
showing low levels of responsiveness can be of an application for detection of sleep drowsiness.  We believe 
that the most promising tools are those based on EDA, because of the simplicity of the circuitry to collect 
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the signal, and the absence of parasympathetic interference.  EDA signals are already collected in some 
wearable devices (e.g. Samsung Simband, Jawbone’s UP3, Empatica’s E4, Microsoft band, Moodmetric’s 
mood ring, Sensoree’s GER mood sweater, etc.) [10], but its application is limited to functions like 
detecting if user is wearing the device or basic analysis as computing the mere conductance level.   
Based on the positive results obtained from the evaluation of CSA electrodes for ECG, sEMG and 
EDA, we consider this electrode to be a reliable alternative for many applications in the future. For point-
of-care applications, CSA electrodes can be used to collect the electrocardiogram at lower cost and higher 
quality, compared to Ag/AgCl.  All the current clinical information derived from the ECG, plus the research 
approaches of HRV can be reliable obtained using CSA electrodes. Also, these electrodes can be used to 
monitor the progression of muscular dystrophies or control muscle activities via signal processing of the 
electromyogram data.  Certainly, with the advent of sophisticated machine learning algorithms and robotics, 
rehabilitation engineering of muscles and limbs, it will be a good opportunity for more noise-resistant and 
cost-effective surface EMG electrodes than the current standard hydrogel-based electrodes. 
 
 
 
 
 
Figure 10.1 – Samsung Simband (left) and EDA data acquired during Stroop task (right).  
The vertical line represents the time when the Stroop task started.  
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Appendix A. List of Abbreviations 
 
ANS: autonomic nervous system 
CSA: Carbon/Salt/Adhesive 
ECG: Electrocardiogram 
EDA: Electrodermal Activity 
EDASymp: electrodermal activity index of sympathetic nervous system 
HRV: heart rate variability 
HRVLF: low frequency component of heart rate variability 
HRVHF: high frequency component of heart rate variability 
NSSCRs: non-specific skin conductance responses 
PSD: power spectral density 
SCL: skin conductance level 
sEMG: surface electromyography 
SM ratio: Signal-to-motion ratio 
SN ratio: Signal-to-noise ratio 
RT: reaction time 
TFS: time-frequency spectrum 
TVSymp: time-varying EDA index of sympathetic control 
VFCDM: variable frequency complex demodulation 
 
 
